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Abstract 
 
Abstract 
Deoxyribonucleic acid (DNA) is the fundamental basis of virtually all living organisms. 
The central dogma in molecular biology refers to DNA as the carrier of the genetic information 
that is first being transcribed into ribonucleic acids (RNA) and further translated into proteins. 
This dogma has been refined, as nucleic acids were also discovered to act as structural and 
regulatory components within cells. In recent years, the new research field DNA 
nanotechnology emerged, in which DNA is used as a molecular building block, whose 
predictable base pairing allows the fabrication of self-assembled two- and three dimensional 
(2D and 3D) DNA nanostructures, which moreover can be spatially functionalized with a broad 
range of biomolecules on the nanometer scale. This unique feature as well as its versatility, 
biodegradability and low toxicity has led to great interest for various applications in a wide 
range of areas. Moreover, the design of DNA-based biomimetic systems has emerged as a 
valuable tool for systematically exploring the complexity of cells, which is also at the center of 
the work shown here. 
In the course of this work, short functional peptides were covalently attached to wire-
frame DNA nanostructures as well as simple three-arm branched DNA junctions and double-
stranded (ds) DNA. In a first approach, DNA tetrahedra and DNA trimers were covalently 
coupled to cell-penetrating peptides (CPP), which mediated a more efficient cellular uptake. 
Thus, it can be assumed that CPP retain their function, even when they are covalently attached 
to DNA, which was one of the main questions within this thesis. 
The second approach, comprising the main part of this dissertation, focused on the 
generation and in vitro characterization of the impact of synthetic actin crosslinkers on both 
reconstituted actin networks and cells. The precise regulation of structural and, thus, 
mechanical properties of living cells is essential for functionalities such as motility, stability and 
shape. These properties are mainly attributed to the cytoskeleton, whose main constituents 
are semiflexible actin filaments as well as numerous actin-binding proteins (ABP), which 
organize the filaments into a variety of higher order structures, e.g. networks and bundles. ABP 
that form transient, physical crosslinks between filaments, due to their empirical nature and 
complexity, do not allow straightforward, systemic studies in which different key parameters 
can be altered independently. To overcome this limitation, naturally occurring actin crosslinkers 
such as α-actinin and fascin were mimicked by synthetically fabricated crosslinkers based on 
DNA and peptides. These were generated through the covalent attachment of actin-binding 
peptides on both sides of a double-stranded DNA spacer and thus solely differed in their affinity 
towards filamentous actin. Bulk shear rheology experiments on reconstituted actin networks 
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revealed that both, the weakly-binding LifeAct® crosslinker (wLX) and the strongly-binding 
Phalloidin crosslinker (sPX) generated the same characteristic mechanical fingerprint as the 
natural crosslinkers α-actinin and fascin, respectively. Moreover, they showed a concentration-
dependent impact on different structural morphologies of actin networks as well as an inhibition 
of actin polymerization.  
Interestingly, these synthetic crosslinkers also interfered with intracellular systems, as 
crosslinker-treated cells showed several altered behaviors. Actin remodeling dynamics, as well 
as migration and invasion were reduced, whereas proliferation and apoptosis rates were not 
affected. Additionally, synthetic crosslinkers possibly impact the process of epithelial-
mesenchymal transition (EMT), in which cells lose their epithelial properties and become 
transformed into cells with enhanced motile and invasive functions. This process comprises 
complex signal transduction pathways, which also depend upon the polymerization and 
depolymerization status of actin. A typical signature of EMT, the formation of actin criss-cross 
stress fibers, was suppressed in wLX-treated, EMT-induced cells, which could also be 
correlated to results of advanced cell mechanical measurements. However, the exact 
mechanism of how synthetic crosslinkers affect cellular functions still remains unclear. Further 
investigations are required to reveal the underlying cause, and furthermore whether they 
suppress EMT, in which case they could become a potential candidate for the treatment of, for 
instance, ocular fibrosis. 
 
Kurzzusammenfassung 
 
Kurzzusammenfassung 
Die Desoxyribonukleinsäure (DNA) stellt die fundamentale Grundlage praktisch aller 
lebenden Organismen dar. Das zentrale Dogma der Molekularbiologie bezieht sich auf DNA 
als Träger der genetischen Information, die zunächst in Ribonukleinsäuren (RNA) transkribiert 
und anschließend in Proteine translatiert wird. Da Nukleinsäuren ebenfalls als strukturelle und 
regulatorische Komponenten innerhalb von Zellen wirken, wurde dieses Dogma überdacht. So 
entstand in den letzten Jahren das neue Forschungsfeld „DNA-Nanotechnologie“, welches 
DNA als molekularen Baustein nutzt. Die vorhersehbare Basenpaarung ermöglicht die 
Herstellung selbstorganisierter zwei- und dreidimensionaler (2D und 3D) Nanostrukturen, 
welche zusätzlich mit einer Vielzahl verschiedener Biomoleküle im Nanometer-Maßstab 
funktionalisiert werden können. Auf Grund dieser einzigartigen Eigenschaft sowie der 
Vielseitigkeit, geringen Toxizität und biologischen Abbaubarkeit, fanden DNA-Strukturen 
verschiedene Anwendungen in einer Vielzahl von Bereichen. Darüber hinaus hat sich das 
Design DNA-basierter, biomimetischer Systeme als ein wertvolles Instrument zur 
systematischen Erforschung der Komplexität von Zellen erwiesen, welches ebenfalls im 
Mittelpunkt der hier gezeigten Arbeit steht. 
Im Rahmen dieser Arbeit wurden kurze funktionelle Peptide kovalent an DNA-
Nanostrukturen gebunden. In einem ersten Ansatz wurden DNA-Tetraeder und DNA-Trimere 
kovalent an zellpenetrierende Peptide (CPP) gekoppelt, welche eine effizientere zelluläre 
Aufnahme vermittelten. 
Der zweite Ansatz, welcher den Großteil dieser Dissertation umfasst, konzentrierte sich 
auf die Generierung und in vitro-Charakterisierung des Einflusses synthetischer Aktin-
Crosslinker sowohl auf rekonstituierte Aktinnetzwerke als auch auf Zellen. Die genaue 
Regulation struktureller und dadurch mechanischer Eigenschaften lebender Zellen ist 
essentiell für Funktionalitäten wie Motilität, Stabilität und Form. Diese Eigenschaften werden 
hauptsächlich dem Zytoskelett zugeschrieben, dessen Hauptbestandteile semiflexible 
Aktinfilamente sowie zahlreiche Aktin-bindende Proteine (ABP) sind, welche die Filamente in 
eine Vielzahl von Strukturen höherer Ordnung, wie z.B. Netzwerke oder Bündel, organisieren. 
ABP, die transiente, physikalische Vernetzungen zwischen Filamenten bilden, erlauben 
aufgrund ihrer empirischen Natur und Komplexität keine direkten systemischen Studien, in 
denen verschiedene Schlüsselparameter unabhängig voneinander verändert werden können. 
Um diese Einschränkung zu überwinden, wurden natürlich vorkommende Aktin-Crosslinker, 
wie α-Actinin und Fascin, durch DNA- und Peptid-basierte, synthetisch hergestellte Crosslinker 
nachgeahmt. Diese wurden durch die kovalente Bindung Aktin-bindender Peptide an beiden 
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Seiten eines doppelsträngigen DNA-Spacers erzeugt und unterschieden sich daher nur in ihrer 
Affinität gegenüber filamentösem Aktin. Rheologische Untersuchungen rekonstituierter Aktin-
Netzwerke zeigten, dass sowohl der schwach bindende LifeAct®-Crosslinker (wLX) als auch 
der stark bindende Phalloidin-Crosslinker (sPX) den gleichen charakteristischen 
mechanischen Fingerabdruck wie die natürlichen Crosslinker α-Actinin bzw. Fascin erzeugen. 
Darüber hinaus zeigten sie einen konzentrationsabhängigen Einfluss auf Struktur-
morphologien von Aktin-Netzwerken sowie eine Hemmung der Aktin-Polymerisation. 
Interessanterweise interferierten synthetische Crosslinker ebenfalls mit intrazellulären 
Systemen und es zeigte sich, dass Crosslinker-behandelte Zellen einige veränderte 
Verhaltensweisen aufwiesen. Sowohl die Aktin-Remodellierungsdynamik als auch die 
Migration und Invasion waren reduziert, während Proliferations- und Apoptoseraten nicht 
beeinflusst wurden. Darüber hinaus beeinflussen synthetische Crosslinker möglicherweise 
den Prozess des epithelial-mesenchymalen Übergangs (EMT), wobei Zellen ihre epithelialen 
Eigenschaften verlieren und in Zellen mit mesenchymalen Charakteristika, u.a. einer erhöhten 
Invasivität, transformiert werden. Dieser Prozess umfasst komplexe Signaltransduktionswege, 
die von der Polymerisations- und Depolymerisationsdynamik von Aktin abhängen. EMT-
induzierte Zellen, welche vorab mit wLX behandelt wurden, unterdrückten die Bildung 
charakteristischer Stressfasern, welche ein typisches Merkmal von EMT darstellen. Dies 
korrelierte zusätzlich mit Ergebnissen durchgeführter zellmechanischer Untersuchungen. Mit 
welchem Mechanismus die synthetischen Crosslinker zelluläre Funktionen beeinflussen, bleibt 
jedoch unklar. Um die zugrundeliegende Ursachen aufzudecken, sind fortführende 
Untersuchungen erforderlich. Dies umfasst ebenfalls eine potentielle Inhibierung von EMT, in 
welchem Fall synthetische Crosslinker zukünftig möglicherweise für die Behandlung von 
Fibrosen, z.B. im Auge, eingesetzt werden könnten. 
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and chemical symbols as well as formulas (e.g. NaCl), the abbreviations listed below are 
used throughout this thesis. 
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1 Introduction  
Cells constitute the fundamental structural, functional and biological building block of all 
living organisms. They are intrinsically complex and represent a collection of multiple 
subsystems. In order to understand their complex behavior, it is necessary to break them down 
into their individual components. This can be accomplished by the usage of very minimal, 
in vitro systems, which lack the overcrowded environment of the inner of a cell as well as the 
tendency to biochemically interact with other cellular systems. Even minor changes to a single 
protein component within one of these systems, for instance a point mutation in the genome, 
can cause severe diseases. To unravel the impact of such disorders from the level of their 
basic molecular interactions, reconstituted systems can be utilized. As an example, a point 
mutation in the actin-binding domain (ABD) of the α-actinin 4 gene (ACTN4) causes a form of 
kidney damage known as focal segmental glomerulosclerosis (FSGS). Ehrlicher et al. found 
that this point mutation led to an increased affinity of the crosslinker α-actinin to actin, which in 
turn resulted in a slowed down intracellular dynamics. By using reconstituted systems, they 
speculated that this mutation caused cellular structures to become excessively solid, which in 
turn caused the failure of the filtration barrier in kidney1. Many more diseases are caused by 
the change of single nucleotide bases in the genome, for instance sickle cell disease2 or 
cardiomyopathy3. Studying these cases often requires genetic engineering of model cell and 
animal models, which is usually tricky and time consuming. As an alternative, nanoscale 
fabrication of biomimetic components can be utilized, in order to create rudimentary model 
systems that mimic their natural, biological counterparts. 
The underlying materials and tools for fabricating these components need to fulfill several 
requirements: First, they must provide the ability to synthesize components on the size scale 
of proteins, second, they should be completely molecular modular to enable the systematic 
integration of bio-interactive functional components, and third, the components must be able 
to interact with the targeted biological system or behave like their biological counterpart. DNA 
and other nucleotide materials fulfill these requirements because of their programmable 
structural properties. DNA is a polymer, whose length can be controllably scaled at a resolution 
of 3.4 Å, since this is the distance between single nucleotide bases4 within the well-known 
double-stranded structure of its most commonly found B-form. Nature already uses nucleic 
acids for structural reasons, for example as ribozymes, which are ribonucleic acid (RNA) 
molecules that catalyze specific biochemical reactions similar to enzymes; non-coding RNAs, 
whose structural features are for instance important during translation; or G-quadruplexes, 
which are present at the end of chromosomes (telomeres) and therefore may be involved in 
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maintaining chromosome stability5. The discovery of nucleic acid structures that also act as 
structural molecules has led to a rethinking of the central dogma of molecular biology, in which 
the primary function of DNA is considered to be the carrier of the genetic information of virtually 
all living organisms that is transcribed into RNA followed by the translation into proteins. 
One of the pioneers of this rethinking is the protein crystallographer Nedrian Seeman. In 
1982, he had the idea to look at DNA from a different perspective from the usual dogma, i.e. 
using DNA as a programmable molecular building block to create two-dimensional (2D) and 
three-dimensional (3D) structures. This laid the foundation of the new research field of DNA 
nanotechnology6. He focused on the ability of DNA to hybridize via the Watson-Crick base 
pairing7 with a complementary DNA strand in a predictable manner to form double-
stranded (ds) DNA. Moreover, inspired by a branched nucleic acid structure known as the 
Holliday junction that for instance occurs during genetic recombination in cells, he considered 
DNA motifs, consisting of more than two strands that hybridize into branched, multi-arm 
junctions. These junctions can link with other branched junctions to form lattices or even more 
complex 3D architectures via the hybridization of “sticky ends”, which are short overhangs of 
single-stranded (ss) DNA6. During the following years, several types of self-assembled 2D and 
3D structures, including covalently-closed wire-frame structures or extended lattices with 
nanometer-sized features, which were achieved through the introduction of crossovers 
between DNA double strands, have been designed and fabricated8–15. In 2005, Goodman et al. 
presented a wire-frame structure, a DNA tetrahedron16, which, due to its simple design, high 
production yield, fast assembly time and optimal size to encapsulate proteins17, has formed 
the basis for a number of subsequent studies18. 
In the diverse and fast-growing field of DNA nanotechnology19, several techniques, such 
as “DNA origami”20, “DNA bricks”21 or “tile-based self-asssembly”22 emerged to create DNA 
nanostructures of different geometries, shapes and rigidities. The last named technique for 
instance was recently utilized to generate DNA nanotubes with programmable diameters, as 
depicted in Figure 1. This is a great example of how DNA structures can be applied to mimic 
subcellular systems, in this case semi-rigid biopolymers such as microtubules, intermediate 
filaments, keratin or actin, which are found in cells and tissues. Whereas the underlying 
structural parameters of these natural biopolymers cannot be controllably altered, DNA 
nanotubes can be precisely tuned with regard to their filament stiffness, which makes them a 
useful tool to study the impact of the persistence length on macroscopic bulk structures of such 
biopolymers. This study revealed that the underlying stiffness of the filaments has a far greater 
impact on bulk network stiffness than had been previously assumed through commonly 
accepted models23,24. Moreover, this DNA-enabled biomimetic strategy has also been used to 
study active systems containing molecular motors25. 
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Figure 1│AFM image of an Eight-helix tube (8HT) network formed at 4 μM. A major limitation of 
structural biopolymers in cells and tissues is that the persistence length cannot be freely tuned to study 
its impact on macroscopic bulk structures. This limitation was resolved by employing structurally 
programmable DNA nanotubes, enabling controlled alteration of the filament stiffness23,24. DNA 
nanotubes (8HT) were imaged via atomic force microscopy (AFM) in air, as described in 4.30.2. Scale 
bar was set to 1 µm. 
 
Besides supplying the underlying structure, DNA nanostructures can be used to position 
single biomolecules or nanoparticles with nanometer precision, in order to additionally provide 
the structure with certain functions. Due to this important feature, as well as its biocompatibility, 
extremely specific base pairing and stability, DNA structures have been applied in research 
fields such as molecular electronics26, plasmonics27, biochemistry28,29 and medicine18,30. 
Comparable to how viruses interact with a host cell, via receptor-ligand interaction, 
functionalized DNA nanostructures interact on the nanometer scale. Schüller et al., for 
instance, precisely decorated the outer surface of DNA origami tubes with cytosine-phosphate-
guanine (CpG)-sequences, which are highly indicative of bacteria DNA and recognized by the 
Toll-like receptor 9 (TLR9) in endosomes, to induce a TLR9-specific immune response in cells. 
They found that CpG-bound DNA origami tubes caused a five-fold increased immune response 
compared to free CpGs, which underlines the potency of spatially localizing bio-active 
molecules onto functionalized DNA nanostructures31. Additionally, smaller and simpler DNA 
structures have been functionalized with biomolecules or particles for various applications 
(2.1).  
As protein-receptor stimulation often targets only small interaction regions, these specific 
binding sites can often be isolated as short peptides, which can also bind and activate the 
considered target, although in most cases with less potency. These peptides have some 
advantages over their native protein counterparts, since they are short and scalably 
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synthesizable with various chemical modifications (e.g. functional conjugation groups) of 
choice. This makes them suitable candidates to add specific biological functions to DNA 
structures which in turn are then usable in many applications. 
With regard to this dissertation, different peptides carrying specific chemical 
modifications were covalently attached to wire-frame DNA structures, three-arm junction 
structures or simple ds DNA spacers in order to create biomimetic constructs on the size scale 
of proteins. These constructs were then tested on minimal, reconstituted systems as a way to 
determine how different parameters, e.g. binding affinity, globally affect living cellular systems. 
In one subproject, the uptake efficacy of DNA tetrahedra into cells was found to be increased 
with the addition of cell-penetrating peptides (CPP), whereas in another subproject, synthetic, 
DNA-peptide structures that mimic crosslinking proteins of the cellular biopolymer actin were 
generated to modulate the properties and dynamics of actin networks. For both projects, it was 
of great interest to test whether the attached functional materials stay intact and retain their 
function even when covalently affixed to DNA. Particularly for the second subproject, two 
fundamental questions came up: First, do these biomimetic constructs have an impact on 
reconstituted systems, i.e. can these minimal systems, which are not as overcrowded as the 
intracellular environment, be tuned with these functionalized DNA structures? Second, do they 
have the capability to function on specific systems within cells? The following section 
introduces the utilized DNA nanostructures as well as strategies to functionalize them. 
Moreover, peptides as well as the corresponding cellular system they interact with are 
presented in more detail. 
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2 Theoretical Background 
2.1 DNA tetrahedron 
DNA is a powerful building block which allows the programmed self-assembly of 
molecular scaffolds, cages and multifunctional carriers with nanoscale dimensions by the 
nature of predictable base pairing. DNA nanostructures offer multiple binding sites for a wide 
variety of biomolecular compounds and allow programmable features such as conformational 
changes triggered by receptor-ligand interactions. Due to the fact that each point in the 
structure is equally addressable, DNA nanotechnology represents a smart technique for the 
nanometer scale arrangement of molecules on 2D or 3D structures. One of the simplest and 
most rigid DNA system that allows variations in spacing, orientation and local stoichiometry is 
the DNA tetrahedron16. This molecule consists of four oligonucleotides, 63 nt each, which run 
around one face and hybridize to form a wire-frame tetrahedron with double-stranded edges 
of ~ 7 nanometers (Figure 2). The single-step self-assembly of DNA tetrahedra is achieved by 
mixing these four partially complementary oligonucleotides in equimolar quantities in 1X TM 
buffer, followed by a temperature-based annealing from 95 °C to 4 °C within a few minutes. 
 
 
Figure 2│Temperature-based self-assembly of DNA tetrahedra. Four partially complementary 
oligonucleotides (63 nt each,) identified by color, are mixed in equimolar amounts in 1X TM buffer (4.3) 
and self-assembled to a wire-frame tetrahedron with double-stranded edges of ~ 7 nm by heating up to 
95 °C for 2 min followed by a rapid cooling to 4 °C16. 
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Originally, four of the six edges of the DNA tetrahedron contain nicks, i.e. breaks in the 
ds DNA backbone, where the 5´and the 3´end of each sequence meet after looping around 
one face of the structure16. Each of these gaps allows the attachment of functional molecules, 
either on the 3´or the 5´end of each individual DNA strand. In this work, DNA sequences were 
designed to result in DNA tetrahedra with one gap in one plane and three gaps in an opposite 
plane, whereby the local stoichiometry of attached peptides could be increased. So far, 
tetrahedral DNA structures have been used in various applications, for instance tetrahedron-
based microarrays32, for siRNA delivery33, for protein encapsulation17,34, as molecular beacon 
to detect tumor-related mRNA35 or for drug delivery36,37. 
Previous studies have shown that DNA nanostructures fuse with the cellular membrane 
and enter the cell via endocytosis, presumably via caveolae-mediated endocytosis. Moreover, 
DNA nanostructures end up in lysosomes as they were observed to co-localize with lysosomal 
markers38. However their uptake might be not as effective since negatively charged DNA 
structures are electrostatically repulsed from negatively charged cell membrane. In order to 
increase the cellular uptake without the usage of transfection agents, which are toxic at high 
concentrations, so-called cell-penetrating peptides (CPP, 2.3) were covalently attached to the 
DNA tetrahedra and DNA trimers in the work presented here. In the following, different 
methods to chemically conjugate peptides to DNA strands are introduced. 
2.2 Functionalization of DNA and corresponding conjugation approaches 
In order to add function to DNA structures (covalent conjugation of e.g. peptides), several 
conjugation approaches were tested and are described in the following. 
2.2.1 Terminal deoxynucleotide transferase (TdT) reaction 
The enzyme terminal deoxynucleotide transferase (TdT) is a specialized polymerase 
which catalyzes the template independent addition of (modified) nucleotides to the 3´ hydroxyl 
end of ss or ds DNA. During the reaction, the free hydroxyl group on the C3 atom of the  
2-deoxyribose reacts with the α-phosphate of the aminoallyl-dUTP. This leads to the cleavage 
of the phosphoanhydride bond and the release of pyrophosphate (PPi). Through the addition 
of desoxy-UTP to the 3´end of the DNA a new hydroxyl group is available and the enzyme can 
add another dUTP. This results in a tailing of DNA with dUTP molecules in dependence on the 
molar excess of dUTP compared to free 3´ DNA strands (Figure 3). In this work, TdT was 
utilized to add a tail of NHS ester reactive aminoallyl-dUTPs, which were finally covalently 
conjugated to peptides via heterobifunctional linkers (4.25). 
Theoretical Background 
 
7 
 
 
Figure 3│Mechanism of TdT reaction using aminoallyl-dUTP. Depending on the molar ratio of free 
3´-ends of DNA strands to aminoallyl-dUTP molecules, the enzyme attaches a tail of dUTPs (n+n). 
 
2.2.2 NHS ester chemistry 
N-hydroxysuccinimide (NHS) esters react with primary amines (- NH2) in amine-free 
buffers within physiologic to slightly alkaline milieu (pH 7 - 9). NHS is released and a stable 
amide bond between two conjugated molecules is formed (Figure 4). For all conjugation 
approaches, NHS ester-containing linker molecules were utilized. Therefore, DNA was either 
amine-modified via TdT as described in 2.2.1 or purchased with single 5´ NH2-modification. 
 
Theoretical Background 
 
8 
 
 
Figure 4│Amine-reactive NHS esters. The primary amine of molecule R2 reacts with NHS ester-
conjugated molecule R1 under the formation of a stable amide bond and the release of NHS. Arrows 
indicate the reaction mechanism. Molecules involved in the reaction are shown with their free electrons. 
 
2.2.3 Maleimide chemistry 
Maleimides specifically react with sulfhydryl groups (- SH) in a pH range of 6.5 – 7.5 and 
form stable thioether bonds (Figure 5). In order to covalently couple cysteine-containing 
proteins or peptides to maleimides, disulfide bonds have to be reduced to free thiols. Most 
reducing agents, such as DTT and β-mercaptoethanol, are thiol-containing compounds and 
need to be excluded from maleimide reaction buffers since they would otherwise compete for 
coupling sites. Alternatively, TCEP that does not contain thiol groups can be used to reduce 
disulfides (Figure 18). In this work, thiol-reactive maleimides were utilized in form of sulfo-
SMCC to covalently couple cysteine-containing peptides to DNA structures. 
 
 
Figure 5│Sulfhydryl-reactive maleimides. Sulfhydryl group of molecule R2 reacts with maleimide-
conjugated molecule R1 and forms a stable thioether bond. Arrows indicate the reaction mechanism. 
Molecules involved in the reaction are shown with their free electrons. 
 
2.2.4 Strain-promoted alkyne-azide cycloaddition (SPAAC) 
The strain-promoted alkyne-azide cycloaddition (SPAAC), also known as copper-free 
click chemistry, is a bioorthogonal reaction of a thermostable cyclooctyne with an azide building 
a triazole. The reaction was first developed by Bertozzi et al. in 200439 and the reaction 
mechanism is shown in Figure 6. However, their work was based on the work by 
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Sharpless et al.40 who invented a modified version of the Huisgen cycloaddition, which 
specifically describes the 1,3 – dipolar cycloaddition between an azide and an alkyne under 
the formation of a triazole but which generally does not run readily under mild, physiological 
conditions. In order to easily proceed the reaction at neutral pH, room temperature and in 
aqueous solution, Sharpless et al. added copper(I) as a catalyst, which gave the reaction the 
name “copper-catalyzed alkyne-azide cycloaddition” (CuAAC, copper-catalyzed click 
chemistry). Since copper is strongly cytotoxic, Bertozzi et al. developed the copper-free click 
chemistry, which runs quickly under physiological conditions, does not require the catalyst and 
thus can be applied in living systems without cellular toxicity41,42. Since SPAAC is a quick 
reaction that results in high yields, peptides of interest were, if possible, purchased with a  
N-terminal N3 group. 
 
 
Figure 6│Reaction mechanism of SPAAC. Strained alkyne (e.g. DBCO) reacts with an azide in a 
covalent manner forming a triazole. Due to the angle distortion of the cyclooctyne, the reaction is sped 
up and does not require a catalyst. Most cyclooctynes react to form regioisomeric mixtures. Arrows 
indicate the reaction mechanism. 
 
2.3 Cell-penetrating peptides (CPP) 
The delivery of bioactive molecules or drugs into cells is an intensively studied research 
field. Since these molecules are often either too big to passively diffuse through the membrane 
or are repulsed due to their charge or polarity, they need a carrier in order to internalize into 
cells. In recent years, different approaches such as electroporation, encapsulation into 
liposomes, viral transfection vectors or microinjection were developed. However, these 
methods often show limitations such as insufficient efficacies or high cytotoxic effects. 
Over the past 20 years, so-called cell-penetrating peptides (CPP) have been intensively 
studied. These peptides are generally short (i.e. up to 40 amino acids) and show the ability to 
transport cargos of different size and charge into different cell types, without a high cytotoxicity. 
Previous studies describe the internalization of different cargos such as proteins43, antisense 
oligonucleotides44, liposomes45 and nanoparticles46 with the help of CPP. The most popular 
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representative CPP are Tat(48-60)47, a short fragment of the HIV 1 TAT transactivation factor 
that was discovered by Frankel et al. in 1988 to show the ability to internalize into cells48 and 
Penetratin, a short fragment of helix 3 (43-58) of the transcription factor antennapedia (Antp) 
homeodomain from Drosophila49. Other important CPP are V2250, Transportan51 and 
Polyarginin52. An overview about the classification of CPP is shown in Table 1. 
 
 
Table 1│Classification of cell-penetrating peptides. CPP are classified by origin or chemical 
properties53. 
By origin  Examples for CPP 
Natural 
Sequence derived/truncated from 
natural protein sequence (protein 
transduction domain) 
TAT, Penetatrin 
Synthetic 
Sequence developed by theoretical 
considerations 
Polyarginine (e.g. R9) 
Chimeric 
Fusion peptides of natural and synthetic 
sequences 
Transportan 
By chemical 
properties 
 Examples for CPP 
Cationic 
At least 8 positive charges, less anionic 
amino acid residues 
Tat, Polyarginine (e.g. R9) 
Amphiphatic 
Both, hydrophobic and hydrophilic 
amino acid residues 
Transportan (primary amphi-
phatic through primary structure) 
and Penetratin (secondary 
amphiphatic through secondary 
structure) 
Hydrophobic Hydrophobic amino acid residues Signal sequence of integrin β 
 
 
Henriques et al. described that antimicrobial peptides, due to their cationic and 
amphiphilic properties, act similarly to cell-penetrating peptides54. These cationic antimicrobial 
peptides (CAMPs) are able to inactivate bacterial or viral pathogens through permeabilization 
of their membranes. Fragments of the CAMP cathelicidin (CAP18)55 were investigated for their 
antimicrobial activity and highly cationic sequences (residues 106 - 125, short C18) were 
identified. This C-terminal region featured an amphipathic alpha-helical conformation that 
might be responsible for antimicrobial activity56. Additionally, it was shown that these cationic 
alpha-helical antimicrobial peptides can be a useful tool for gene delivery57. A shortened 
version of C18, named sC18 (corresponding to residues 106 - 121 of CAP18) that was first 
reported by Neundorf et al. in 200958, was utilized in the work presented here to increase the 
internalization efficacy of DNA tetrahedra and DNA trimers. 
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sC18 consists of 16 amino acid residues (GLRKRLRKFRNKIKEK, Table 5) and belongs 
to the group of amphipathic CPP58. The peptide has nine positively and one negatively charged 
residues and a theoretical pI of 12.02 (calculated with ProtParamTool (4.12)). Thus, under 
physiological conditions it is highly positively charged. As most other CPP, sC18 was also 
described to internalize into cells via endocytosis58, which describes the process of active 
uptake of molecules into cells by invaginating regions of the plasma membrane. 
Two mechanisms of endocytosis exist: phagocytosis and pinocytosis. During 
phagocytosis (“cell eating”), macromolecules, cell debris or even whole bacteria are up taken 
by specialized cells, including macrophages, monocytes and neutrophils. In contrast, 
pinocytosis (“cell drinking”) involves the invagination of fluids or smaller particles and is carried 
out by most cell types59. Conner et al. classified the different types of pinocytosis as depicted 
in Figure 7: macropinocytosis59–62, clathrin-mediated endocytosis (CME)60,63,64, caveolae-
mediated endocytosis65–70, and clathrin- and caveolae-independent endocytosis71. The 
intracellular fate of internalized compounds strongly depends on the previously mentioned 
pathways used. Most common fates after internalization into cells are degradation in 
lysosomes, recycling back to the plasma membrane as well as trafficking to organelles like the 
Golgi apparatus or translocation into the cytosol60. 
In order to investigate the mechanism of the endocytotic uptake of sC18 in more detail, 
Neundorf et al. conducted co-localization studies of carboxyfluorescein-labeled sC18 with 
transferrin-TexasRed, a marker for clathrin-mediated endocytosis. They found, at least for 
HeLa and MCF-7 cells, a co-localization of the peptide and the marker within some vesicles, 
which indicates a cellular uptake of sC18 by CME. Most of sC18 does not escape from 
endosomes, as no translocation into the cytosol was seen at 37 °C. Rather this CPP ends up 
in lysosomes that contain acidic hydrolases as well as other enzymes, where it is digested58. 
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Figure 7│Endocytotic pathways. Phagocytosis describes the uptake of larger molecules, cell debris 
or even whole bacteria, whereas during pinocytosis fluids or smaller molecules are uptaken. The 
subtypes of pinocytosis, classified by Conner et al.59 are shortly described in the following. 
Macropinocytosis59–62: Macropinocytosis displays the most effective way to internalize large amounts 
of extracellular fluid. Large membrane protrusions are formed in an actin-driven process which further 
collapse onto and fuse with the plasma membrane to build large endocytic vesicles, called 
macropinosomes. The fate of macropinosomes is cell specific. Clathrin-mediated endocytosis 
(CME)60,63,64: Clathrin forms triskelions, that assemble into basket-like lattices and induces the 
deformation of the plasma membrane into clathrin-coated pits on the cytoplasmic side of the membrane. 
The binding of a GTPase, called dynamin, mediates the fission of the membrane and the formation of 
vesicles. Clathrin-coated vesicles become uncoated and fuse with early endosomes, which are slightly 
acidic (pH 6). Early endosomes are able to mature into late endosomes, which have a pH below 6. 
These fuse with lysosomal vesicles of pH 5 that contain acidic hydrolases as well as other enzymes, 
which are responsible for the degradation of endocytozed molecules. Caveolae-mediated 
endocytosis65–70: Caveolae are cholesterol- and sphingolipid-rich bulb-shaped invaginations of the 
plasma membrane, which are formed by caveolin. Similar to CME, binding of dynamin causes the 
invagination of the plasma membrane and vesicles are subsequently pinched off. The intracellular 
pathway of vesicles is probably similar to what was previously reported for CME. Clathrin- and 
caveolae-independent endocytosis71: Some of their uptake pathways are constitutive, whereas others 
are triggered by specific signals. They also differ in their mechanisms and kinetics of formation, 
associated molecular machinery and cargo destination. Illustration redrawn from Mayor & Pagano 
(2007)71 and Holm (2011)72. 
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2.4 The actin cytoskeleton 
All eukaryotic cells exhibit a cytoskeleton, which is responsible for a variety of tasks. It is 
responsible for three broad and important functions: it spatially organizes the contents of the 
cell, it connects the cell physically and biochemically to the external environment, and it 
generates coordinated forces that enable the cell to move, change their shape and to provide 
a certain mechanical stability. These processes depend on an interconnected network of 
filamentous polymers and regulatory proteins, which are the constituents of the cell´s 
cytoskeleton73. Its three main components are microtubules, which for instance are responsible 
for separating chromosomes and long-range transport of large particles, intermediate filaments 
that function as intracellular ligaments and tendons as they primarily fulfill structural tasks, and 
actin filaments, which provide the mechanical structure and motility of a cell74,75. In the 
following, the major component, i.e. the actin cytoskeleton, will be explained in more detail with 
focus on the process of actin polymerization and depolymerization as well as on diverse actin-
based structures with distinct architectures that assemble during migration of cells. 
Actin is an ATP-binding protein with a molecular mass of ~42 kDa that is present in cells 
either as monomers (called G-actin or globular actin) or as filaments (known as F-actin, 
filamentous actin or microfilaments). Actin filaments are long helical polymers that assemble 
by the reversible endwise polymerization of monomers, thereby ATP is hydrolyzed to ADP and 
inorganic phosphate (Pi) is released. As the two ends of each filament have distinct 
biochemical properties, actin filaments are polar. The fast-growing end, where polymerization 
primarily occurs, is called the barbed end (plus end), whereas the slower-growing end is 
designated the pointed end (minus end). G-actin polymerization and F-actin depolymerization 
are under tight control by monomer- and filament-binding proteins that regulate the monomer 
pool, orchestrate the formation of filaments, organize filaments into arrays, and depolymerize 
filaments for monomer recycling, which is an important feature of actin dynamics76. Actin 
filaments are organized into bundles and networks by a variety of crosslinking proteins. The 
resulting filament length as well as the type of crosslink strongly determines the mechanical 
properties of the whole structure.  
All cells contain an actin cortex, which is a dense network of filamentous actin that is 
located just beneath the plasma membrane. These filaments are generally oriented with their 
barbed ends facing toward the plasma membrane77 and are connected to it via several 
transmembrane proteins. Thus, the actin cortex supports the plasma membrane to resist 
tension, which makes it to one of the main determinants of cell shape and motility78,79. 
Moreover, cortical actin polymerization is of importance in the invagination of extracellular 
materials via phagocytosis and pinocytosis as well as in the formation of acto-myosin 
contractile structures in nonmuscle cells such as stress fibers and the contractile ring79. 
Furthermore, it is thought that spatially restricted cortical polymerization is the driving force to 
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form membrane protrusions, such as lamellipodia and filopodia, during cell locomotion. These 
protrusive structures exhibit distinct filament geometries as depicted in Figure 8. 
 
 
Figure 8│Schematic illustration of the actin cytoskeleton in a migrating cell. This overview shows 
major cellular structures that occur in a migrating cell. The schematic cell drawn here does not 
correspond to a specific cell type. In order to migrate, a cell first acquires a characteristic polarized 
morphology in response to extracellular signals. At the cell front, actin polymerization drives the 
extension of membrane protrusions such as lamellipodia, which contain branched actin filaments, and 
filopodia that exhibit non-branched actin filaments which are tightly bundled by several proteins including 
fascin. At the leading edge of the lamellipodium the cell forms adhesions that connect the extracellular 
matrix to the actin cytoskeleton to anchor the protrusion and tract the cell body. Finally, in order to move 
forward, the cell retracts its trailing edge by combining actomyosin contractility and disassembly of 
adhesions at the rear. Illustration modified from Le Clainche & Carlier (2008)80. 
 
Sheet-like lamellipodia contain a network of branched “dendritic” actin filaments81 that 
are suggested to be able to push along a broad length of the plasma membrane and are 
thought to be the major engine for cell movement82. In contrast, spike-like filopodia with their 
long, parallel bundle organization are particularly well designed to serve as the cell´s sensory 
and guiding organelles, which function to explore the local environment and form 
cell - substrate or cell - cell interactions83. Behind the highly dynamic leading edge there is a 
more stable region, called the lamella, which contributes to cell migration by coupling the actin 
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network to myosin II-mediated contractility and substrate adhesion, i.e. stress fibers84. Stress 
fibers are contractile actin bundles composed of actin and nonmuscle myosin II (NMMII) found 
in nonmuscle cells85. In order to form this highly regulated actomyosin structure, they 
additionally contain crosslinking proteins such as α-actinin86. Stress fibers span through the 
cytoplasm and are often anchored to focal adhesions, which connect the extracellular matrix 
(ECM) to the actin cytoskeleton87,88.  
Model of actin polymerization at the leading edge of a cell 
Prior work has shown that in vitro polymerization of actin in presence of actin 
crosslinkers, for instance α-actinin, results either in an isotropic gel of filaments or parallel 
bundles89. For a long time, it remained unclear how cells use these proteins to assemble an 
ordered and polarized structure. In order to assemble such an ordered network, a cellular 
component that initiates actin polymerization and crosslinking in a highly localized manner is 
needed. This long sought cellular nucleator of actin filaments was discovered to be the Arp2/3 
complex90–93. The WASp/Scar complex was found to be the regulator of the nucleation activity 
of the Arp2/3 complex94–97. WASp proteins are named after the Wiskott-Aldrich syndrome, in 
which mutations in the gene encoding WASp cause immune and blood deficiencies. Scar is 
also known as WAVE since the same protein was discovered independently by two groups, 
however nowadays the name WAVE is more commonly used98. Based on these findings, 
Pollard et al. postulated a concrete, quantitative mechanism for the assembly and disassembly 
of lamellipodia at the leading edge of a cell, which they called the dendritic-nucleation 
model76,99. 
As depicted in Figure 9, their model proposes that (1) external signals activate surface 
receptors in a first place. The associated signal transduction pathways then produce (2) active 
Rho-GTPases, such as Rac, Cdc42 and RhoG83, and phosphatidylinositol 4,5-bisphosphate 
(PIP2), which in turn (3) activate WASp/Scar proteins. Their activation leads again to an (4) 
activation of the Arp2/3 complex, which binds to the sides or tip of a preexisting actin filament 
and (5) induces the formation of a new daughter filament that branches off the mother 
filament79,100. These filaments grow rapidly from their barbed ends and (6) push the membrane 
forward. Pushing of the membrane, the actual protrusive event, is believed to occur not by 
elongation of the actin filament per se but by an “elastic Brownian ratchet” mechanism, in which 
thermal energy bends the nascent short filaments, storing elastic energy. Unbending of an 
elongated filament against the leading edge would then provide the driving force for 
protrusion83,100. After a short time, i.e. within a second or two, (7) elongation of barbed ends is 
terminated by capping protein. Since new Arp2/3 complexes are incorporated during filament 
branching, the system requires their continuous activation. If nucleation activity drops to zero, 
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capping stops polymerization automatically101. Actin subunits in this branched network quickly 
hydrolyze their bound ATP to ADP-Pi but slowly dissociate the γ-phosphate (filament aging). 
Thus, ATP hydrolysis and the dissociation of P i is postulated to regulate actin filament 
disassembly102. In a next step, (9) actin depolymerization factor ADF/cofilin, which binds to 
ADP rather than ATP or ADP-Pi, mediate severing and depolymerization of older filaments at 
a rate that is controlled by some of the same signals that stimulate assembly. For instance, 
PIP2 that was previously mentioned to be part of the activation of WASp/Scar proteins, displace 
capping protein from barbed ends103. ADP-bound actin monomers are recycled by (10) profilin, 
which exchanges ADP to ATP, whereby (11) the pool of ATP-actin monomers is refilled. A 
phosphorylation of ADF/cofilins (12) by LIM kinase blocks the interaction of ADP-actin 
filaments and monomers with ADF/cofilins104. LIM kinase itself is activated by p21-activated 
kinase (PAK), which in turn is regulated by Rho-family GTPases105. ADF/cofilin is 
dephosphorylated and thus activated by a specific phosphatase called slingshot106.  
 
 
Figure 9│Treadmilling/Dendritic nucleation model for actin networks at the leading edge of a cell. 
(1) Extracellular signals activate receptors. (2) The associated signal transduction pathways produce 
active Rho-family GTPases and PIP2 that (3) activate WASp/Scar proteins. (4) WASp/Scar proteins 
bring together Arp2/3 complex and an actin monomer on the side of a preexisting filament to form a 
branch. (5) Rapid growth at the barbed end of the new branch (6) pushes the membrane forward.  
(7) Capping protein terminates growth within a second or two. (8) Filaments age by hydrolysis of ATP 
bound to each actin subunit (white subunits turn yellow) followed by dissociation of the γ - phosphate 
(subunits turn red). (9) ADF/cofilin promotes phosphate dissociation, severs ADP-actin filaments and 
promotes dissociation of ADP-actin from filament ends. (10) Profilin catalyzes the exchange of ADP for 
ATP (turning the subunits white), returning subunits to (11) the pool of ATP-actin bound to profilin, ready 
to elongate barbed ends as they become available. (12) Rho-family GTPases also activate PAK and 
LIM kinase, which phosphorylates ADF/cofilin. This tends to slow down the turnover of the filaments76. 
Image from Pollard et al. (2000)76. 
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Furthermore, there are plenty of other proteins, which play supporting roles in the 
dendritic actin network. Cortactin, for instance, stabilizes branches whereas α-actinin (2.5.1) 
and filamin A stabilize the entire network by crosslinking actin filaments79. The length of actin 
filaments in lamellipodia depends on the balance of actin-binding proteins. Furthermore, an 
increase of capping protein activity, for instance, diverts actin monomers from elongation to 
nucleation which reduces actin filament length and increases nucleation by the Arp2/3 
complex107. An increase of VASP in turn promotes filament elongation which results in longer 
filaments108. Another actin-binding protein, which promotes both, actin disassembly as well as 
polymerization is gelsolin. Gelsolin is a very potent, Ca2+-dependent actin filament severing 
protein. After breaking actin filaments, gelsolin remains attached to the barbed end as a cap, 
thus preventing polymerization. Uncapping of gelsolin from these filaments generates many 
polymerization-competent ends from which actin can grow to rebuild the cytoskeleton to new 
specifications. Thus, gelsolin can also promote actin polymerization due to severing followed 
by an uncapping of filaments109.  
Filopodial protrusion, in contrast, is thought to occur by a filament treadmilling 
mechanism, in which actin filaments within a bundle elongate at their barbed ends and release 
actin monomers from their pointed ends79. Within this structure, elongation of filaments is 
favored over branching. Many proteins including Ena/VASP proteins, which bind barbed ends 
of actin filaments and antagonize both capping and branching, thereby allowing continuous 
elongation of filaments, are enriched in filopodia. Same was described for formins such as 
mDia1 that protects barbed ends from capping and thereby promotes actin filament elongation 
without branching80. Moreover, actin filaments are bundled by fascin (2.5.2), which thereby 
might generate the stiffness needed to allow efficient pushing of the plasma membrane in 
filopodia79,83. 
Cell motion depends on the protrusion of the leading edge, the traction of the cell body 
as well as the retraction of the tail. Within these processes, as already mentioned, the 
mechanical coupling of actin dynamics and the substrate is controlled by cell matrix adhesion 
which functions as a “molecular clutch”. If the polymerizing actin network and the substrate are 
connected, membrane protrusion occurs. Additionally, this connection leads to the conversion 
of the actomyosin tension into traction of the cell body and retraction of the tail. In contrast, if 
there is no connection between adhesions and the actin cytoskeleton, no protrusion occurs 
because actin treadmilling is mainly converted into retrograde flow80,110.  
The actin cytoskeleton is highly regulated and has a wide variety of architectures that 
are associated with specific functional structures73. The mechanisms of actin polymerization 
as well as their corresponding regulators are not still not yet fully understood and require further 
investigation. For instance, in order to further reveal the influence that actin-binding proteins 
or peptides have upon the mechanical properties of actin filament networks, minimal systems 
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of purified proteins reconstituted in vitro are used. Section 2.8 introduces a method, which is 
utilized to explore the impact of actin-crosslinking proteins on the actin mechanics and gives 
some examples of characterized actin crosslinkers, which naturally occur in cells. 
2.5 Naturally occurring actin crosslinkers 
Cells exhibit a broad range of actin-binding proteins, including actin crosslinkers, such 
as filamin111, scruin112, espin113, α-actinin114 or fascin115,116 (see Table 2). Both of the latter 
named actin crosslinkers are introduced in more detail in the following sections, as these two 
proteins were to be mimicked by synthetically produced crosslinking constructs (2.6) within this 
work. 
2.5.1 Alpha-actinin - the “weak” binder 
Alpha-actinin is a ubiquitously conserved actin crosslinking protein found in both muscle 
and nonmuscle cells at points where actin is anchored to a variety of intracellular structures. It 
is member of a highly conserved family of actin-binding proteins, the spectin superfamily117. 
Alpha-actinin functions as a homodimer, consisting of two identical peptides that are arranged 
in an antiparallel fashion. It was reported to have a subunit molecular weight of 
94 – 103 kDa118,119 that appeared in electron micrographs120 as a 30 - 40 nm long rod with 
globular regions at each end. Studies of the α-actinin amino acid sequence as well as data 
obtained from proteolysis experiments showed that it is composed of three domains. The N-
terminal 250 amino acid (aa) residues form an actin-binding domain (ABD)121. The central rod-
like domain is formed by four spectrin-like, triple-helical coiled-coil repeats, each of 122 amino 
acid residues. These spectin repeats as well as the linker sequences between them confer an 
important mechanical property on α-actinin: the molecule has significant elasticity, which 
allows it to resist mechanical strain, a useful feature for a protein found in many types of cellular 
adhesion114. The C-terminal calmodulin (CaM)-like domain, consisting of 150 residues, 
contains two EF-hand motifs (helix-loop-helix), which bind Ca2+ and thereby regulate the actin-
binding affinity122,123. An illustration of the conformation of α-actinin is given in Figure 10.  
A number of different α-actinin isoforms were identified119,124–127 and are grouped into two 
distinct classes: muscle and nonmuscle cytoskeletal isoforms. Whereas binding of nonmuscle 
actinin to actin is calcium sensitive, binding of muscle isoforms is calcium insensitive124. 
Skeletal, cardiac and smooth muscle isoforms (isoforms 2 and 3) are localized in the Z-disk, 
which is the boundary between sarcomeres in striated muscle, where it cross-links actin 
filaments form adjacent sarcomeres, forming a lattice-like structure that stabilizes the muscle 
contractile apparatus128. Whereas α-actinin 2 is found in the cardiac and oxidative skeletal 
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muscle, α-actinin 3 is overexpressed in glycolytic skeletal muscle fibers129. The following 
section introduces the functions of nonmuscle α-actinins in more detail. 
Alpha-actinin of nonmuscle cells 
Alpha-actinin of nonmuscle cells occurs at the cytoplasmic face in multiple subcellular 
regions, including cell-cell and cell-matrix contact sites, cellular protrusions, lamellipodia as 
well as stress fiber dense regions, indicating that it plays multiple important roles in the cell. 
This includes the linkage of the cytoskeleton to many different transmembrane proteins in a 
variety of junctions and the regulation of the activity of multiple receptors. Furthermore, it 
serves as a scaffold to connect the cytoskeleton to diverse signaling pathways114. 
Both nonmuscle isoforms (isoforms 1 and 3) were found to be associated with stress 
fibers and focal adhesions117,130. However, their distribution differs in highly motile cells. Alpha-
actinin isoform 4 is more concentrated in circular dorsal ruffles and was reported to be closely 
associated with newly formed macropinosomes131,132. Point mutations in the ABD of the  
α-actinin 4 gene (ACTN4), which cause a form of kidney damage known as focal segmental 
glomerulosclerosis (FSGS), showed an increased affinity for F-actin that resulted in slowing 
down of intracellular dynamics1. The major nonmuscle isoform 1 was shown to be distributed 
along stress fibers in a distinct, periodic array86. Moreover, it was shown to localize at highly 
dynamic regions, such as lamellipodia at the leading edges of migrating cells133,134. Due to the 
fact that nonmuscle α-actinin 1 has been reported to play diverse roles in both actin-filament 
as well as integrin β1135 and α-catenin134 binding, its protein expression levels have been 
correlated with many cell functions, such as adhesive strength, cell motility, cell growth rates, 
as well as metastatic transformation136,137. Glück et al. reported, for instance, that the 
downregulation of α-actinin in 3T3 fibroblasts led to an increased cell motility, whereas an 
overexpression showed a strongly reduced migration137. Moreover they found that an 
overexpression of α-actinin 1 in SVT2 cells led to a complete suppression of their ability to 
form tumors in syngeneic BALB/c mice, which suggests, that α-actinin, which is also localized 
in cell junctions, may have an effective suppressive effect on the tumorigenic properties136. 
 
The biomechanical behavior of reconstituted actin networks enriched with α-actinin is 
described in section 2.8.2. 
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2.5.2 Fascin - the “strong” binder 
Fascin is a 55 kDa monomeric protein that crosslinks actin filaments in vitro into unipolar 
and tightly packed, stiff bundles with well-defined diameters115,138,139. In living cells, it assists in 
the organization of two major forms of actin-based structures which are cortical cell protrusions 
that mediate cell interactions and migration, and cytoplasmic microfilament bundles that 
contribute to cell architecture and to intracellular movements116. Fascin particularly localizes to 
a number of highly dynamic cellular structures that require strong mechanical support, such as 
stress fibers, microvilli, filopodia as well as lamellipodia140,141. Moreover, fascin is highly 
expressed in specialized cells which are particularly rich in filopodia, such as neurons and 
mature dendritic cells, as well as in many transformed cells such as HeLa cells142,143. In 
vertebrates, three forms of fascin are encoded on the genome: fascin 1 (also known as fascin), 
which is broadly expressed by mesenchymal tissues and in the nervous system144, fascin 2, 
which is found in retinal photoreceptor cells145 and fascin 3, which only occurs in testis146. 
Fascin consists of four beta-trefoil domains and, as an actin-crosslinking protein, 
contains at least two actin-binding sites. One site is located in the first beta-trefoil domain 
between amino acid residues 33 - 47 at the amino terminus. The other actin-binding site is 
assumed to lie between aa 277 - 493142. The amino acid residue Ser 39147, which is located 
within the first actin-binding site, plays an important role. The actin-bundling activity of fascin 
is inhibited by phosphorylation of Ser 39 by protein kinase Cα (PKCα) that blocks the activity 
of the N-terminal actin-binding site143. PKCα is a regulator of focal adhesions. It is activated by 
integrin-mediated adhesion and has significant regulatory effects on cell migration. 
Anilkumar et al. found that the specific blockade of the fascin/PKCα interaction increases cell 
migration on fibronectin in conjunction with increased fascin protrusions and remodeling of 
focal adhesions. Thus, the interaction of fascin and PKCα represents a point of intersection 
that regulates the balance between contractile adhesions and protrusions and thereby 
modulates cell migratory behavior148. 
 
The biomechanical behavior of reconstituted actin networks in presence of fascin is 
described in section 2.8.2. 
2.6 Synthetic actin crosslinkers 
In contrast to permanent, chemical crosslinks in classical polymer systems, biological 
crosslinks such as those introduced in the previous sections have a far broader parameter 
space defined by the molecular details of their binding and connective regions. Factors such 
as affinity, size, flexibility, orientation, and biochemical switches allow these components to 
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function beyond simply imposing local affine responses against external deformations149–152. 
The coexistence of bundles and regular networks are ubiquitous in mixtures of actin with the 
naturally occurring crosslinker α-actinin, possibly due to its low binding affinity153–156. Likely, 
molecular and physical details of the naturally occurring crosslinkers enable the structural 
polymorphism that is important to the mechanical behaviors of cells. This, however, imposes 
a central limitation to systematic investigations and development of biomimetic or bio-inspired 
materials: using different native biological crosslinkers to explore the phase space of one 
parameter (e.g. using α-actinin and fascin to vary binding strength) is unavoidably coupled with 
unwanted variations of several other parameters89,140. Genetic mutation can be used to perturb 
crosslinker properties such as binding kinetics or size1,157,158, however, its empirical nature and 
complexity inhibits systematic studies where different key parameters can be modified in a 
completely decoupled manner. This natural limitation was resolved in the work presented here 
by engineering purely synthetic actin crosslinkers (4.28), whose core building block is a 20 nm 
long, double-stranded DNA, which can be covalently coupled to actin-binding peptides on both 
sides via a copper-free click chemistry approach (SPAAC). Thus, the basic geometry of the 
crosslinkers are conserved while properties such as binding affinity towards actin can be tuned 
independently by varying the attached actin-binding peptides. Here, either LifeAct® (2.7.1) or 
Phalloidin (2.7.2) was covalently conjugated to both ends of the DNA spacer as the means to 
mimic α-actinin (2.5.1) as a weak, or fascin (2.5.2) as a strong binder, respectively. For 
simplicity, the weak LifeAct®-based and the strong Phalloidin-based crosslinkers are denoted 
as wLX and sPX in the following. The imitation of natural crosslinkers by synthetic ones is 
exemplarily shown for α-actinin and wLX in Figure 10. 
 
 
Figure 10│Mimicking the naturally occurring crosslinker α-actinin with wLX. This illustration 
exemplarily shows the imitation of the natural occurring weakly-binding actin crosslinker α-actinin (PDB 
code: 4D1E) with the DNA-based LifeAct® crosslinker (wLX). ABD, actin-binding domain (aa residues 
34 – 254); ABP, actin-binding peptide (in this case LifeAct®). Spacer domains are colored in blue: i.e. 
aa residues 255 - 892 for α-actinin, which is 30 - 40 nm in length; 60bp DNA spacer for wLX, which is 
20 nm in length. Illustration of α-actinin was conducted with PyMOL. 
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2.7 Actin-binding peptides 
2.7.1 LifeAct® 
In 1998, Asakura et al. discovered an F-actin-binding protein of a molecular mass of 
~140 kDa, which was named Abp140. They found that Abp140 directly interacts with F-actin 
and binds along the sides of F-actin. In addition, immunofluorescence studies as well as green 
fluorescent protein (GFP) fusions revealed that Abp140 co-localized with filamentous actin 
structures159,160. Riedl et al. found that the first 17 amino acids (MGVADLIKKFESISKEE) of 
Abp140 were sufficient to mediate actin localization comparable to the full-length protein. 
Interestingly they also reported that this short peptide, named LifeAct®, is conserved among 
close relatives of Saccharomyces cerevisiae but absent from other organisms, which made it 
an attractive in vivo actin marker for higher eukaryotes within the last years161. LifeAct®-GFP 
fusions stained filamentous actin structures such as lamellipodia, filopodia or stress fibers in 
eukaryotic cells and tissues. Also, they observed no signs of cytotoxicity, abnormal morphology 
or of growth retardation in transiently or stably transfected cell lines161. Furthermore, Riedl et al. 
measured the affinity of LifeAct® to F-actin with a dissociation constant KD of 2.3 ± 0.9 µM and 
found that LifeAct® did not affect nucleation and elongation phases of actin polymerization as 
well as depolymerization rates in vitro (pyrene assay)161. 
2.7.2 Phalloidin 
Phalloidin is a toxin that belongs to the group of phallotoxins and was isolated from the 
death cap mushroom Amanita phalloides by Feodor Lynen and Ulrich Wieland in 1937162. It is 
a bicyclic heptapeptide that contains a cysteine-tryptophan linkage (tryptathionine bond). 
Phalloidin was found to bind tightly and specifically to filamentous actin with a KD of 
~ 9 nM ± 2 nM and reported to stabilize actin filaments from a variety of depolymerizing 
agents163,164. Simulations on F-actin gave evidence that Phalloidin interacts with three actin 
subunits and therefore stabilize subunit interactions165. Moreover, Estes et al. showed that 
phalloidin decreases the critical concentration for actin polymerization in vitro as it reduces the 
dissociation rate constant of monomers from filament ends166. Phalloidin was also reported to 
inhibit the binding of ADF/cofilin to actin filaments167. Due to its strong binding to F-actin, 
fluorochrome-conjugated phalloidins are widely used in microscopy to visualize actin 
structures within cells. 
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2.8 Reconstituted actin networks (in vitro) 
As mentioned in section 2.4, F-actin assembles at different structural morphologies in 
order to provide the cell with certain functions. Whereas the actin cortex, which determines the 
shape and the mechanical strength of a cell, is composed of a network of crosslinked filaments, 
closely-packed actin bundles provide support or create membrane protrusions which are 
important for cellular motility. Processes, such as cell motion, cell division as well as 
intracellular transport require strongly regulated spatial and temporal remodeling of actin 
networks. In order to control the network assembly and disassembly, the morphology and the 
biomechanical properties of the actin network, cells make use of actin-binding proteins (ABP). 
However, since a lot of these proteins occur simultaneously in the cytoskeleton, it is rather 
difficult to conclude any correlation of the network morphology and the viscoelastic response 
in vivo. In order to investigate this correlation in vitro in a non-overcrowded environment, 
reconstituted actin networks, a very minimal system, are used. Thereby, different actin/ABP 
mixtures can be investigated while the biochemical network composition can be precisely 
controlled. Isolated and purified actin can be maintained as G-actin (monomers) by eliminating 
nearly all salts present, including calcium ions rather than magnesium ions and storing it under 
mildly alkaline conditions, i.e. 1X G-buffer conditions (4.3). This G-actin solution can then be 
induced to form filaments by adding a concentrated buffer mix, i.e. 20X KME-buffer (4.3) that 
alters pH, switches divalent cations, and increases salt concentrations into the physiological 
range168. Moreover, fluorescently labeled actin derivatives, such as pyrene-actin, are a useful 
tool to study the kinetics of actin polymerization and depolymerization in vitro as the 
fluorescence intensity increases linearly with the degree of polymerization169,170. According to 
this reconstitution of actin networks, the physical as well as biochemical effects of ABP can be 
independently correlated to both the network mechanics and the structural morphology. In 
order to characterize complex actin filament assemblies, different experimental techniques 
such as rheology, light scattering, microscopy, conventional biochemical methods as well as 
theoretical modellings and simulations were combined in recent years. A rather old but 
common technique to investigate the biomechanical properties of reconstituted actin networks 
is shear rheology, which is described in the following section. 
2.8.1 Shear rheology of reconstituted actin networks 
Rheology is utilized to investigate both, the elastic as well as the viscous properties of a 
material. Those materials, which behave as a combination of elastic and viscous components, 
are named viscoelastic materials. As actin shows this kind of characteristic, it is classified a 
viscoelastic biopolymer. The influence of actin-binding proteins and/or actin crosslinkers on 
the mechanical properties of actin networks are of great interest in science and have been 
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studied intensively via shear rheology, which is defined as the characterization of flow or 
deformation originating from an applied shear stress.  
 
 
Figure 11│Principles of shear rheology. (A) Illustration of an actin sample that is polymerized 
between a plate and a cone (picture kindly provided by Jörg Schnauß). (B) The sample experiences a 
certain stress, which is, in correlation to its biomechanical properties, transmitted through the sample. 
The responding strain is measured on the fixed plate. (C) Doing this in an oscillatory fashion, the 
complex shear modulus G* can be derived, which includes both, the elastic response as well as the 
viscous response of the system. The shear modulus describes the tendency of a sample to shear, i.e. 
the deformation of shape at a constant volume.  
 
In rheology, schematically illustrated in Figure 11 A, the actin sample is sitting between 
a rotating cone and a fixed plate. On the upper side of the actin sample, a certain shear stress 
is applied. The shear stress 𝜎, as shown in Equation 1, is defined as the force F per area A on 
which the force acts (Figure 11 B).  
      
𝜎 =   
𝐹
𝐴
 
              Equation 1 
 
Depending on its viscoelastic properties, the applied force is transmitted through the 
actin sample and the response of the system, i.e. the strain, is measured with respect to the 
lower fixed plate. The shear strain γ is defined as the transverse displacement Δx over the 
initial length l, as seen in Equation 2. 
      
𝛾 =   
𝛥𝑥
𝑙
 
              Equation 2 
 
The shear modulus G, also known as the modulus of rigidity, is defined as the ratio of 
shear stress to the shear strain, as given in Equation 3.  
 
 
A B C 
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𝐺 =   
𝜎
𝛾
=
𝐹 𝐴⁄
𝛥𝑥 𝑙⁄
 
              Equation 3 
 
Performing the measurement in an oscillatory fashion, i.e. at a certain angular 
frequency ω, the complex shear modulus G* (ω) [Pa] can be derived, as shown in Equation 4. 
The complex shear modulus can be divided into the elastic/shear modulus (Equation 5) and 
the viscous/loss modulus (Equation 6), corresponding to G´ and G´´, respectively. The elastic 
modulus G´ at a frequency of 1 Hz is referred as to the plateau modulus G0. 
     
𝐺∗(𝜔) = 𝐺 ´(𝜔) + 𝑖𝐺 ´´(𝜔) 
              Equation 4 
     
𝐺´ (𝑒𝑙𝑎𝑠𝑡𝑖𝑐 𝑚𝑜𝑑𝑢𝑙𝑢𝑠) =
𝜎
𝛾
 𝑐𝑜𝑠 𝛿 
              Equation 5 
     
𝐺´´ (𝑣𝑖𝑠𝑐𝑜𝑢𝑠 𝑚𝑜𝑑𝑢𝑙𝑢𝑠) =
𝜎
𝛾
 𝑠𝑖𝑛 𝛿 
              Equation 6 
 
The corresponding phase angle δ (Figure 11 C) measures the relative importance of 
viscous to elastic contributions for a material at a given frequency and is defined as followed 
in Equation 7. An ideal, purely elastic material (solid-like) behaves with δ = 0 °, whereas a 
purely viscous material, i.e. a material behaving as a Newtonian fluid, behaves with δ = 90 °. 
Viscoelastic materials are defined to show phase angles between 0 ° and 90 °. Pure, 
viscoelastic actin networks displayed a phase angle around 40 ° (5.3.1). An example of the 
time course of the stress function (blue curve) and the corresponding strain function (magenta 
curve) for a viscoelastic material is given in Figure 11 C. 
     
𝑡𝑎𝑛𝛿 (𝜔) =
𝐺´´(𝜔)
𝐺´(𝜔)
 
              Equation 7 
 
The viscous (G´´) as well as elastic (G´) moduli of a reconstituted actin network are 
exemplarily illustrated in Figure 12. As the elastic properties dominate in actin networks, G´ is 
emphasized in this work. 
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Figure 12│Viscous and elastic properties of a reconstituted actin network. Actin was polymerized 
at a concentration of 24 µM and measured via shear rheology. The elastic modulus G´ (blue curve) as 
well as the viscous response G´´ (green curve) are plotted over the applied frequency. The applied strain 
was 5 %. G0, which is the elastic modulus G´ at a frequency of 1 Hz, is exemplarily black edged. 
 
2.8.2 Structure and mechanics of reconstituted actin networks 
Both the structural morphology and the viscoelastic properties of the formed actin 
network strongly depend on the concentration as well as on the biochemical and 
micromechanical properties of the crosslinker, i.e. the affinity of the actin-binding domains 
towards F-actin, the number of binding domains as well as the length and flexibility of the 
spacer in between. Two generic types of F-actin assemblies can be distinguished: networks of 
individual crosslinked actin filaments and actin bundles. However, in particular regions of the 
cytoskeleton either one of these assembly types may dominate or they may appear in 
coexistence. The main goal of ongoing and past research is to understand the local structures 
and rearrangements invoked by the different actin crosslinkers150. Several naturally occurring 
actin crosslinkers, such as α-actinin151,171,172, filamin173–175, fascin139,140,174 as well as crosslinker 
mutants176 have been explored concerning their influence on the biomechanical properties as 
well as on the structural morphology of actin networks in vitro. Besides microscopic analysis, 
this includes the investigation of such networks via shear rheology. Table 2 gives an exemplary 
overview about the in vitro found structural morphologies that can be correlated to the in vivo 
function of some actin crosslinkers as well as actin-binding proteins.  
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Table 2│Examples of actin-binding proteins studied in vivo and in reconstituted actin networks 
Actin 
crosslinker 
In vivo function 
Structural morphology of reconstituted 
actin networks 
Large actin crosslinker  
  α-actinin α-actinin is the most prominent 
actin-bundling protein in stress 
fibers and is also found in 
cellular protrusions such as 
lamellipodia114. 
At low concentrations, α-actinin forms 
orthogonally crosslinked actin networks 
whereas at higher concentrations bundles 
are formed89,177. 
   Filamin Filamin is omnipresent in 
eukaryotic cells. It is found in 
stress fibers and reported to be 
involved in signaling pro-
cesses111. 
Below a certain threshold concentration, 
filamin crosslinks actin filaments into an 
orthogonal network, whereas above this 
concentration filamin builds branched actin 
bundles, which are curved due to internal 
stresses111,173,175,178. 
Small actin crosslinker  
   Fascin Fascin is found in dynamic, 
cortical cell protrusions such 
as filopodia82. 
Above a critical concentration, fascin forms 
actin networks of straight, parallel 
bundles179.  
   Espin Espin is an actin-bundling 
protein found in brush border 
microvilli and hair cell stero-
cilia113,113. 
Espin forms long, straight and parallel actin 
bundles similar to fascin180. 
Actin-
binding 
protein 
In vivo function 
Structural morphology of reconstituted 
actin networks 
   Heavy mero-
myosin 
(HMM, i.e. a 
subfragment 
of myosin II) 
HMM is the larger subfragment 
of the molecular motor 
myosin II that contains the 
ATPase region and the actin-
binding region. HMM does not 
occur in cells as it is obtained 
by chymotrypsin digestion of 
myosin II181. 
HMM binds, in absence of ATP, to actin 
filaments in the rigor state and thus can 
form interfilamental crosslinks. Actin/HMM 
networks were shown to be homogene-
ously and isotropically crosslinked without 
embedded bundle structures182. 
   Tropomyosin Tropomyosin was shown to 
protect F-actin from dis-
assembly through ADF/ 
cofilin183. 
Tropomyosin binds end to end to actin 
filaments, spanning over seven actin 
subunits along the filament184 and does not 
form interfilamental crosslinks. Thus, 
actin/tropomyosin networks consist of 
single, entangled actin filaments. 
 
 
As already mentioned, structural morphologies of actin networks depend on crosslinker 
properties such as concentration, length and affinity. For instance, in order to induce a major 
effect on the global structure and mechanics of a solution of actin filaments, a critical 
crosslinker concentration is needed. Below this threshold, some crosslinkers such as  
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α-actinin89 and HMM185 induce local heterogeneities. Those heterogeneities increase with 
increasing crosslinker concentration until the crosslinking proteins are equally distributed and 
cause a global change in the network structure. This transition was previously reported for  
α-actinin as different structural morphologies were induced in a concentration-dependent 
manner. Entangled actin solutions were weakly crosslinked at low α-actinin concentrations and 
an increase in concentration led to composite networks of crosslinked actin filaments and 
bundles. At high α-actinin concentrations bundled networks and even clusters of actin bundles 
were observed150. 
Moreover, it was shown that small crosslinkers such as fascin179 and espin180 tend to 
tightly pack actin filaments into bundles, whereas larger actin crosslinkers, such as  
α-actinin89,177 and filamin111,173,175 induce a more complex behavior, as they formed crosslinked 
networks of actin filaments at low concentrations and purely bundled or composite networks 
at high concentrations. This was also supported by engineered actin crosslinkers that had 
actin-binding domains separated by different numbers of Dicteostelium discoideum filament 
rods, i.e. they differed in length but not in affinity towards F-actin. In this case, the shortest 
crosslinkers showed the highest F-actin bundling propensity158.  
Furthermore, the affinity of the actin crosslinker towards F-actin is an important factor. 
Wachsstock et al. studied the impact of the α-actinin affinity and found that different affinities 
towards actin cause different bundling threshold concentrations89. The impact of the weakly-
binding crosslinker α-actinin (2.5.1) and the strongly-binding crosslinker fascin (2.5.2) on the 
biomechanical properties of reconstituted actin networks was intensively investigated in the 
past. Within rheological measurements, F-actin/α-actinin solutions caused a monotonic 
increase of G´ with increasing α-actinin concentrations. Accordingly, the phase angles 
displayed a monotonic decrease with increasing crosslinker concentration, which indicates the 
system became more elastic. The strong crosslinker fascin did also show this monotonic 
increase of G´ until a certain concentration was reached. However, above this threshold 
concentration, actin/fascin networks displayed a non-monotonic behavior. Initially, the elastic 
modulus drastically increased until reaching a peak which subsequently relaxed to a more 
viscous dominated state. The corresponding phase angles increased at high fascin 
concentrations, indicating the system becoming more viscous. The behavior of the drastic 
increase of G´ followed by a drop in elasticity was referred to as the “elasticity burst”140. In 
2011, Lieleg et al. showed that actin networks simultaneously polymerized with fascin formed 
pre-stressed structures which are bent beyond their equilibrium configuration139 due to the fact 
that filament elongation186 is faster than dissociation of the strongly-binding crosslinker187. The 
relaxation, i.e. the decrease of G´, could be induced by glassy dynamics aiming to release the 
stress towards equilibrium139, and/or occur due to filament breakage, as filaments are 
subjected to significant bending forces188. 
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2.9 Epithelial-mesenchymal transition (EMT) 
The epithelial-mesenchymal transition (EMT) describes a biological process, in which a 
polarized epithelial cell that normally interacts with basement membrane via its basal surface, 
is transformed to a non-polarized mesenchymal cell, which imparts the transformed cell with 
enhanced capabilities of migration, invasiveness, evasion of apoptosis and increased 
production of extracellular matrix (ECM) components. The degradation of the underlying 
basement membrane as well as the ability to migrate away from the epithelial layer represents 
a signal for the completion of an EMT. Several molecular processes are involved in both the 
initiation and the completion of EMT, which include the activation of transcription factors, 
expression of characteristic cell-surface receptors, reorganization and expression of 
cytoskeletal proteins, production of matrix metalloproteinases (MMPs) that degrade ECM 
components, as well as changes in the expression of specific microRNAs. Moreover, factors 
regulating EMT are often used as biomarkers to study different phases of EMT. EMT is 
involved in many cellular processes, including development, fibrosis, and cancer, and 
depending on its function it is classified into three EMT subtypes as described in Table 3189.  
 
 
Table 3│Classification of epithelial-mesenchymal transition (EMT)189 
EMT subtype Characteristics 
  Type 1 This subtype is associated with implantation, embryo formation and 
organ development. It is organized to generate diverse cell types that 
share common mesenchymal phenotypes. Moreover, this type neither 
causes fibrosis nor an invasive phenotype. Type 1 EMTs can generate 
mesenchymal cells that have the potential to undergo a mesenchymal-
epithelial transition (MET) in order to build secondary epithelia. 
 Type 2 This EMT subtype is associated with wound healing, tissue 
regeneration and organ fibrosis. Further, these EMTs are associated 
with inflammation and terminate once inflammation is attenuated. 
  Type 3 This type of EMT is present in neoplastic cells that have previously 
undergone genetic changes, specifically in genes that favor clonal 
outgrowth and the development of localized tumors. Cancer cells 
undergoing a type 3 EMT may invade and metastasize and thereby 
generate the final, life-threatening form of cancer progression. 
   
 
Tumor cell dissemination is critical in cancer progression and involves various 
processes, including EMT (type 3), leading to the formation of metastases at remote loci. As 
EMT progress, epithelial cell-cell contacts are dissolved and cells lose their apical-basal 
polarity189. Additionally, epithelial junction proteins, for instance epithelial (E)-cadherin, and 
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other epithelial markers are downregulated and the expression of mesenchymal adhesion and 
marker proteins, such as α-smooth muscle actin (SMA), is increased190. Moreover, the actin 
cytoskeleton is drastically reorganized and phenotypic changes occur to enable the cell to 
acquire a front-rear polarity and motility. In the end, cells gain invasive properties due to an 
increased expression and secretion of MMPs. Furthermore, these cells are able to synthesize 
components of the ECM, i.e. collagen and fibronectin, to reconstitute their micro-
environment189,191,192. Conversely, after reaching a secondary colonization site, cancer cells 
that have acquired mesenchymal properties are able to revert to an epithelial phenotype 
through mesenchymal-epithelial transition (MET), thus reacquiring the properties of the original 
tumor following metastasis193. Figure 13 schematically gives an overview about changes that 
cells undergo during EMT, involving upregulated proteins (markers) for both phenotypes, 
respectively. 
 
 
Figure 13│Schematic of epithelial-mesenchymal transition (EMT). During EMT, cells lose their 
epithelial characteristics and acquire mesenchymal properties. This involves the loss of epithelial 
cell - cell contacts and apical-basal polarity. Moreover, transformed cells gain mesenchymal markers 
and invasive properties, characterized by a reorganization of the actin cytoskeleton and an increased 
expression of matrix metalloproteases (MMPs) as well as extracellular matrix components. Picture 
modified from Katsuno et al. (2013)193 and Kalluri & Weinberg (2009)189. 
 
In case of many carcinomas (type 3 EMT), EMT-inducing signals, such as hepatocyte 
growth factor (HGF), epithelial growth factor (EGF), platelet-derived growth factor (PDGF) and 
transforming growth factor beta (TGF-β), appear to be responsible for the induction or 
functional activation of a broad range of EMT-inducing transcription factors189. In the following, 
the induction of EMT mediated by TGF-β is introduced in more detail with special focus on 
cancer cell progression. 
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TGF-β signaling in EMT 
Two possible signaling pathways have been identified as mediators of TGF-β-induced 
EMT: the Smad and the non-Smad pathways, as depicted in Figure 14. Both signaling 
pathways are initiated upon the interaction of TGF-β with a tetrameric cell surface complex of 
two type II and two type I transmembrane kinase receptors, TβRII and TβRI. Following TGF-β 
binding, TβRII directly phosphorylates TβRI. Within the Smad pathway, the intracellular 
mediators Smad2 and Smad3 then are phosphorylated. Two activated Smad2/3 proteins 
combine with one Smad4 to form a trimeric Smad complex that is translocated into the 
nucleus194,195. In conjunction with other nuclear cofactors, Smad signaling regulates the 
expression of the three families of EMT-inducing transcription factors, Snail/Slug, zinc finger 
E-box binding homeobox 1 and 2 (ZEB1/2), and Twist196. These transcription factors repress 
the expression of epithelial markers, in turn activate the expression of mesenchymal 
markers193 and thus promote EMT. For instance, Vincent et al. reported the direct interaction 
of the Smad3/4 complex with regulatory promoter sequences of Snail, which form an active 
complex that binds to regulatory promoter sequences of the genes encoding the epithelial 
junction proteins occludin and E-cadherin, leading to TGF-β-induced repression of their 
expression197. In addition to Smad signaling, TGF-β also initiates non-Smad signaling from the 
TβRII/TβRI complexes, leading to the activation of pathways that are more commonly seen as 
effectors of receptor tyrosine kinase signaling, such as PI3K-Akt-mTOR and Rho-GTPases 
pathways198, leading to increased motility and invasion, as well as changes in protein synthesis 
and cytoskeletal reorganization193,199,200. Reorganization of the actin network is associated with 
the myocardin-related transcription factor (MRTF) - serum-response factor (SRF) signaling 
pathway, which connects both the canonical and the non-canonical pathway (see Figure 15). 
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Figure 14│Simplified schematic of Smad and non-Smad signaling in TGF-β-induced EMT. TGF- β 
signaling induces EMT through Smad (canonical) and non-Smad (non-canonical) pathways, where, 
upon ligand binding, two type II (TβRII) and two type I (TβRI) transmembrane kinase receptors 
phosphorylate and activate Smad2 and Smad3. Those activated Smad proteins complex with Smad 4 
and translocate into the nucleus where it regulates the transcription of target genes through interactions 
with other transcription factors (TKF) and transcription cofactors (TKCF). Thereby, three families of 
EMT-inducing transcription factors are upregulated: Snail/Slug family, zinc finger E-box binding 
homeobox 1 and 2 (ZEB1 and ZEB2) family and Twist family. These transcription factors are responsible 
for the repression of the expression of epithelial markers and the upregulation of the expression of 
mesenchymal markers. Other pathways, which do not involve Smad proteins, are also activated by 
TGF- β. For instance, TGF- β activates small GTPases, including Rho, which leads to an increase in 
migration and invasion as well as changes in protein synthesis and reorganization of the actin 
cytoskeleton. The MRTF-SRF signaling pathway affects the reorganization of the actin cytoskeleton and 
connects the canonical and non-canonical Smad pathway, illustrated in magenta. A more detailed 
overview is shown in Figure 15. Abbreviations: TGF-β, transforming growth factor β; TβRI, TGF-β 
receptor type I; TβRII, TGF-β receptor type II; TKF, transcription factor; TKCF, transcription cofactor;  
P, phosphorylated. Schematic modified from Katsuno et al. (2013)193. 
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Figure 15│MRTF-mediated regulation of SRF-dependent cytoskeletal target genes. The MRTF-
SRF signaling pathway affects the reorganization of the actin cytoskeleton and connects both the Smad 
and the non-Smad pathway. A detailed description of the MRTF-SRF signaling pathway is to be found 
in the text below. Abbreviations: TGF-β, transforming growth factor β; TβRI, TGF-β receptor type I; 
TβRII, TGF-β receptor type II; Rho GEFs, Rho guanine nucleotide exchange factors; ROCK, Rho-
associated kinase; LIMK, LIM kinase; WASp, Wiskott-Aldrich syndrome protein; WAVEs, WASp-family 
verpolin homologues; Arp2/3, Actin-related protein 2/3; ABPs, Actin-binding proteins; GSK3, Glycogen 
synthase kinase-3β; MRTF, Myocardin-related transcription factor; SRF, Serum-response factor; CArG, 
palindromic CC(A/T)6GG DNA sequence; P, phosphorylated. Image modified from Olson & Nordheim 
(2010)201 and Charbonney et al. (2011)202 
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The activation of several membrane receptors, for instance TGF-β receptors and  
E-cadherins at adherens junctions, affects the cytoskeletal actin dynamics, as they modulate 
the activity of Rho GTPases203 through Rho guanine nucleotide exchange factors (Rho GEFs). 
Rho-associated kinase (ROCK), formins, Wiskott-Aldrich syndrome protein (WASp), WASP-
family verprolin homologues (WAVEs), actin-related protein 2/3 (Arp2/3) complex, as well as 
other actin-binding proteins (ABPs) are effectors of Rho GTPases and orchestrate actin 
polymerization by incorporating G-actin into F-actin204. High levels of cytoplasmic G-actin retain 
MRTF in the cytoplasm, whereas an incorporation of G-actin into filamentous action liberates 
MRTF to translocate into the nucleus. In the nucleus it forms a complex with the transcription 
factor SRF205, which then binds to the CArG region (palindromic CC(A/T)6GG DNA sequence) 
and triggers the expression of a subset of SRF target genes, i.e. mostly cytoskeletal genes. 
Nuclear MRTF can be complexed by nuclear G-actin, which inhibits MRTF-mediated 
stimulation of SRF-dependent transcription and facilitates MRTF nuclear export206. SRF target 
genes include actin itself as well as many genes that modulate actin dynamics, such as 
gelsolin, vinculin and cofilin. These ABP might stimulate cytoplasmic actin polymerization, 
complex cytoplasmic MRTF or increase levels of nuclear G-actin to downregulate MRTF-
mediated transcription, and stimulate nuclear export of MRTF. The disassembly of epithelial 
cell contacts is an initiating event in the process of EMT. The subsequent release of catenins, 
such as α-catenin and p120 catenin, activates actin dynamics through interaction with Rho 
GTPases207. Moreover, E-cadherin contributes to MRTF activation through the liberation of  
β-catenin, which neutralizes Smad3, a strong inhibitor of MRTF. Additionally, β-catenin 
maintains the stability of MRTF by suppressing the Smad3-mediated recruitment of glycogen 
synthase kinase-3β (GSK3) to MRTF, an event that otherwise leads to MRTF ubiquitination 
and degradation, which results in a consequent loss of SRF/MRTF-dependent proteins202.  
SRF target genes, which are regulated through MRTF, encode many proteins that are 
related to actin cytoskeletal activities. According to their contributions to actin function, SRF-
regulated gene products are grouped into three categories, which are: structural effectors  
(e.g. actin itself, integrin β1, vinculin, tropomyosin 1), effectors of actin turnover (e.g. cofilin 1, 
gelsolin, villin) and regulators of actin dynamics (e.g., filamin A, talin 1, MMP-9). MMP-9 is 
involved in extracellular matrix remodeling, angiogenesis and migration201. Finally, 
Schratt et al. generalized that SRF affects actin treadmilling by regulating the expression of 
additional proteins involved in actin turnover downstream of RhoA208. 
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3 Objective 
DNA nanostructures consist of partially complementary sequences that self-assemble 
into double-stranded objects in a temperature-dependent process. Since the underlying DNA 
sequence is known, the exact attachment of functional groups to DNA strands through different 
chemical reactions is possible. The nanometer-precise arrangement of biofunctional molecules 
such as peptides at specific distances is unique and a major benefit of those constructs. This 
has led to great interest for several medical applications and is also part of this thesis. 
The first aim of this work was to establish a “plug and play“ platform for the covalent 
attachment of functional peptides to DNA nanostructures. Therefore, different conjugation 
methods should be tested and finally high product yields achieved. Once peptide-conjugated 
DNA structures were available, three major questions were to be answered: 
 
1) Do the attached biofunctional materials retain their functionality when there are 
covalently bound to DNA structures? 
 
2) Can these peptide-functionalized DNA constructs be applied to tune reconstituted 
in vitro systems? 
 
3) Are these biomimetic DNA structures able to function on particular systems inside of 
living cells? 
 36 
 
 
Material and Methods 
37 
 
4 Material and Methods 
For all methods, sterile filter tips (Greiner Bio-One International GmbH, Austria) and 
reaction tubes were utilized. DNA LoBind reaction tubes (Eppendorf AG, Germany) were used 
for DNA containing samples. All buffers and solutions were prepared using Millipore water and, 
if not stated differently, sterilized through autoclavation. 
4.1 Chemicals 
Aminoallyl-dUTP Thermo Fisher Scientific, USA 
Ammonium persulfate Carl Roth GmbH, Germany 
ATP Thermo Fisher Scientific, USA 
Azidopropionic acid sulfo-NHS ester Jena Bioscience GmbH, Germany 
Biochrom AG™ Donor Horse Serum Thermo Fisher Scientific, USA 
Calcein AM, cell-permeant dye Thermo Fisher Scientific, USA 
Camptothecin Abcam, UK 
Cell carrier buffer Zellmechanik Dresden GmbH, Germany 
CellTracker™ Blue CMAC Thermo Fisher Scientific, USA 
Cholera Toxin Sigma-Aldrich, Germany 
Cultrex® 10X Coating Buffer Biozol Diagnostica, Germany 
Cultrex® 5X BME Solution Biozol Diagnostica, Germany 
Cultrex® 10X Cell Dissociation Solution Biozol Diagnostica, Germany 
DBCO-NHS ester Jena Bioscience GmbH, Germany 
DMEM/Ham's F-12, stable glutamine Biochrom AG, Germany 
DNA Gel Loading Dye (6X) Thermo Fisher Scientific, USA 
Dimethyl sulfoxide Sigma-Aldrich, Germany 
dNTP Mix Thermo Fisher Scientific, USA 
DPBS, no calcium, no magnesium (1X) Thermo Fisher Scientific, USA 
Ethanol, absolute Carl Roth GmbH, Germany 
Ethidium bromide Carl Roth GmbH, Germany 
Fluorescein Phalloidin  Thermo Fisher Scientific, USA 
Fluoroshield™ with DAPI Sigma-Aldrich, Germany 
Fluoroshield™ Sigma-Aldrich, Germany 
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Gelatin solution, Type B, 2 % in dd H2O Sigma-Aldrich, Germany 
Gibco® Trypsin-EDTA (0.05 %), phenol red Thermo Fisher Scientific, USA 
Gibco FluoroBrite DMEM Thermo Fisher Scientific, USA 
Hoechst® 33342 Thermo Fisher Scientific, USA 
HyClone™ Fetal Bovine Serum Thermo Fisher Scientific, USA 
Hydrocortisone Sigma-Aldrich, Germany 
Insulin Sigma-Aldrich, Germany 
Latrunculin B Sigma-Aldrich, Germany 
Lipofectamine® 3000 Thermo Fisher Scientific, USA 
LysoTracker™ Deep Red Thermo Fisher Scientific, USA 
MEM Amino Acids Solution (50X) Thermo Fisher Scientific, USA 
MEM Vitamin Solution (100X) Thermo Fisher Scientific, USA 
Opti-MEM® I Reduced-Serum Medium Thermo Fisher Scientific, USA 
Penicillin-Streptomycin (10,000 U/ml) Thermo Fisher Scientific, USA 
Pierce™ Immobilized TCEP Disulfide Reducing 
Gel 
Thermo Fisher Scientific, USA 
Poly-L-ornithine Sigma-Aldrich, Germany 
Roti®-Histofix 4 % Carl Roth GmbH, Germany 
Rotiphorese® Gel 40 (29:1): 40 % acrylamide/ 
bisacrylamide 
Carl Roth GmbH, Germany 
SYBR® Gold nucleic acid gel stain Life Technologies, USA 
SYBR® Green I nucleic acid gel stain Life Technologies, USA 
TCEP Sigma-Aldrich, Germany 
TEMED Carl Roth GmbH, Germany 
Trypan Blue Stain 0.4 % Biozym, Germany 
WST-1 Roche, Switzerland 
 
All other chemicals including salts, buffer reagents etc. were obtained from Sigma-
Aldrich, Carl Roth GmbH or AppliChem. 
4.2 Enzymes, standards and kits 
The restriction enzymes BamHI-HF®, EcoRI-HF® and EcoRV-HF® were purchased from 
New England Biolabs (USA) and used according to manufacturers’ instructions. 
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Dnase I Thermo Fisher Scientific, USA 
Exonuclease III New England Biolabs, USA 
E.Z.N.A.® Endo-Free Plasmid Mini Kit I VWR, USA 
Gel Loading Dye, Purple (6X) New England Biolabs, USA 
GeneRulerTM 1 kb DNA Ladder Thermo Fisher Scientific, USA 
GeneRulerTM Low Range DNA Ladder Thermo Fisher Scientific, USA 
Glucose Oxidase from Aspergillus niger Sigma-Aldrich, Germany 
Hot Start Taq DNA Polymerase New England Biolabs, USA 
Human EMT 3-Color Immunocytochemistry Kit Bio-Techne Corporation, USA 
NucleoSpin® Gel and PCR Clean up Kit Macherey - Nagel, Germany 
PageRuler™ Unstained Protein Ladder Thermo Fisher Scientific, USA 
PE Annexin V Apoptosis Detection Kit I BD Bioscience, USA 
Pierce™ BCA Protein Assay Kit Thermo Fisher Scientific, USA 
RNase A Sigma-Aldrich, Germany 
T4 DNA Ligase New England Biolabs, USA 
Terminal Transferase, recombinant Roche, Switzerland 
4.3 Buffers and solutions 
10X TM 100 mM Tris base pH 8.1, 50 mM MgCl2 
1X TM  10 mM Tris base pH 8.1, 5 mM MgCl2 
10X TM II 100 mM Tris base pH 8.1, 500 mM MgCl2 
1X TM II 10 mM Tris base pH 8.1, 50 mM MgCl2 
Elution buffer 10 mM Tris base pH 7.4, 450 mM NaCl2 
1X TBE 89 mM Tris base, 89 mM Boric acid, 2 mM EDTA 
  
5X TBEM 445 mM mM Tris base, 445 mM Boric acid, 10 mM EDTA, 
25 mM MgCl2 
  
1X TBEM 89 mM Tris base, 89 mM Boric acid, 2 mM EDTA,  
5 mM MgCl2 
1X TAE 40 mM Tris-Acetate pH 8, 1 mM EDTA 
Agarose solution 1 % (w/v) Agarose, 50 ml 1X TAE, 2 µl EtBr 
10X SDS running buffer 250 mM Tris base, 1.92 M Glycine, 1 % (w/v) SDS 
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5X Non-reducing sample buffer 4 % (v/v) SDS, 20 % (v/v) Glycerol, 0.01 % (v/v) 
Bromophenol blue, 125 mM Tris-HCl pH 6.8 
  
Washing buffer 50 mM Tris-HCl pH 7.5, 5 mM CaCl2, 1 µM ZnCl2, 
2.5 % (v/v) Triton-X-100 
  
Incubation buffer 50 mM Tris-HCl pH 7.5, 5 mM CaCl2, 1 µM ZnCl2, 
1 % (v/v) Triton-X-100 
  
Staining solution 0.125 % (w/v) Coomassie Brillant Blue R-250,  
45.5 % (v/v) EtOH, 9.2 % (v/v) Acetic acid 
Destaining solution 30 % (v/v) EtOH, 10 % (v/v) Acetic acid 
  
1X PBS-T  137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, 0.1 % (v/v) Tween-20, pH 7.4 
  
Blocking solution 10 % HyClone™ Fetal Bovine Serum, 1 % BSA,  
0.3 % Triton-X100 
  
TFB I 50 mM MnCl2, 100 mM KCl, 10 mM CaCl2,  
15 % (v/v) Glyerol, 30 mM Potassium acetate, pH 6.1 
  
TFB II 10 mM MOPS, 10 mM KCl, 75 mM CaCl2,  
15 % (v/v) Glyerol, pH 7 
  
10X G-buffer 50 mM Tris-HCl pH 7.8, 1 mM CaCl2, 2 mM ATP,  
10 mM DTT, 0.1 % (w/v) NaN3 
  
1X G-buffer 5 mM Tris-HCl pH 7.8, 0.1 mM CaCl2, 0.2 mM ATP,  
1 mM DTT, 0.01 % (w/v) NaN3 
20X KME 20 mM MgCl2, 2 M KCl, 4 mM EGTA 
  
20X F-buffer 100 mM Tris-HCl pH 7.8, 4 mM ATP, 20 mM MgCl2,  
2 mM CaCl2, 2 M KCl, , 20 mM DTT, 0.2 % NaN3,  
1 mM EGTA 
  
10X F-buffer 50 mM Tris-HCl pH 7.8, 2 mM ATP, 10 mM MgCl2,  
1 mM CaCl2, 1 M KCl, 10 mM DTT, 0.1 % (w/v) NaN3, 
0.5 mM EGTA 
  
1X F-buffer 5 mM Tris-HCl pH 7.8, 0.2 mM ATP, 1 mM MgCl2,  
0.1 mM CaCl2, 0.1 M KCl,1 mM DTT, 0.01 % (w/v) NaN3), 
0.05 mM EGTA 
10X Anti-bleaching buffer 10 mM Tris-HCl pH 8, 50 mM NaCl, 0.4 % (w/v) Glucose 
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4.4 Organisms 
4.4.1 Bacteria 
E. coli DH5α (Thermo Fisher Scientific, USA) 
Genotype: F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, mk+) phoA 
supE44 thi-1 gyrA96 relA1 λ- 
4.4.2 Human cell lines 
All cell lines were purchased at the American Type Culture Collection (ATCC), USA. 
 
HeLa HeLa is the oldest and most commonly immortal human 
epithelial cell line used in scientific research. These cells were 
isolated from a cervical adenocarcinoma of Henrietta Lacks, a  
31-year old woman, in 1951 without her knowledge or consent. The 
cell line was named ´HeLa´ because of the first two letters of the 
patient's first and last name209. 
 
MDA-MB-231 MDA-MB-231 is a well-established, highly invasive and 
tumorigenic epithelial cell line originating from the metastatic sites 
(pleural effusions) of adenocarcinomas in the mammary gland of a 
51-year old European woman210. These cells are aneuploid since 
chromosomes N8 and N15 are missing. MDA-MB-231 are spindle-
shaped cells which grow randomly, can become confluent and are 
distinct from fibroblasts211. 
 
MCF-10A MCF-10A is a well-known non-tumorigenic epithelial cell line. 
Cells were originally isolated from the benign mammary gland of a 
36 year old Caucasian woman suffering from extensive fibrocystic 
disease212. These cells are immortal, but otherwise normal, 
noncancerous breast epithelial cells. MCF-10A cells are strongly 
adherent: depending on the cell density, it takes about 
15 min - 20 min to detach them from plastic surfaces using 
0.05 % Gibco® Trypsin-EDTA (4.37.2). 
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4.5 Culture media 
Media for E. coli growth: 
 
LB medium213 1 % (w/v) Tryptone, 0.5 % (w/v) Yeast extract, 1 % (w/v) NaCl 
For plates: 1.5 % (w/v) Agar Agar were added 
 
 
 
SOC medium214 2 % (w/v) Tryptone, 0.5 % (w/v) Yeast Extract, 10 mM NaCl,  
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 · 7 H2O, 20 mM Glucose 
NaCl, KCl, MgCl2, MgSO4 and Glucose were sterile filtered and 
added after autoclavation. 
 
Media for human cell lines: 
 
HeLa RPMI 1640 supplemented with 15 % (v/v) HyClone™ Fetal Bovine 
Serum, 1X MEM Amino Acids Solution (50X) and 1X MEM Vitamin 
Solution (100X) 
  
MDA-MB-231 DMEM, high Glucose, GlutaMAX™ supplemented with 10 % (v/v) 
HyClone™ Fetal Bovine Serum 
  
MCF-10A DMEM/Ham's F-12, stable glutamine, supplemented with 5 % (v/v) 
Biochrom AG™ Donor Horse Serum, 20 ng/ml Epidermal Growth 
Factor (EGF), 10 µg/ml Insulin, 100 ng/ml Cholera Toxin, 500 ng/ml 
Hydrocortisone, 1 % (v/v) Penicillin/Streptomycin 
  
2X Freeze medium 50 % (v/v) cell specific growth medium, supplemented with 
30 % (v/v) Serum (HyClone™ Fetal Bovine Serum for HeLa and 
MDA-MB-231; Biochrom AG™ Donor Horse Serum for MCF-10A 
cells), 20 % (v/v) DMSO as cryoprotectant 
 
All bacteria media were autoclaved at 121 °C, 2.1 bar for 20 min prior to usage. Human 
cell culture media were mixed and sterile filtered using a TPP® Filtermax rapid bottle-top filter 
(Dr. Ilona Schubert Laborfachhandel) with a pore size of 0.22 µm. 
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4.6 Media additives 
LB media as well as agar plates for the selection of positive E. coli DH5α clones after 
transformation were supplemented with 50 µg/ml Kanamycin. Kanamycin stock solutions were 
prepared in Millipore water at a concentration of 50 mg/ml. 
Epithelial-to-mesenchymal-transition (EMT) was induced by the addition of transforming 
growth factor beta (TGF-β). For those experiments, MCF-10A medium as well as  
Opti-MEM® I Reduced-Serum Medium were supplemented with 10 ng/ml TGF-β. 
4.7 Plasmids 
pTagGFP-N 
(Evrogen, Russia) 
pTagGFP-N is an eukaryotic expression vector encoding 
green-fluorescent protein TagGFP and designed to generate 
TagGFP-tagged fusions or to express TagGFP in human cells. The 
vector backbone comprises immediate early promoter of 
cytomegalovirus (PCMV IE) for protein expression, SV40 origin for 
replication in human cells expressing SV40 T-antigen, pUC origin of 
replication for propagation in E. coli and f1 origin for ss DNA 
production. The multiple cloning site (MCS) is located between  
PCMV IE and TagGFP coding sequence. SV40 early promoter 
provides NeoR gene expression to select stably transfected 
eukaryotic cells using G418. Bacterial promoter provides KanR gene 
expression in E. coli. 
  
pTag-LifeAct-GFP-N 
(this work) 
The vector pTagGFP-N was used to integrate the DNA 
sequence, encoding LifeAct®, via EcoRI and BamHI into the MCS 
(4.18). 
4.8 DNA oligonucleotides 
All DNA oligonucleotides were purchased from Biomers.net GmbH (Germany) as 
lyophilized product and further solubilized with Millipore water to a final concentration of 
100 µM, respectively. Nucleotides marked with * indicate a PTO modification. Bolded 
sequences are highlighting an EcoRV digestion site. 
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Table 4│DNA oligonucleotides 
Name Sequence 5´3´ 
DNA tetrahedron  
  TetS1 AGGCAGTTGAGACGAACATTCCTAAGTCTGAAATTTATCACC
CGCCATAGTAGACGTATCACC 
TetS2 CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGAGG
GTCCAATACCGACGATTACAG 
TetS3 GGTGATAAAACGTGTAGCAAGCTGTAATCGACGGGAAGAGC
ATGCCCATCCACTACTATGGCG 
TetS4 CCTCGCATGACTCAACTGCCTGGTGATACGAGGATGGGCAT
GCTCTTCCCGACGGTATTGGAC 
TetS1* CTAAGTCTGAAATTTATCACCCGCCATAGTAGACGTATCACC
AGGCAGTTGAGACGAACATTC 
TetS2 - Cy3 Cy3 - CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGC
GAGGGTCCAATACCGACGATTACAG 
TetS4 - Cy5 Cy5 - CCTCGCATGACTCAACTGCCTGGTGATACGAGGATGG
GCATGCTCTTCCCGACGGTATTGGAC 
TetS1* - NH2 NH2 - TCTAAGTCTGAAATTTATCACCCGCCATAGTAGACGTA
TCACCAGGCAGTTGAGACGAACATTC 
TetS2 - NH2 NH2 - TCTTGCTACACGATTCAGACTTAGGAATGTTCGACATG
CGAGGGTCCAATACCGACGATTACAG 
TetS3 - NH2 NH2 - TGGTGATAAAACGTGTAGCAAGCTGTAATCGACGGGA
AGAGCATGCCCATCCACTACTATGGCG 
TetS4 - NH2 NH2 - TCCTCGCATGACTCAACTGCCTGGTGATACGAGGATG
GGCATGCTCTTCCCGACGGTATTGGAC 
  
DNA Trimer  
  
AB - NH2 NH2 – ACTATCTTTGGTCTATTATCTTGAGTCATC 
B*C - NH2 NH2 - GATGACTCAAGATAAACACACACACAACTA 
C*A* - NH2 NH2 - TAGTTGTGTGTGTGTTAGACCAAAGATAGT 
AB - PTO - NH2 NH2 – A*C*T*A*T*CTTTGGTCTATTATCTTGAGT*C*A*T*C* 
B*C - PTO - NH2 NH2 - G*A*T*G*A*CTCAAGATAAACACACACACA*A*C*T*A* 
C*A* - PTO - NH2  NH2 - T*A*G*T*T*GTGTGTGTGTTAGACCAAAGA*T*A*G*T* 
C*A* - PTO - Cy3 Cy3 - T*A*G*T*T*GTGTGTGTGTTAGACCAAAGA*T*A*G*T* 
B*C - PTO - BHQ2 G*A*T*G*ACTCAAGATAAACACACACACAA*C*T*A - BHQ2 
  
Crosslinker  
  60fw-NH2 NH2 - GCTTTCTTCTCTAAATACATCTTCACGTCGATATCACCA
TAACTCAGGTAAGGAGGTCAA 
60rv-NH2 NH2 - TTGACCTCCTTACCTGAGTTATGGTGATATCGACGTGA
AGATGTATTTAGAGAAGAAAGC 
60fw-NH2-PTO NH2 - G*C*T*T*T*C*T*T*T*C*T*A*A*A*T*A*C*A*T*C*T*T*C*A*C*
G*T*C*G*A*T*A*T*C*A*C*C*A*T*A*A*C*T*C*A*G*G*T*A*A*G* 
G*A*G*G*T*C*A*A* 
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60rv-NH2-PTO NH2 - T*T*G*A*C*C*T*C*C*T*T*A*C*C*T*G*A*G*T*T*A*T*G*G* 
T*G*A*T*A*T*C*G*A*C*G*T*G*A*A*G*A*T*G*T*A*T*T*T*A*G*A*
G*A*A*G*A*A*A*G*C* 
60fw GCTTTCTTCTCTAAATACATCTTCACGTCGATATCACCATAAC
TCAGGTAAGGAGGTCAA 
60rv-Cy3 Cy3 - TTGACCTCCTTACCTGAGTTATGGTGATATCGACGTGA
AGATGTATTTAGAGAAGAAAGC 
60fw-Cy3 Cy3 - GCTTTCTTCTCTAAATACATCTTCACGTCGATATCACCA
TAACTCAGGTAAGGAGGTCAA 
60rv-BHQ2 TTGACCTCCTTACCTGAGTTATGGTGATATCGACGTGAAGAT
GTATTTAGAGAAGAAAGC – BHQ2 
60fw-5´NH2 - 3´TT-Cy3 NH2 - GCTTTCTTCTCTAAATACATCTTCACGTCGATATCACCA
TAACTCAGGTAAGGAGGTCAATT - Cy3 
LifeAct® insert  
  LifeAct-fw-EcoRI AATTCATGGGCGTGGCCGACCTGATCAAGAAGTTCGAGAGC
ATCAGCAAGGAGGAG 
LifeAct-rv-BamHI GATCCTCCTCCTTGCTGATGCTCTCGAACTTCTTGATCAGGT
CGGCCACGCCCATG 
PCR primer  
  
Kol-PCR-rv-pTaqGFP TCTTGAAGAAGTCGTTCATC 
Kol-PCR-fw-LifeAct ATGGGCGTGGCCGACCTGAT 
  
4.9 Peptides 
All peptides were obtained as lyophilized products and solubilized with Millipore water or 
methanol to a final concentration of 2 mM - 5 mM, respectively. 
 
Table 5│Peptides 
Name Sequence NC Source 
sC18 
variants 
Cys - sC18 CGLRKRLRKFRNKIKEK Prof. Dr. Ines Neundorf, 
University of Cologne 
 
B: Azidolysin Azide - sC18 BGLRKRLRKFRNKIKEK 
Azide-LifeAct® 
Ac-MGVADLIKKFESISKEEGG-
azidolysine-amid 
PSL Peptide Specialty 
Laboratories GmbH, 
Germany 
Amino-Phalloidin 
Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-
Trp-(4R)-4-hydroxy-4-Me-Orn) 
(Sulfide bond between Cys and 
indol-2-yl) 
Bachem AG, 
Switzerland 
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4.10 Proteins 
EGF Recombinant Human Protein Thermo Fisher Scientific, USA 
Pyrene Muscle Actin (Rabbit skeletal muscle) Cytoskeleton Inc., USA 
Muscle Actin (Rabbit skeletal muscle) Isolated from rabbit muscles, 
Fraunhofer IZI, Leipzig 
  
Recombinant Human TGF-beta 1 Bio-Techne GmbH, Germany 
Recombinant Human Fascin protein Abcam, UK 
4.11 Equipment and expendables 
7900HT Fast Real-Time PCR System  Applied Biosystems, USA  
8-well on cover glass II  Sarstedt, Germany 
8-well on glass, detachable Sarstedt, Germany 
AFM cantilever ACTA-10 AppNano, USA 
AFM cantilever USC-F0.3-k0.3  Asylum Research, USA  
Äkta Avant 25 GE Healthcare Europe GmbH, 
Germany 
Amicon®-Ultra-4 centrifugal filter units, 10K MWCO  EMD Millipore, Germany  
Amicon®-Ultra-0.5 centrifugal filter units, 
3K MWCO, 30 K MWCO 
EMD Millipore, Germany  
Atomic force microscope NanoWizard 3.0  JPK Instruments AG, Germany  
BioPhotometer (spectrophotometer)  Eppendorf AG, Germany  
BioSep™SEC-s2000 column Phenomenex, USA 
CELLSTAR® Filter Cap Cell Culture Flasks, TC-
treated 
Greiner Bio-One International GmbH, 
Austria 
CELLSTAR® multiwell plates (96-well, 24-well, 12-
well, 6-well) 
Greiner Bio-One International GmbH, 
Austria 
Centrifuge 5424 R Eppendorf AG, Germany 
Combitips Advanced® Eppendorf AG, Germany 
Cover slips, 24 mm x 60 mm VWR, USA 
Cultrex® 24 Insert Cell Invasion / Migration 
Chamber 
Biozol Diagnostica, Germany 
CryoPure tube 2.0 ml Sarstedt, Germany 
Culture-Inserts, 2-well Ibidi, Germany 
DNA LoBind reaction tube (1.5 ml, 2 ml) Eppendorf AG, Germany  
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Dynamic Shear Rheometer (ARES) TA Instruments, USA 
Eppendorf ThermoMixer® C Eppendorf AG, Germany 
Flow cytometer iQue™ Screener IntelliCyt®, USA 
Gel documentation system Gel Jet Imager   Intas, Germany 
Gel electrophoresis apparatus Power Supply 
Power Pac Basic 
BioRad Laboratories, Germany 
HeraeusMultifuge® 3SR+ Thermo Fisher Scientific, USA 
Incubator Function Line B20  Thermo Fisher Scientific, USA 
Incubator HERAcell® 240  Thermo Fisher Scientific, USA 
KIMTECH SCIENCE® Precision Wipes  Kimberly-Clark Professional, 
Germany  
LightCycler® 480 Sealing Foil  Roche Life Science, Switzerland  
LSM 710/AxioObserver Carl Zeiss Microscopy GmbH, 
Germany 
Leica DM IRB phase contrast microscope Leica Microssystems GmbH, 
Germany 
Leica DMIL LED inverted microscope Leica Microssystems GmbH, 
Germany 
Luna II™ automated cell counter Biozym, Germany 
Luna™ cell counting slides Biozym, Germany 
Magnetic stirrer MR Hei-Tec Heidolph, Germany 
Mettler Toledo™ XP6U Micro Comparator Mettler-Toledo, Germany 
Mica “V1”, 12 mm round  Plano GmbH, Germany  
MicroAmp® Fast Optical 96-Well Reaction Plate  Applied Biosystems, USA  
Microliter centrifuge Micro 200 R  Andreas Hettich GmbH & Co.KG, 
Germany  
Microplate 96-well (black), fluorotrac Greiner Bio-One International GmbH, 
Austria 
Microscope slides, 25 mm x 75 mm VWR, USA 
Mini-PROTEAN® Tetra Handcast Systems BioRad Laboratories, Germany 
Mr. FrostyTM freezing container Thermo Fisher Scientific, USA 
Multipette® M4 Eppendorf, Germany 
NanoDrop ND-1000 UV/Vis  PEQLAB Biotechnologie GmbH, 
Germany  
New Brunswick™ Innova® 44 incubator shaker New Brunswick Scientific, USA 
Parafilm® M Sigma-Aldrich, Germany  
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pH Meter Lab 870  SI Analytics GmbH, Germany  
Polymax 1040 waving platform shaker Heidolph Instruments GmbH & Co. 
KG, Germany 
Quintix® Analytical Balance 2102-1S Sartorius Lab Instruments GmbH, 
Germany 
Real-time deformability cytometer (RTDC) 
AcCellerator 
Zellmechanik Dresden GmbH, 
Germany 
Reprorubber® Thin Pour JPK Instruments AG, Germany 
Rotilabo®-syringe filters CME 0.22 μm Carl Roth GmbH, Germany  
Spinning disc confocal microscope (Inverted Axio 
Observer.Z1/Yokogawa CSU-X1A 5000) 
Carl Zeiss Microscopy GmbH, 
Germany 
SPROUT® MINI CENTRIFUGE 12V Heathrow Scientific® LLC, USA 
Sterile tweezers Dr. Ilona Schubert Laborfachhandel, 
Germany 
TECAN Infinite® M1000 Tecan Group AG, Switzerland 
TPP® Filtermax rapid bottle-top filter, 0.22 µm Dr. Ilona Schubert Laborfachhandel, 
Germany 
TProfessional Thermocycler Biometra GmbH, Germany  
UVette®  Eppendorf AG, Germany  
Vortex-Genie® 2 Scientific Industries Inc., USA 
Water bath  GFL Gesellschaft für Labortechnik 
mbH, Germany  
Zetasizer Nano ZSP Malvern Instruments, UK 
4.12 Software 
Gel-Dokumentationssoftware Intas GDS Intas, Germany 
JPK SPM and DP software (AFM measurements 
and data processing) 
JPK Instruments AG, Germany 
Gwyddion (processing AFM images) http://gwyddion.net/ 
PyMOL (3D structures of proteins) https://pymol.org/2/ 
ForeCyt v4.1 IntelliCyt®, USA 
ShapeOut (evaluation RTDC measurements) Zellmechanik Dresden GmbH, 
Germany 
ZEN2 blue Carl Zeiss Microscopy, Germany 
Magellan 5 Tecan Group AG, Switzerland 
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ImageJ (plus Mitobo plugin) https://imagej.nih.gov/ij/; 
https://imagej.net/MiToBo 
ChemSketch (drawing chemical formula) http://www.acdlabs.com/resources/ 
freeware/chemsketch/ 
ProtParamTool ExPasy (http://www.expasy.ch) 
Reverse translation tool http://www.bioinformatics.org/sms2/ 
rev_trans.html 
Codon usage database http://www.kazusa.or.jp/codon/ 
Adobe Illustrator CS4 Adobe Systems, USA 
Microsoft Office 2016 Microsoft, USA 
Citavi 5 Swiss Academic Software, 
Switzerland 
Ligation calculation tool https://nebiocalculator.neb.com/#!/ 
ligation 
4.13 Isolation of plasmid DNA from E. coli cells 
Plasmid-DNA, which was further used in human cell culture, was isolated from E. coli 
using the E.Z.N.A.® Endo-Free Plasmid Mini Kit I (VWR) according to manufacturers’ 
instructions. Plasmid-DNA was stored at -20 °C in elution buffer. 
4.14 Determination of DNA concentration 
DNA concentration was measured by absorbance (UV/VIS) spectroscopy at 260 nm 
using the NanoDrop ND-1000 UV/VIS spectrophotometer (PEQLAB Biotechnologie GmbH). 
Using the Lambert-Beer equation (Equation 8), with A = absorbance at 260 nm, ε = extinction 
coefficient at 260 nm [μl · ng-1 · cm-1], c = DNA concentration [ng · µl-1] and d = layer 
thickness [cm], the amount of absorbed light can be related to the concentration of the 
absorbing DNA.  
 
𝐴 =  𝜀 ×  𝑐 ×  𝑑 
        Equation 8 
 
The average extinction coefficient of ds DNA at 260 nm is 0.02 μl · ng-1 · cm-1, of ss DNA 
it is 0.027 μl · ng-1 · cm-1. DNA purities were estimated form the ratio of absorbance at 260 nm 
and 280 nm (A260/A280). 
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4.15 Electrophoretic separation of DNA 
4.15.1 Agarose gel electrophoresis 
For analytic separation of plasmid-DNA and DNA fragments, 1 % (w/v) agarose gels 
containing EtBr were used (4.3). DNA samples (100 ng each) were mixed with 6X DNA loading 
buffer and separated with a constant voltage of 100 V. After 60 min, DNA was visualized using 
the gel documentation system Gel Jet Imager (Intas). GeneRulerTM 1 kb DNA Ladder (Thermo 
Fisher Scientific) was run on the agarose gel as a molecular weight standard to determine the 
size of DNA fragments. 
4.15.2 Native Polyacrylamide gel electrophoresis (PAGE) 
In order to analyze the functionalization of short, ss DNA fragments as well as small DNA 
nanostructures, such as the DNA tetrahedron, native PAGE gels were utilized. 
Six % - 20 % (v/v) PAGE gels , containing 6 % - 20 % (v/v) Acrylamide-bisacrylamide (29 : 1), 
1X TBE (4.3), 1 % (w/v) APS and 0.1 % TEMED, were prepared using the Mini-PROTEAN® 
Tetra Handcast System (Bio-Rad). DNA samples (100 ng) were mixed with 6X DNA loading 
buffer and added into rinsed gel slots. Native PAGE gels were run at 100 V - 120 V for 
60 min - 90 min at room temperature in 1X TBE buffer. After running, gels were stained for 
5 min with SYBR® Gold nucleic acid gel stain (1 : 10,000 dilution in 1X TBE) and further 
visualized under UV-light using the Gel documentation system Gel Jet Imager (Intas). 
GeneRulerTM Low Range DNA Ladder (Thermo Fisher Scientific) was run on native PAGE gels 
as a molecular weight standard. 
PAGE gels containing DNA tetrahedra, both gel and running buffer were supplemented 
with 5 mM MgCl2 in order to stabilize the DNA structures. 
4.16 Ethanol precipitation 
For purification of modified oligonucleotides, samples were mixed with 0.1X volumes  
3 M sodium acetate and 2X volumes of absolute ethanol followed by a 5 min incubation in 
liquid nitrogen. Right after, samples were centrifuged for 1 h at 4 °C and 16,500 rcf. The 
supernatant was carefully removed and the pellet was air dried for 5 min to 10 min. Purified 
DNA was dissolved in 1X DPBS or Millipore water and stored at -20 °C prior to usage. 
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4.17 Spin filtration 
To purify DNA structures from excess peptides or other conjugation molecules, Amicon®-
Ultra Centrifugal Filter Devices  (EMD Millipore) varying in size (e.g. Amicon®-Ultra-0.5, 
Amicon®-Ultra-4) and MWCO (e.g. 3 K, 10 K, 30 K) were used according to manufacturer´s 
instructions. All devices were pre-rinsed with corresponding buffer or Millipore water. 
4.18 Cloning 
4.18.1 Restriction digest of Plasmid DNA 
Vector pTagGFP-N was digested with BamHI and EcoRI according to manufacturers’ 
instructions. Linearized vector was further purified with NucleoSpin® Gel and PCR Clean up 
Kit (Macherey - Nagel) and analyzed via 1 % (w/v) agarose gel electrophoresis. 
4.18.2 Hybridization of cloning insert 
The aim of the cloning was the generation of a vector encoding the LifeAct® sequence161 
with whom HeLa cells could be transfected to visualize actin structures within cells. In order to 
receive the correct DNA sequence that could be transcribed and translated in HeLa cells 
(4.4.2) later on, the original peptide sequence was back translated under the codon usage of 
Homo sapiens sapiens (4.12). Additionally, the obtained sequence was extended with EcoRI 
and the complementary strand with BamHI digestion sites. Since LifeAct® is a short peptide, 
the corresponding DNA sequence is likewise short. Thus, the DNA sequence was not obtained 
by gene amplification but synthesized through Biomers.net GmbH (Germany). Complementary 
sequences, already containing BamHI or EcoRI digestion sites (4.8), were hybridized at 50 nM 
in a final volume of 20 µl using the TProfessional Thermocycler (Biometra GmbH). 
 
Denaturation 95 °C 2 min 
Hybridization  81 °C 10 min 
Storage 4 °C  
 
The resulting ds DNA fragment had BamHI and EcoRI overhangs of four nucleotides 
each, as they would be generated during digestion with corresponding restriction enzymes. 
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4.18.3 Ligation 
Using the ligation calculator (4.12), the mass of insert required at a molar insert : vector 
ratio of 5 : 1 for a typical ligation reaction with T4 DNA Ligase (New England Biolabs) was 
calculated. The reaction mixture was incubated for 1 h at room temperature and heat 
inactivated for 10 min at 65 °C afterwards. 
 
Reaction mixture: 
 Concentration Mastermix (1X) 
Linearized, purified pTagGFP-N (4730 bp) 23.41 nM 1.46 µl 
Hybridized DNA fragment (56 bp) 50 nM 1.71 µl 
10X T4 DNA Ligase buffer  2 µl 
T4 DNA Ligase 1 U/ml 1 µl 
dd H2O  13.83 µl 
  Σ = 20 µl 
4.19 Transformation 
4.19.1 Preparation of competent E. coli cells 
Competent E. coli cells were prepared according to Green & Rogers (2013)215. Five ml 
LB medium were inoculated with 50 µl of E. coli DH5α cells and cultured overnight at 37 °C in 
a New Brunswick™ Innova® 44 incubator shaker (New Brunswick Scientific). The next day, 
100 ml LB medium were inoculated with 1 ml stationary E. coli overnight culture and grown at 
37 °C and 200 rpm until an OD600 of 0.45 - 0.55 was reached. After placing them on ice for 
10 min, cells were centrifuged for 4 min at 4 °C and 4,000 rpm. The supernatant was discarded 
and the pellet resuspended in 30 ml ice-cold TFB I buffer. After 45 min incubation on ice, cells 
were again pelleted at 4,000 rpm for 4 min at 4 °C and resuspended in 4 ml ice-cold TFB II 
buffer. Aliquots of 50 µl each were pipetted into 1.5 ml reaction tubes, immediately frozen in 
liquid nitrogen and stored at -80 °C. 
4.19.2 Transformation of E. coli 
For transformation of E. coli DH5α, 5 µl of inactivated ligation solution was pipetted to 
50 µl partially thawed cells. The mixture was incubated for 30 min on ice and then heat-
shocked for 30 s at 42 °C. After heat-shock, samples were placed on ice for 5 min. Right after, 
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400 µl ice-cold SOC medium were added and cells incubated for 60 min at 37 °C and 300 rpm 
in an Eppendorf ThermoMixer® C (Eppendorf AG). Transformed cells were plated at different 
concentrations on kanamycin-selective agar plates and incubated overnight at 37 °C. As a 
negative control, untransformed E. coli DH5α cells were plated. Since these cells do not carry 
the pTagGFP-N vector, they should not grow on kanamycin-containing agar plates. 
4.20 Amplification of DNA fragments through polymerase chain reaction 
Polymerase chain reaction (PCR) was utilized to amplify DNA fragments. DNA 
amplification was performed using Hot Start Taq DNA Polymerase (New England Biolabs) 
according to manufacturers’ instructions. PCR products were analyzed by agarose gel 
electrophoresis (4.15.1). 
Colony PCR 
To determine the presence of the LifeAct® insert in the plasmid construct of previously 
transformed competent E. coli DH5α cells, a colony PCR was performed. Positive clones were 
identified using insert specific primers (4.8, supplemental Figure S 7). After transformation, 
single colonies were picked from agar plates using an inoculation needle and resuspended in 
5 µl dd H2O in 0.2 µl PCR reaction tubes. After resuspension, 15 µl of the following reaction 
mixture were added to a final volume of 20 µl. 
 
Reaction mixture: 
 Mastermix (1X) 
10 µM Kol_PCR_rv_pTaqGFP 1 µl 
10 µM Kol_PCR_fw_LifeAct 1 µl 
10 mM dNTP Mix 0.4 µl 
10X Hot Start Taq DNA Polymerase buffer 2 µl 
Hot Start Taq DNA Polymerase 0.1 µl 
dd H2O 10.4 µl 
 Σ = 15 µl 
 
As negative control, 0.1 µl pTagGFP-N (empty vector) was pipetted into 4.9 µl dd H2O in 
a 0.2 ml PCR reaction tube and 15 µl of the reaction mixture were added. Gene amplification 
was performed in a TProfessional Thermocycler (Biometra GmbH). 
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Reaction protocol: 
 
Initial denaturation 95 °C 2 min 
Denaturation 95 °C 30 s 
Annealing 52 °C 30 s 
Elongation 60 °C 45 s 
Final elongation 60 °C 5 min 
Storage 4 °C  
4.21 DNA Sequence analysis 
Plasmid-DNA was verified by DNA sequencing. Samples of 50 ng/µl to 100 ng/µl were 
analyzed at GATC Biotech AG (Germany). 
4.22 Cultivation and storage of E. coli cells 
E. coli was generally grown at 37 °C in shaking cultures using various media (4.5). Cell 
growth was determined in an UVette® (Eppendorf AG) by measuring the optical density at 
600 nm (OD600) using the spectrophotometer BioPhotometer (Eppendorf AG). Plasmid-
carrying cells were selected through corresponding antibiotics in media and agar plates  
(4.5, 4.6). Agar plates were incubated overnight at 37 °C in the microbiological incubator 
Function Line B20 (Thermo Scientific Heraeus). For long-term storage of E. coli cells, glycerol 
stocks were prepared. Therefore, 250 µl of 80 % (v/v) glycerol were added to 750 µl of mid-log 
phase E. coli cells and stored at -80 °C. 
4.23 Folding of DNA structures 
4.23.1 Folding of DNA tetrahedra 
Four partially complementary oligonucleotides with 63 nt each were hybridized to form 
DNA tetrahedra16. DNA sequences (Table 4) were mixed in equimolar amounts in 1X TM buffer 
(4.3). The folding of the structure with S1 and S1* differed in the assembly of tetrahedra with 
either two nicks each face or three nicks on one face and one nick on another face. DNA 
tetrahedra were typically hybridized at 500 nM to 1 µM. The reaction mixture was heated to 
95 °C for 2 min and rapidly cooled down to 4 °C using a TProfessional Thermocycler 
40 cycles 
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(Biometra GmbH). The assembly was analyzed via 6 % (v/v) native PAGE (4.15.2) and 
visualized by AFM imaging (4.30.1, Figure 30). 
 
Example reaction mixture to assemble 500 nM DNA tetrahedra: 
 
10 µM TetS1/TetS1* 2.5 µl 
10 µM TetS2  2.5 µl 
10 µM TetS3 2.5 µl 
10 µM TetS4 2.5 µl 
10X TM 5 µl 
dd H2O 35 µl 
 Σ = 50 µl 
  
4.23.2 Folding of DNA trimers 
Similar to the self-assembly of DNA tetrahedra, DNA trimers were formed. Here, three 
partially complementary DNA strands of 30 nt each were designed to form a three-arm junction 
when they hybridize. To illustrate the geometry, the open ends of a DNA trimer were 
designated A, B, and C, respectively. The names of the DNA strands (Table 4) indicate their 
complementarity to the part of the other sequences. As an example, strand AB is 
complementary to A* of the C*A* strand and B is complementary to B* of the B*C strand. DNA 
sequences were mixed in equimolar amounts to a final concentration of 2 µM in  
100 mM KH2PO4 pH 7.2. DNA trimers were assembled in a TProfessional Thermocycler 
(Biometra GmbH) and subsequently analyzed via 10 % (v/v) native PAGE. 
 
Example reaction mixture and assembly program: 
 
50 µM AB 4 µl  Denaturation 95 °C 2 min 
50 µM B*C  4  µl  Hybridization  48 °C 15 min 
50 µM C*A 4 µl  Storage 4 °C ∞ 
1 M KH2PO4 pH 7.2 10 µl     
dd H2O 78 µl     
 Σ = 100 µl     
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4.24 Size exclusion chromatography (SEC) 
Even though the self-assembly of DNA tetrahedra was at a high yield, a decent amount 
of aggregations formed. In order to separate correctly formed structures from aggregates, DNA 
tetrahedra were purified with SEC using an Äkta Avant 25 (GE Healthcare Europe GmbH) 
chromatography system. DNA tetrahedra were assembled at 500 µl of 1 µM (4.23.1) in 
1X TM II buffer (4.3) and injected into a 0.5 ml injection loop using a plastic syringe. The 
sample was the applied onto a BioSep™SEC-s2000 column (Phenomenex), pre-equilibrated 
with 1X TM II (mobile phase buffer). The flow rate was set to 0.6 ml/min and the DNA structures 
were isocratically eluted with elution buffer (4.3). DNA was detected at 260 nm and peak 
fractions collected. Samples were analyzed via 8 % (v/v) native PAGE (4.15.2). Fractions of 
same peaks were pooled, concentrated and buffer exchanged to 1X TM buffer via spin filtration 
using Amicon®-Ultra-0.5 centrifugal filter units with 30 K MWCO (4.17). 
4.25 Heterobifunctional linkers 
Bifunctional linkers possess different reactive groups at either end and are used to 
covalently couple molecules, such as DNA, peptides, proteins or dyes that carry specific 
functional groups. These crosslinking reagents allow for both single-step conjugations as well 
as for sequential conjugations. Figure 16 shows heterobifunctional linker molecules that were 
utilized in this work. Detailed reaction mechanisms of individual functional groups are to be 
found in section 2.2.2, 2.2.3 and 2.2.4, respectively. 
Sulfo-SMCC is a water-soluble linker reactive to primary amine groups via  
N-hydroxysuccinimide (NHS) ester (red) and sulfhydryls via maleimide group (purple). This 
linker was used to covalently couple DNA to cysteine-containing peptides (Figure 19). DBCO-
NHS ester also reacts with primary amines via NHS ester (red) but can be further clicked to 
azide-containing molecules via its DBCO group (green, Figure 21). Also involved in copper-
free click chemistry is the bifunctional linker azidopropionic acid sulfo-NHS ester. Again it has 
activity for primary amine groups but can be clicked to strained alkynes in a SPAAC reaction 
(2.2.4). 
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Figure 16│Chemical structures of utilized heterobifunctional linkers. All three used linker 
molecules contain (sulfo)-NHS esters (red) that react with primary amines. Sulfo-SMCC contains a 
maleimide group that is reactive for sulfhydryl groups. Both DBCO-NHS ester as well as azidopropionic 
acid sulfo-NHS ester are utilized in copper-free click chemistry. A DBCO group (green) reacts with an 
azide (pink) under the formation of a triazole. The reaction mechanisms of these functional groups are 
described in 2.2.2, 2.2.3 and 2.2.4, respectively. 
4.26 Functionalization of DNA tetrahedra with CPP 
In order to tune the dynamics of the active cellular uptake and internal trafficking of DNA 
nanostructures, DNA tetrahedra were modified with cell-penetrating peptides (CPP). In the 
following, two different conjugation strategies, leading to either DNA tetrahedra with CPP 
chains or DNA tetrahedra with single CPP attached, are introduced. 
4.26.1 DNA tetrahedra functionalized with CPP chains 
Before the manufacturing process is described in more detail, a brief overview of the 
individual steps is pictured in Figure 17. Initially, a tail of aminoallyl-dUTPs was added to single 
Tet sequences using TdT. After purification, DNA tetrahedra with amino-modified sequences 
were assembled and sulfo-SMCC, a bifunctional linker, which reacts with primary amine 
groups as well as sulfhydryl groups, was added. Excess linker molecules were removed 
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through spin filtration and cysteine-containing CPP, which were previously reduced with TCEP, 
were added to react with the maleimide group of sulfo-SMCC in a covalent manner. 
 
 
Figure 17│Schematic of engineering DNA tetrahedra carrying CPP chains. Partially 
complementary Tet sequences were modified with aminoallyl-dUTP at the 3´ end using TdT. After the 
assembly of modified strands, sulfo-SMMC was covalently attached to the DNA structure via NHS ester. 
In a last step, TCEP reduced CPP containing a free sulfhydryl group were bound to the DNA tetrahedron 
in a covalent manner via the maleimide group of the bifunctional linker. 
 
In the following, the conjugation strategy for the generation of DNA tetrahedra carrying 
CPP chains is explained in more detail. 
 
Terminal deoxynucleotidyl transferase (TdT) reaction 
In order to enable the multiple binding of sulfo-SMCC and thus CPP, Tet sequences (4.8) 
were enzymatically modified with aminoallyl-dUTPs on the 3´-ends using Terminal 
deoxynucleotidyl transferase (TdT, Roche). The reaction mechanism is illustrated in Figure 3 
and explained in 2.2.1. The reaction mixture for each Tet sequence was incubated for 30 min 
at 37 °C in an Eppendorf ThermoMixer® C (Eppendorf AG). To stop the reaction, the samples 
were placed on ice and 2 µl of 0.2 M EDTA were added. Aminoallyl-dUTP elongated DNA 
sequences were purified either by ethanol precipitation (4.16) or using the NucleoSpin® Gel 
and PCR Clean up Kit (Macherey - Nagel) according to manufacturers’ instructions. DNA 
samples were eluted with pre-warmed 100 mM KH2PO4, instead of the elution buffer delivered 
with the kit since this buffer contained Tris which would disturb the following NHS ester 
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reaction. DNA concentrations were determined using a NanoDrop ND-1000 UV/VIS 
spectrophotometer (PEQLAB Biotechnologie GmbH) (4.14). 
 
The TdT reaction mixture consisted of: 
 
approximately 100 pmol free 3´ ends of TetS1 / S1* / S2 / S3 / S4  
200 µM aminoally-dUTP in different ratios (1 : 3 or 1 : 10)  
5X TdT reaction buffer 4 µl 
25 mM CoCl2 4 µl 
TdT 0.1 µl 
dd H2O x µl 
 Σ = 20 µl 
 
Assembly of amine-modified Tet sequences 
Aminoallyl-dUTP elongated Tet sequences were mixed in equimolar amounts and folded 
as explained in 4.23.1 at 500 nM. Modified DNA tetrahedra were not folded in 1X TM buffer 
but in 100 mM KH2PO4. 
 
Addition of sulfo-SMCC 
The heterobifunctional linker sulfo-SMCC (Figure 16) was freshly prepared prior to use 
at a stock concentration of 10 mM in DMSO and subsequently added in a 50-fold molar excess 
towards DNA. The reaction mixture was incubated overnight at room temperature. The next 
day, samples were spin filtered using Amicon®-Ultra-0.5 centrifugal filter units with 3 K MWCO 
(4.17) to get rid of excess sulfo-SMCC which would interfere with the maleimide reaction in the 
next step. 
 
Reduction of Cystein-containing CPP with TCEP and addition to DNA tetrahedra 
CPP (Cys - sC18) were solubilized at a concentration of 2 mM - 5 mM with Millipore 
water (4.9). Since Cys - sC18 peptides contain N-terminal cysteines, they tend to form dimers 
via disulfide bridges. In order to bind them to DNA tetrahedra, disulfide bonds had to be cleaved 
by reduction with tris(2-carboxyethyl)phosphine (TCEP)216 (Figure 18). TCEP is particularly 
useful when cysteine residues are coupled to maleimides. It is stable in aqueous solutions, 
tolerates a wide pH range and does not undergo rapid oxidation that often occurs with other 
reducing agents such as dithiotreitol (DTT) and β-mercaptoethanol217,218. In order to remove 
TCEP after reduction, TCEP conjugated agarose beads were utilized (Pierce™ Immobilized 
TCEP disulfide reducing gel, Thermo Fisher Scientific). Sixty µl of TCEP disulfide reducing gel 
were spun for 1 min at 1,000 rcf. After the supernatant was removed, TCEP agarose beads 
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were mixed with 30 µl 2 mM Cys - sC18 and incubated for 2 h at room temperature. The 
mixture was then spun again for 1 min at 1,000 rcf and the supernatant, containing reduced 
peptides, was transferred into a new reaction tube. Reduced peptides were added to SMCC-
conjugated DNA tetrahedra in a 100-fold molar excess and incubated at 4 °C overnight. 
 
 
Figure 18│Reduction of disulfides with TCEP219. Disulfide bonds that occur within cysteine-
containing peptides or proteins can be rapidly cleaved by tris(2-carboxyethyl)phosphine. This reduction 
is rather important when coupling thiol-containing molecules to maleimides. 
 
 
Figure 19│Reaction mechanism of conjugation of DNA and peptide via sulfo-SMCC. The primary 
amine group of the DNA reacts with the sulfo-NHS ester of sulfo-SMCC in a first step under the release 
of sulfo-NHS (red). In a second step, the DNA bound linker molecule reacts with sulfhydryl-groups of 
previously reduced cysteine-containing peptides via its maleimide group (purple). 
 
The whole conjugation process was stepwise analyzed via 6 % (v/v) native PAGE 
(4.15.2). The final structure was also investigated via AFM imaging (4.30.1, Figure 30). 
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4.26.2 DNA tetrahedra functionalized with single CPP molecules 
To gain a better overview about the fabrication process, the different steps are illustrated 
in Figure 20. In order to generate DNA tetrahedra with single CPP functionalization, Tet 
sequences already containing a 5´ NH2 modification were first conjugated to DBCO-NHS 
esters. After purification, DBCO-modified Tet strands were clicked to an azide-containing CPP 
via copper-free click chemistry (SPAAC). Finally, CPP-conjugated oligonucleotides were 
assembled to functionalized DNA tetrahedra. 
 
 
Figure 20│Schematic of engineering DNA tetrahedra coupled to single CPP molecules. Partially 
complementary Tet sequences already synthesized with a 5´ NH2 modification were covalently coupled 
to DBCO-NHS esters. In the next step azide-containing CPP were clicked to DBCO-functionalized 
strands (SPAAC, see 2.2.4). Purified, CPP-conjugated strands were assembled to the full DNA 
structure. 
 
In the following, the conjugation strategy for the fabrication of DNA tetrahedra 
functionalized with single CPP molecules is explained in more detail and an overview about 
the chemical reactions is given in Figure 21. 
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Figure 21│Reaction mechanism of conjugation of DNA and peptide via DBCO-NHS ester. Amine-
reactive DBCO-NHS esters react with NH2 groups of DNA (red). NHS is released and DNA covalently 
coupled to DBCO, which further reacts with an azide-containing peptide under the formation of a trizole 
in a covalent manner (green). 
 
Addtion of DBCO-NHS ester 
The heterobifunctional linker DBCO-NHS ester (Figure 16) was freshly prepared prior to 
use at a stock concentration of 10 mM in DMSO. The dissolved linker was subsequently added 
to 5´NH2 Tet sequences (4.8) in a 100-fold molar excess and incubated overnight at room 
temperature. Next day, samples were purified using the NucleoSpin® Gel and PCR Clean up 
Kit (Macherey - Nagel) according to manufacturers’ instructions. DBCO-functionalized 
oligonucleotides were eluted in pre-warmed 1X TM buffer and DNA concentrations were 
determined using a NanoDrop ND-1000 UV/VIS spectrophotometer (PEQLAB Biotechnologie 
GmbH) (4.14). 
 
Addition of Azide-containing CPP 
Azide-containing CPP (azide - sC18) were freshly solubilized at a concentration of  
2 mM - 5 mM with Millipore water (4.9). In the next step, peptides were added to DBCO-
modified oligonucleotides in a 50-fold to 100-fold molar excess and incubated overnight. 
Samples were eluted with 1X TM buffer after the subsequent purification with the NucleoSpin® 
Gel and PCR Clean up Kit (Macherey - Nagel). Concentrations were spectrophotometrically 
measured at a NanoDrop. 
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Annealing of CPP-conjugated oligonucleotides 
CPP-conjugated Tet sequences were mixed in equimolar amounts and assembled as 
explained in 4.23.1 at 500 nM. The whole conjugation process was stepwise monitored via 
6 % (v/v) native PAGE (4.15.2). The final structure was also investigated with AFM imaging 
(4.30.1, Figure 30). 
4.27 Functionalization of DNA trimers with CPP 
DNA trimers were functionalized with single CPP as previously described with DNA 
tetrahedra (4.26.2). Amine-modified oligonucleotides (Table 4) were first coupled to DBCO-
NHS esters. After purification, DBCO-modified trimer strands were clicked to an azide-
containing CPP (Table 5) via copper-free click chemistry (SPAAC). Samples were eluted with 
1X TM buffer after the subsequent Kit purification and concentrations were spectro-
photometrically determined at a NanoDrop. Finally, CPP-conjugated oligonucleotides were 
hybridized to a functionalized DNA trimer as explained in 4.23.2 and assembly monitored via 
10 % native PAGE (4.15.2). 
 
 
Figure 22│Functionalization of DNA trimers with single CPP molecules. Partially complementary 
oligonucleotides containing a 5´ NH2 modification were covalently bound to DBCO. In the next step, 
azide-containing CPP were clicked to DBCO-functionalized strands (SPAAC, see 2.2.4). Kit purified, 
CPP-conjugated oligonucleotides were assembled to DNA trimers. 
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4.28 Engineering synthetic actin crosslinkers 
At the very beginning, complementary DNA strands are hybridized and covalently 
conjugated to dibenzocyclooctyne via DBCO-NHS ester on each site of the double strand. 
After purification, azide-containing actin-binding peptides were clicked to previously attached 
DBCO groups. An overview about the engineering process is given in Figure 23. 
 
 
Figure 23│Engineering synthetic actin crosslinkers. A copper-free click chemistry approach39 was 
used to covalently attach actin-binding peptides to ds DNA. After hybridization of the complementary 
strands, DBCO-NHS ester covalently reacts with primary amine groups on each end of the double-
stranded DNA-spacer. Subsequently, an azide-containing actin-binding peptide reacts with the previous 
attached DBCO group in a covalent manner. 
 
In a first step, complementary 60 nt DNA strands (Table 4) were mixed in equimolar 
amounts and hybridized in 100 mM KH2PO4 pH 7.2 at a final concentration of 25 mM in a 
TProfessional Thermocycler (Biometra GmbH) with the following program: 
 
Denaturation 95 °C 2 min 
Hybridization  71.6 °C 15 min 
Storage 4 °C ∞ 
 
DBCO-NHS ester was dissolved in DMSO to a concentration of 10 mM, added in a 100-
fold molar excess to previously hybridized DNA, and incubated overnight at room temperature. 
DBCO-modified ds DNA was purified via ethanol precipitation (4.16) and concentrations were 
measured using a NanoDrop ND-1000 UV/VIS spectrophotometer (PEQLAB Biotechnologie 
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GmbH) (4.14). Next, azide-containing peptides (i.e. LifeAct®, Table 5) were added in a 50 to 
100-fold molar excess to DBCO-DNA and incubated over night at room temperature. 
 
 
Figure 24│Coupling of azidopropionic acid sulfo-NHS ester to amine-Phalloidin. Phalloidin 
carrying a primary amine group was covalently conjugated to an azide group via azidopropionic acid 
sulfo-NHS ester. 
Material and Methods 
66 
 
Since Phalloidin could not be purchased as azide-coupled molecule, azidopropionic acid 
sulfo-NHS ester (Figure 24) was coupled to amine-Phalloidin (4.9) to introduce an azide group. 
Therefore, azidopropionic acid sulfo-NHS ester was dissolved in DMSO to a concentration of 
10 mM, mixed in equal molar amounts with amine-Phalloidin in 100 mM KH2PO4 pH 7.2, and 
incubated over night at room temperature. No further purifications were performed and peptide 
was added in a 50 to 100-fold molar excess to DBCO-DNA as described above. 
To remove excess peptides, samples were spin filtered using Amicon®-Ultra-4 centrifugal 
filter units with 10K MWCO (4.17) in 1X DBPS (w/o Calcium, w/o Magnesium). The successful 
synthesis and the purity of wLX and sPX was verified via 10 % (v/v) native PAGE (4.15.2). 
Synthetic crosslinkers were stored at - 20 °C with no detectable degradation. 
4.29 Stability of DNA structures 
To investigate how stable utilized DNA structures (i.e. DNA trimers and crosslinkers with 
and without phosphorothioate (PTO) modifications) are against nucleases, they were 
incubated with DNase I (endonuclease) and Exonuclease III. 
In a first approach, PTO-capped as well as uncapped DNA trimers (Table 4) were 
assembled (4.23.2) at a final concentration of 2 µM. DNA trimers were mixed with 
Exonuclease III (New England Biolabs) and 10X NEBuffer according to manufacturers’ 
instructions and were incubated for 1 min, 5 min, 10 min, 20 min and 30 min at 37 °C in a 
Eppendorf ThermoMixer® C (Eppendorf AG), respectively. Right after, the enzyme was heat-
inactivated for 20 min at 70 °C. Samples were analyzed via 10 % (v/v) native PAGE (4.15.2). 
Similar experiments were conducted for 60bp DNA that was used for engineering synthetic 
actin crosslinkers. In this case, full-PTO protected 60bp DNA as well as unprotected 60bp DNA 
(Table 4) were hybridized as described in 4.28. Double-stranded DNA (100 ng) were mixed 
with DNaseI and corresponding 10X DNase I buffer as well as with Econuclease III and 
10X NEBuffer according to manufacturers’ instructions. As controls, samples were mixed with 
Opti-MEM® I Reduced-Serum Medium and dd H2O. All samples were incubated for 30 min at 
37 °C and analyzed via 12 % (v/v) native PAGE. 
In a second approach, DNA strands containing a 5´ Cyanine 3 and the complementary 
strand a 3´ BHQ2 (black hole quencher 2) were utilized. As long as Cy3 and BHQ2 are close 
together, fluorophore's emission is suppressed. In case of degradation through nucleases, 
BHQ2 and Cy3 are not close anymore and the fluorescence signal increases. The 5´ Cy3-60fw 
and 3´ BHQ2-60rv strand (Table 4) without PTO-modifications were hybridized as previously 
mentioned (4.28.). Furthermore, PTO-capped Cy3-BHQ2 DNA trimers as well as uncapped 
Cy3-BHQ2 DNA trimers (Table 4) were assembled (4.23.2). Samples were mixed as described 
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below and pipetted in triplicates à 100 µl into black 96-well plates (Microplate 96-well (black), 
fluorotrac, Greiner Bio-One). 
 
Reaction mixture: 
 
Mastermix
 (1X) 
Final concentration 
10 µM DNA (i.e. DNA trimer or 60bp DNA) 1.5 µl 150 nM 
10X Enzyme buffer 10 µl 1X 
10X Anti-bleaching buffer 10 µl 1X 
250 U/ml Glucose oxidase 16 µl 40 U/ml 
1,000 U/ml DNase I or 10,000 U/ml Exonuclease III 1 µl 10 U/ml or 100 U/ml 
dd H2O 61.5 µl  
 Σ = 100 µl  
 
Fluorescence intensities were read out with a TECAN Infinite® M1000 reader (Tecan 
Group AG) at an excitation of 550 nm and an emission of 570 nm. Samples were measured 
over 30 min and fluorescence was recorded every 30 s. Fluorescence intensities of triplicates 
were averaged. DNA trimers and 60bp DNA, which were not treated with nucleases, served 
as control. 
4.30 Atomic force microscopy (AFM) 
AFM imaging is an ideal technique to determine whether the DNA nanostructure was 
formed correctly and possibly how it appears with modifications. All AFM images were acquired 
with a NanoWizard 3.0 (JPK Instruments AG) and recorded in alternating contact 
(AC) / tapping mode at room temperature at a line rate of 1 Hz - 5 Hz with JPK SPM software. 
Unmodified and CPP-conjugated DNA tetrahedra were visualized and characterized in fluid 
using a USC-F0.3-k0.3 cantilever (Asylum Research) whereas DNA tubes were measured in 
air using an ACTA-10 (AppNano) cantilever. The properties of the cantilevers used in this work 
are listed below (Table 6). 
 
Table 6│Properties of cantilevers used for AFM measurements 
Cantilever Force constant Resonance frequency 
ACTA-10 37 (13 - 77) N/m 300 (200 - 400) kHz 
USC-F0.3-k0.3 0.3 (0.06 - 1.0) N/m 180 (60 - 350) kHz 
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The sample preparation differed from measurements recorded in air or fluids (4.30.2 and 
4.30.1). After the cantilever was secured to the glass block and put into the AFM head, the 
laser sum signal as well as vertical and lateral deflection was adjusted. Cantilever specific 
calibrations were made and the AFM head was approached to the surface in contact mode. 
After reaching the surface of the sample, the cantilever was retracted and the contact mode 
switched to AC mode. This step involved the selection of a set point according to the calibrated 
frequency. After the AFM head again reached the sample´s surface, the measurement started. 
Since SPM software produces images of different channels per scan, JPK DP software was 
applied to select height or phase images. Further analysis and processing was performed with 
Gwyddion software. 
4.30.1 AFM imaging of DNA tetrahedra in fluids 
Cleaned and freshly cleaved mica surface was incubated with 100 µl poly-L-ornithine for 
10 min and washed three times with 100 µl 1X TM buffer (4.3) to remove unbound DNA and 
debris. Positively charged poly-L-ornithine is used to bind negatively charged DNA on the mica. 
Two µl - 5 µl of the Amicon®-purified sample was pipetted on the previously prepared mica 
surface and incubated for 10 min at room temperature. Directly after, the surface was washed 
twice with 100 µl 1X TM buffer. In order to measure the sample under stable conditions, a 
plastic ring was glued (Reprorubber® Thin Pour, JPK Instruments AG) around the mica surface 
to construct a chamber that was filled up with 1X TM buffer. The cantilever bearing the  
USC-F0.3-k0.3 tip was secured to the glass block and, in order to prevent air bubbles between 
cantilever and glass block, a drop of 1X TM buffer was applied on the back of the chip. The 
glass block was then put into the AFM head and the cantilever was used with a spring constant 
of ~ 0.29 N/m and a resonance frequency of ~ 168 kHz. 
4.30.2 AFM imaging of Eight-helix tubes (8HT) in air  
Pre-hybridized 8HT were deposited on a cleaned and freshly cleaved mica surface 
(Plano GmbH) attached to a microscope slide. After a settling time of 10 min samples were 
spun at 6,000 rpm (SPROUT® Mini centrifuge, Heathrow Scientific® LLC) in short intervals to 
minimize the alignment of attached 8HTs. The cantilever bearing the Gold-coated ACTA-10 tip 
was secured to the glass block, put into the AFM head and used with a spring constant of 
~ 54 N/m and a resonance frequency of ~ 300 kHz. 
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4.31 Actin preparation 
Globular actin (G-actin) was prepared from rabbit muscle (rabbits provided by Fraunhofer 
IZI, Leipzig) in two steps220. First, skeletal muscle actin was extracted and dried as acetone 
powder according to the method of Pardee and Spudich221 and second, the actual actin prep 
adapted from the lab of Marie-France Carlier was conducted to isolate solely actin. Monomeric 
actin (in 1X G-buffer) was polymerized to F-actin by the addition of 20X KME-buffer (4.3) at a 
final concentration of 24 µM and 1X F-buffer. 
4.32 Bulk shear rheology 
Immediately after inducing actin polymerization by the addition of 20X KME-buffer to  
G-actin enriched w/ or w/o synthetic crosslinkers, a sample volume of 175 μl was loaded to the 
dynamic shear rheometer (ARES, TA Instruments, USA) equipped with a cone (diameter 
25 mm, 0.04 rad). The network between the cone and the plate was surrounded with a 2.5 ml 
1X F-buffer bath (4.3) similarly as described previously222,223 to avoid a direct contact of the 
sample with air. The sample chamber was sealed with a cap equipped with wet sponges to 
suppress evaporation. Measurements were performed at 20 °C and followed the sequence:  
(i) The time evolution of the polymerization was monitored for 2 h (one data point per minute; 
γ = 5 %; f = 1 Hz), which was subsequently followed by a (ii) short frequency sweep (γ = 5 %; 
f = 0.01 Hz to 30 Hz; 5 data points per decade), (iii) long frequency sweep (γ = 5 %; 
f = 0.001 Hz to 30 Hz; 21 data points per decade), (iv) short frequency sweep, (v) strain sweep 
(f = 1 Hz; γ = 0.0125 % to 100 %; 20 data points per decade), (vi) short frequency sweep, and 
(vii) strain sweep. The sequence has been designed to test the robustness of the system over 
time and the frequency of 1 Hz has been chosen to display the values for G0. 
EcoRV-HF®-digestion of sPX 
To investigate the necessity of two actin-binding domains on one crosslinker for the 
stiffening of reconstituted actin networks, bulk rheology measurements on actin with functional, 
undigested as well as EcoRV-HF®-digested sPX that were incubated for 1 h at 37 °C were 
performed. Crosslinker DNA was designed with an EcoRV digestion site almost in the middle 
of the double strand (4.8). A digestion of this results in a 32bp and a 28bp fragment. Prior to 
rheology measurements, 1624 ng sPX (final concentration of 0.24 µM in 175 µl final sample 
volume) were incubated with 5 µl of EcoRV-HF® (20,000 units/ml, New England Biolabs) and 
1.75 µl of 10X CutSmart® buffer (New England Biolabs) in a final volume of 20 µl for 1 h at 
37 °C. No inactivation of the enzyme was performed. After EcoRV-HF®-incubation, the 
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digested sample was directly added to actin, 10X G-buffer and 20X KME-buffer to a final 
volume of 175 µl. Thereby, actin polymerization was induced and rheological measurements 
were performed as previously described. In addition, EcoRV-HF®-digestion of sPX was proved 
via 10 % (v/v) native PAGE (4.15.2). 
4.33 Static light scattering (SLS) 
Static light scattering (Malvern Instruments Ltd., Zetasizer Nano ZSP, UK) was used to 
observe the dependence of actin morphology140,224 on synthetic crosslinker concentrations. 
The scattering of the incident He-Ne-Laser beam (633 nm, 10 mW) by the sample (20 µl) in a 
quartz cuvette (Malvern, ZEN2112) was detected at a fixed angle of 173 °. To prevent 
evaporation during long-term measurements, the cuvette was sealed with mineral oil 
(molecular biological grade, BioReagent, Sigma Aldrich Co., Germany). The final actin 
concentration was 24 µM. The crosslinker concentration ranged from 0 µM to 9.6 µM 
(R = 0 to 0.4). The scattering of the sample was measured every minute for 1.5 h and 
scattering intensities were arithmetically averaged after 30 min of equilibration. 
4.34 Spinning disc confocal microscopy 
Monomeric actin was mixed under 1X G-buffer conditions (4.3) at a molar ratio of 3 : 1 
with Phalloidin-tetramethylrhodamine B isothiocyanate (Phalloidin-TRITC, Sigma-Aldrich) for 
visualization. Synthetic crosslinkers with two LifeAct® binding domains (wLX) were added to 
yield a final R = 0.333, R = 0.01, and R = 0.001 or with two Phalloidin binding domains (sPX) 
to yield a final R = 1, R = 0.1, and R = 0.01, respectively. Polymerization was initialized by 
increasing the salt concentration to 1X F-Buffer conditions (4.3) after mixing all components, 
leading to a final actin concentration of 3 µM. Immediately after starting the polymerization 
process the premixed solution was deposited into a sample chamber as described 
previously154. Measurements were performed on a spinning disc confocal microscope (inverted 
Axio Observer.Z1/Yokogawa CSU-X1A 5000 (Carl Zeiss Microscopy GmbH, Germany), 100x 
oil immersion objective (Plan-Apochromat 100x/1.40 Oil DIC M27)) and recorded with a 
Hamamatsu Camera at an exposure time of 50 ms. Image series were exported using the 
ZEN 2 software provided by the company (Carl Zeiss Microscopy GmbH). 
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4.35 Macroscopic behavior of actin in an inclined cuvette 
Three different samples, i.e. 24 µM actin only, 24 µM actin enriched with sPX (R = 0.4) 
and 24 µM actin supplemented with sPX (R = 0.4) that was incubated for 1 h at 37 °C with 
300 U EcoRV-HF® (New England Biolabs) prior to the experiment, were prepared similar as 
described above. Final samples were pipetted into a small cuvette at a volume of 150 µl each. 
Additionally, a small amount of free Phalloidin-TRITC was added to dye the solution for a better 
contrast and visibility. After 40 min resting time at room temperature, the cuvette with the 
respective sample was placed on an inclined plane with a 20 ° angle. Images were recorded 
every second using a commercially available digital camera. 
4.36 Actin polymerization / depolymerization assay (pyrene assay) 
In order to investigate whether the synthetic actin crosslinkers interfere with actin 
polymerization or depolymerization, a pyrene assay using pyrene muscle actin (Cytoskeleton 
Inc.) was conducted. Those actin monomers had been modified to contain covalently linked 
pyrene molecules at the cysteine 374 residue via N-(1-pyrene) iodoactetamide. The 
fluorescent signal of monomer pyrene-actin is enhanced during its polymerization into 
filaments, making it an ideal tool for monitoring both actin polymerization as well as 
depolymerization. 
Lyophilized pyrene-actin was reconstituted according to manufacturers’ instructions and 
further diluted to 0.6 mg/ml (i.e. 13.95 µM) with 1X G-buffer (4.3). To depolymerize actin 
oligomers, the solution was placed on ice. After 1 h, pyrene-actin was spun for 30 min at 
14,000 rpm and 4 °C to remove any residual nucleating centers. Working concentrations of 
pyrene-actin varied between 6 µM and 10 µM. The reaction was performed in a black 96-well 
plate (Microplate 96-well (black), fluorotrac, Greiner Bio-One) at room temperature.  
 
Example for reaction mixture for pyrene-actin w/o crosslinkers: 
 Final concentration Volume  
13.95 µM pyrene-actin in 1X G-buffer 6 µM 43 µl 
10X G-buffer 1X 5.7 µl 
10X Anti-bleaching buffer 1X 10 µl 
400 U/ml Glucose oxidase (GOx) 40 U/ml 10 µl 
dd H2O  26.3 µl 
20X KME 1X 5 µl 
  Σ = 100 µl 
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All components, except for 20X KME buffer, were mixed (4.3). Prior to induction of 
polymerization, a fluorescence baseline at 405 nm base was recorded. The process of pyrene-
actin filament formation induced by the addition of 20X KME buffer was monitored over time 
and fluorescence measured every 1 min or 5 min. After 90 min, depolymerization was induced 
by the addition of Latrunculin B (Sigma-Aldrich) to a final concentration of 200 µM and 
fluorescence measured for another 90 min. 
Glucose and GOx served as an anti-bleaching agent and GOx was added to the mixture 
at last in order to prevent a rapid degradation of glucose. Synthetic crosslinkers were added 
at R = 1, R = 0.2, R = 0.1, R = 0.08, R = 0.02 and R = 0.01. 
4.37 Basic cell culture techniques 
HeLa, MDA-MB-231 and MCF-10A cells were cultivated in their corresponding cell 
culture medium (4.5) in 75 cm2 CELLSTAR® Filter cap cell culture flasks (Greiner Bio-One) as 
a monolayer culture in 5 % CO2 humidified atmosphere at 37 °C in an incubator HERAcell® 240 
(Thermo Fisher Scientific). All culture media and buffers were pre-warmed to 37 °C in a water 
bath (GFL Gesellschaft für Labortechnik mbH) prior to usage. 
4.37.1 Changing culture medium 
Since cells constantly consume nutrients and thereby produce waste products, culture 
medium was routinely renewed every 2 – 3 days. Phenol red, which was supplemented in all 
culture media, served as pH indicator. A color change of the medium from red to orange/yellow 
indicated an acidification due to waste products and the necessity to change the medium. 
Therefore, old medium was aspirated and cells washed with 5 ml 1X DPBS (without Ca2+ and 
Mg2+). DPBS was removed and 10 ml fresh medium were added to cover the cells. Cells were 
placed into the incubator. 
4.37.2 Passaging cells 
Many cell types, especially cell lines that double quite fast (~ every 24 h), change their 
growth rate as well as gene expression depending on the cell density in the culture vessel. 
This occurs particularly when cells grow fully confluent, meaning that 100 % of the growth area 
is covered by a monolayer of cells. In order to maintain a consistent proliferative phenotype 
and to regulate the population density, cells were routinely sub-cultured every 3rd to 5th day. 
Again, old medium was aspirated and cells washed with 5 ml 1X DPBS (Volume for 75 cm2 
flasks). DPBS was removed and cell trypsinized by the addition of 2 ml 0.05 % Gibco® Trypsin-
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EDTA (Thermo Fisher Scientific). Trypsinization times differed between cell lines. Whereas 
HeLa and MDA-MB-231 cells were incubated with trypsin for only 2 -3 min, MCF-10A cells 
needed about 18 min to fully detach from the surface. After cells were detached, 5 ml fresh 
medium, containing FCS to inactivate trypsin, were added and mixed with the detached cells. 
Then, the whole cell suspension was transferred into a sterile 15 ml falcon® tube. After a 
centrifugation time of 5 min at 1150 rpm in a HeraeusMultifuge® 3SR+ (Thermo Fisher 
Scientific), the supernatant was discarded and cells were resuspended in 1 ml fresh medium. 
Ten ml fresh medium were pipetted into a new 75 cm2 culture vessels and 100 µl to 500 µl of 
the cell suspension were added. Culture vessel was swayed slightly back and forth in order to 
equally distribute the cells. Cells were placed into the incubator. 
4.37.3 Freezing, thawing and quality control of human cell lines 
For long-term storage of human cell lines, cryopreservation was performed225. During 
this process, cell solutions are frozen with a cryoprotectant, usually DMSO, to impede cell 
death or damage due to the formation of ice crystals. To generate cryostocks, 500 µl 
2X Freeze medium (4.5) were mixed with 500 µl cell suspension of 3 - 10 x 106 cells/ml in 2 ml 
CryoPure tubes (Sarstedt). Stocks were cooled slowly, i.e. - 1 °C/min, to - 80 °C using a  
Mr. FrostyTM freezing container (Thermo Fisher Scientific) and subsequently stored in the 
vaporous phase of liquid nitrogen at - 156 °C. 
To culture frozen cryostocks of cells, cells were rapidly, but not fully, thawed at 37 °C in 
a water bath for ~ 1 min. Directly after, cryostock solution was transferred into a 15 ml falcon® 
tube containing 5 ml fresh medium and spun for 5 min at 1150 rpm in a HeraeusMultifuge® 
3SR+ (Thermo Fisher Scientific). The supernatant was discarded and cell pellet resuspended 
in 2 ml fresh medium, which was then transferred into a 75 cm2 CELLSTAR® Filter cap cell 
culture flask (Greiner Bio-One), containing 10 ml fresh culture medium. 
In order to maintain cell culture quality, cell stocks were screened for bacteria and fungi 
using a Leica DMIL LED inverted microscope (Leica Microssystems GmbH), and tested for 
viable cell counts as well as growth potential. Additionally, cells were checked for the presence 
of Mycoplasma species every three months. Since these small bacteria are difficult to detect 
with conventional light microscopy and resistant to antibiotics, they often remain undetected. 
However, they may cause cellular changes, such as changes in metabolism and cell growth. 
All cell lines were checked for Mycoplasma contamination via qPCR at GATC Biotech AG. 
4.37.4 Determination of cell count and viability 
Cell count and viability was determined by a Luna II™ automated cell counter (Biozym). 
Therefore, 10 µl cell suspension were pre-mixed with 10 µl Trypan Blue Stain 0.4 % (Biozym) 
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and 10 µl of this mixture were subsequently transferred into a Luna™ cell counting slide 
(Biozym). Cell count and viability were read out by the device. 
4.37.5 Fixation of cells 
Cells were grown on detachable 8-well glass slides (Sarstedt). To fix them, e.g. after 
transfection with wLX, old medium was removed and cells washed three times for 2 min with 
1X PBS-T (4.3). PBS-T buffer was removed and wells filled with 300 µl 4 % Roti®-Histofix 
(Paraformaldehyde diluted in PBS, Carl Roth GmbH) each. After 10 min incubation at room 
temperature, Roti®-Histofix was removed and wells washed three times for 2 min with  
1X PBS-T. After washing, chambers were removed from the glass slide, which was then 
covered with mounting medium Fluoroshield™ (Sigma-Aldrich) and finally sealed with a cover 
slip (VWR). Fixed cell samples were stored protected from light in a transport box at room 
temperature. 
4.37.6 Staining of cells 
4.37.6.1 Staining of living cells 
In order to fluorescently image intracellular structures of living cells, dye molecules that 
are able to pass the cell membrane were used. Nuclei were stained utilizing Hoechst® 33342, 
lysosomes were observed with LysoTracker™ Deep Red and to visualize the cytosol, 
CellTracker™ Blue CMAC was used. All dyes were prepared in stock solutions according to 
manufacturers’ instructions and further diluted in Opti-MEM® to desired working 
concentrations, which are listed in Table 7. 
 
Table 7│Working concentrations of utilized dyes for live-cell imaging 
Dye Working concentration 
Hoechst® 33342 5 µM 
LysoTracker™ Deep Red 0.5 µM 
CellTracker™ Blue CMAC 10 µM 
 
 
After incubation with DNA structures, cells were washed with 300 µl 1X DPBS and 
subsequently incubated with 300 µl of corresponding dye solution for 15 min in the incubator. 
After this, cells were washed three times with 1X DPBS. In order to drastically reduce 
background fluorescence caused by phenol red in cell media, chambers were filled up with 
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300 µl Gibco FluoroBrite DMEM. Cells were imaged via confocal laser scanning microscopy 
using a LSM 710 (Carl Zeiss Microscopy GmbH). Corresponding settings for LSM imaging are 
described in 4.40.7. 
4.37.6.2 Staining of fixed cells 
Compared to staining of living cells, fixed cells are stained with dyes that cannot pass 
cellular membranes or those which are very toxic, such as phalloidin. Since cells are 
permeablilized with 1X PBS-T buffer after fixation (4.37.5), dyes can easily flow into cells and 
stain intracellular structures. During this work, actin structures were visualized utilizing 
Fluorescein (FITC)-Phalloidin (Thermo Fisher Scientific). FITC-Phalloidin was diluted to a 
working concentration of 100 nM in 1X PBS-T. Sixty µl of this solution were added to previously 
fixed and permeabilized cells and incubated for 20 min at room temperature. Then, cells were 
washed three times for 2 min with 1X PBS-T buffer. Chambers were detached from glass slide, 
mounting medium was added and cells sealed with a cover slip. In order to co-stain for nuclei, 
mounting medium Fluoroshield™ containing DAPI (Sigma-Aldrich) was utilized. 
4.37.7 Internalization of DNA into cells with Lipofectamine™ 3000 
The uptake of DNA-structures or ds DNA strongly depends on the amount of 
Lipofectamine™ 3000 transfection reagent (Thermo Fisher Scientific) in the transfection 
mixture. Since Lipofectamine™ 3000 is known to be cytotoxic at high concentrations, it was 
necessary to determine which concentration still gives good internalization rates but does not 
induce apoptosis of cells (supplemental Figure S 10, Figure S 11, Figure S 12 and 
supplemental Table S 1). Concerning this issue, the following experiments were conducted. 
4.37.7.1 Lipofectamine™ 3000 concentration-dependent internalization of DNA 
In order to determine, which Lipofectamine™ 3000 concentration gives high 
internalization efficacies, cells were transfected with a dilution series of Lipofectamine-
complexed 300 nM Cy3-labeled 60nt ss DNA. MDA-MB-231 cells (4.4.2) were seeded at 
1 x 106 cells/ml in 100 µl in 96-well plates and incubated overnight at 37 °C in the incubator. 
The next day, medium was removed and cells washed with 1X DPBS. Fifty µl of transfection 
mixture containing 0 % (v/v) to 12 % (v/v) Lipofectamine™ 3000 were added. After transfection 
(4.37.8) for 2 h, the transfection mixture was removed and cells washed twice with 50 µl 
1X DPBS. In order to analyze them via flow cytometry, cells were detached and suspension 
was analyzed via iQue™ Screener (IntelliCyt®) (4.11) under the excitation and detection of Cy3 
in the FL2 channel. Mean fluorescence intensities of cell population transfected with different 
Lipofectamine concentrations were analyzed and compared. 
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4.37.7.2 Cytotoxicity of LipofectamineTM 3000 
Since Lipofectamine™ 3000 is cytotoxic at high concentrations, a dilution series should 
gain information about the concentration, which still achieves a correspondingly high 
internalization efficacy (4.37.7.1) without killing the cells. Therefore, cells were seeded at 
1 x 106 cells/ml in 100 µl in 96-well plates and incubated overnight at 37 °C in 5 % CO2 
humidified atmosphere. The next day, medium was removed and cells washed with 1X DPBS. 
Fifty µl transfection mixture containing 0 % (v/v) to 12 % (v/v) LipofectamineTM 3000 were 
added. After transfection (4.37.8) for 2 h, cells were analyzed for apoptosis (4.40.1). 
4.37.8 Transient transfection of human cell lines 
Transfection of HeLa, MDA-MB-231 and MCF-10A cells was performed using 
Lipofectamine™ 3000. Volumes of transfection mixtures used depended on the size of the 
wells and are listed in Table 8. 
 
Table 8│Volumes of transfection mixtures for different cavities 
Microplate/insert Volume of transfection mixture/well 
6-well 1000 µl 
12-well 500 µl 
96-well 50 µl 
2-well culture insert (2D migration) 70 µl 
 
 
For a transfection mixture of 50 µl total, 0.75 µl Lipofectamine™ 3000 were pipetted to 
25 µl Opti-MEM® I Reduced-Serum Medium (Thermo Fisher Scientific) and incubated for 5 min 
at room temperature. Meanwhile, DNA (e.g. crosslinker sample) was diluted in 25 µl  
Opti-MEM® to twice of the desired concentration. After 5 min, 25 µl of the 
Lipofectamine™ 3000/Opti-MEM® mixture was pipetted to previously diluted DNA resulting in 
a final DNA concentration of typically 150 nM to 600 nM. The transfection mixture, at a 
LipofectamineTM 3000 concentration of 0.75 % (v/v), was complexed for 30 min at room 
temperature. For larger or smaller volumes of transfection mixtures, the volumes of 
Lipofectamine™ 3000 and Opti-MEM® were adjusted according to the previously described 
ratios. 
Cells were seeded one or two days before transfection. For some assays, cells were 
starved for 24 h with Opti-MEM® I Reduced-Serum Medium before transfection to attain high 
internalization rates. After washing with 1X DBPS, cells were fully covered with transfection 
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mixture and incubated for 4 h to 6 h at 37 °C in the incubator. Finally, the transfection mixture 
was removed and replaced with fresh either serum-containing or serum-free media. 
Transfected monolayer cultures were cultured at 37 °C for 24 h to 72 h. 
Determination of DNA internalization efficacies 
Before conducting all following cell based assays, it was necessary to investigate how 
effective utilized cell lines internalize DNA nanostructures when complexed with 0.75 % (v/v) 
Lipofectamine™ 3000. Therefore, cells were seeded at 2 x 105 cells/ml in 500 µl in 24-well 
plates and incubated overnight in the incubator. The next day, cells were washed with 
1X DPBS and subsequently transfected (4.37.8) for 2 h or 4 h with 300 nM or 600 nM Cy3-
labeled 60bp DNA (Table 4), that was hybridized as described for synthetic actin crosslinker 
production (4.28). In order to remove fluorescent DNA constructs that were not internalized 
and probably bind unspecific to cell surfaces, cells were washed twice with 1X DPBS. Cells 
were detached and suspension was analyzed at the flow cytometer iQue™ Screener 
(IntelliCyt®) (4.11) under excitation and detection of Cy3 in the FL2 channel. Cells treated only 
with LipofectamineTM 3000 but without DNA served as control. Internalization efficacy was 
determined by the relative number of positively classified cells compared to negative control 
populations. 
4.38 Localization and stability studies of CPP-conjugated DNA structures 
The intracellular localization of CPP-conjugated DNA tetrahedra as well as their stability 
within cells was investigated via confocal laser scanning microscopy (LSM). Therefore, DNA 
tetrahedra coupled to the FRET pair Cy3 and Cy5, referred to as FRETrahedra, were utilized. 
FRETrahedra that could be further modified with CPP, were assembled using Cy3 and Cy5-
labeled strands as well as two amine-modified sequences (Table 4). Covalent conjugation to 
sC18 was performed as described in 4.26.2. HeLa cells (4.4.2) were seeded at 1.66 x 105 
cells/ml in 300 µl in 8-well chamber slides (8-well on cover glass II, Sarstedt) and incubated 
for 24 h at 37 °C in 5 % CO2 humidified atmosphere. Cells were washed with 1X DPBS and 
CPP-coupled FRETrahedra as well as unmodified FRETrahedra, diluted to 200 nM in  
Opti-MEM®, were incubated with HeLa cells for 24 h in the incubator. Right after, cells were 
stained with 10 µM CellTracker™ Blue CMAC for 15 min as described in 4.37.6.1. Live-cell 
imaging was conducted via confocal laser scanning microscopy (4.40.7). 
Similar to CPP-FRETrahedra localization, the intracellular localization of PTO-capped, 
CPP-conjugated Cy3-DNA trimers was investigated. PTO-capped Cy3-DNA timers (Table 4) 
were sC18-functionalized as described in 4.27. Cells were treated as described above but 
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incubated for 2 h with 400 nM either unmodified PTO-capped Cy3-DNA timer as well as CPP-
functionalized ones. Cells were stained with 5 µM Hoechst® 33342 and 0.5 µM LysoTracker™ 
Deep Red for 15 min (4.37.6.1) and subsequently, live-cell imaging was performed. 
4.39 Labeling of intracellular actin structures with Cy3-wLX 
The intracellular localization of Cy3-labeled wLX and thus possible staining of 
filamentous actin structures was also studied by LSM imaging. Therefore, HeLa cells (4.4.2) 
were seeded at 2.5 x 105 cells/ml in 300 µl in 8-well chamber slides (8-well on glass, 
detachable, Sarstedt) and incubated overnight at 37 °C in the incubator. The next day, cells 
were washed with 1X DPBS and further transfected for 6 h with either 1000 ng pTag-LifeAct-
GFP-N plasmid DNA or 75 nM to 300 nM Cy3-labeled wLX as described in 4.37.8. Directly 
after transfection, cells were fixed and permabilized as explained in section 4.37.5. In order to 
stain actin structures differently, untreated HeLa cells were stained with FITC-Phalloidin as a 
control (4.37.6.2). Nuclei of cells were stained with DAPI-containing mounting medium prior to 
LSM imaging (4.40.7). 
4.40 Cell-based assays 
4.40.1 Apoptosis assay 
During apoptosis, cells change their plasma membrane structure to signal suicide to the 
environment. In early apoptotic cells, phosphatidylserine (PS) is translocated from the inner 
leaflet and exposed on the outer leaflet of the plasma membrane226. Annexin V, a phospholipid-
binding protein, exhibits a high affinity for binding selectively to PS in presence of Ca2+ ions 
even if conjugated to fluorochromes such as Phycoerythrin (PE). In order to distinguish 
between early and later stages of apoptosis, in which cells lose their membrane integrity, a 
vital dye such as 7-amino-actinomycin (7-AAD) is often additionally used. Whereas viable cells 
with intact membranes exclude 7-AAD, membranes of dead and damaged cells are permeable 
to 7-AAD. It preferably intercalates in ds DNA at GC-rich regions and thereby changes its 
fluorescent properties. Viable cells are negative for both Annexin V and 7-AAD, early apoptotic 
cells are Annexin V positive and 7-AAD negative, whereas late apoptotic or dead cells are 
positive for both Annexin V and 7-AAD. 
The possible induction of apoptosis triggered by internalized synthetic crosslinkers was 
investigated with PE Annexin V Detection Kit I (BD Bioscience) according to manufacturers’ 
instructions. MDA-MB-231 cells (4.4.2) were seeded at 0.5 x 106 cells/ml in 1 ml in 12-well 
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plates and incubated overnight in the incubator. The next day, medium was removed, cells 
washed with 1X DPBS and transfected with 300 nM wLX and control samples as described in 
4.37.8. After 4 h, transfection mixture was removed, cells were washed with 1X DPBS and 
1 ml fresh serum-containing medium were added. Cells were incubated for 24 h in the 
incubator. The next day, supernatant was transferred into a new 1.5 ml reaction tube and kept. 
Cells were washed with 400 µl 1X DPBS and subsequently trypsinized by the addition of 50 µl 
0.05 % Trypsin-EDTA (4.37.2). After 3 min, 800 µl FCS-containing medium (4.5) were added, 
cell suspension transferred into a 1.5 ml tube and cells spun for 5 min at 1150 rpm in a 
centrifuge 5424 R (Eppendorf AG). The supernatant was discarded and cells resuspended in 
the previously kept supernatant in order to include apoptotic or dead cells that did not adhere 
to the surface after 24 h. Cells were again spun for 5 min at 1150 rpm and pellet resuspended 
in 400 µl fresh medium. Cell count was measured using the Luna II™ automated cell counter 
(Biozym) (4.37.4) and 1 x 105 cells each sample were transferred into a new 1.5 ml reaction 
tube. Cells were washed twice with ice-cold 1X DPBS, resuspended in 100 µl cold 1X Annexin 
binding buffer and transferred into a 96-well plate (V-bottom, Greiner Bio-One International 
GmbH). Three µl PE Annexin V and 1 µl 7-AAD were added and samples incubated for 20 min 
at room temperature protected from light. Samples were measured with a flow cytometer 
iQue™ Screener (IntelliCyt®). Annexin V was measured with FL2 channel, whereas 7-AAD 
was measured with FL3 and a compensation value of 20 % since the spectral emission 
characteristics of PE-labeled Annexin V overlapped with those of 7-AAD and correspondingly 
gave false positive signals in the FL3 channel. To correctly adjust the value of compensation 
as well as the setting of suitable gates, camptothecin (Abcam), which specifically induces 
apoptosis, served as a positive control. For this purpose, 1 x 106 cells were incubated in a 
volume of 1 ml with 6 μM camptothecin for 5 h and 1 x 105 cells were subsequently stained 
with PE-Annexin V and 7-AAD as described above. Cells treated for 24 h with 7 % (v/v) DMSO 
served as a second positive control in each experiment. The software ForeCyt® v4.1 was used 
to receive histograms and dot plots as well as corresponding statistical analysis. 
4.40.2 WST-1 Proliferation assay 
MDA-MB-231 cells (4.4.2) were seeded at 0.5 x 106 cells/ml in 2 ml in 6-well plates and 
incubated overnight in the incubator. The next day, cells were transfected (4.37.8) with 
300 nM wLX as well as control samples. After an incubation of 4 h in the incubator, transfection 
mixture was removed, cells washed and detached from plastic surface using 200 µl 
0.05 % Trypsin-EDTA (4.37.2). After addition of 800 µl serum-containing medium, cell 
suspension was transferred into a 1.5 ml reaction tube and cells spun for 5 min at 1150 rpm. 
The supernatant was discarded and cells resuspended in fresh medium. Cell count and viability 
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was measured with Luna II™ automated cell counter (Biozym) as described in 4.37.4. Cells 
were seeded in triplicates at 0.1 x 106 cells/ml in 150 µl per 96-well of four individual cell culture 
microplates and incubated for 30 min (plate 0), 24 h (plate 1), 48 h (plate 2) and 72 h (plate 3) 
at 37 °C in 5 % CO2 humidified atmosphere, respectively. After 24 h, 48 h and 72 h, 15 µl cell 
proliferation reagent WST-1, containing WST-1 and an electron coupling reagent, were added 
using a Multipette® M4 (Eppendorf AG). The Slightly red water soluble tetrazolium salt 1 (WST-
1) is cleaved to dark red formazan227 (Figure 25) through membrane-associated, NADH-
dependent oxidoreductase enzymes228, classified as EC 1. The amount of formazan dye 
formed directly correlates with the number of metabolically active cells. 
 
 
Figure 25│Formation of Formazan through cleavage of WST-1. The slightly red tetrazolium salt 
WST-1 is cleaved to dark red formazan by cellular enzymes227. EC = electron coupling reagent; 
EC1 = oxidoreductase. Schematic modified from Ishiyama et al. (1993)229. 
 
Absorbance at 450 nm was measured after an incubation time of 60 min and 90 min in 
the incubator using a TECAN Infinite® M1000 reader (Tecan Group AG). The reference 
wavelength was set to 690 nm. 
In spite of the fact that theoretically the same cell numbers were seeded, the dilution of 
cell suspensions may have slightly differed whereby the number of cells effectively seeded 
varied from sample to sample but not from plate to plate. For this reason, WST-1 proliferation 
reagent was added to plate 0 exactly 30 min after seeding of cells. Absorbance at 450 nm was 
measured after 60 min and 90 min incubation as described above. Cells treated with 
7 % (v/v) DMSO in serum-containing medium served as a positive control, since DMSO is toxic 
and provokes cell death. 
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4.40.3 2D Migration assay 
To investigate the migrative potential of crosslinker-transfected cells, HeLa cells (4.4.2) 
were seeded into a previously placed silicone culture insert (Figure 26). Seventy µl cell 
suspension of a concentration of 5 x 105 cells/ml were pipetted into both wells of the insert. 
Additionally, the outer area of the insert was filled with 400 µl serum-containing medium (4.5). 
Cells were incubated overnight at 37 °C in 5 % CO2 humidified atmosphere. The next day, 
cells were transfected in culture inserts for 4 h as described in 4.37.8. After transfection, 
transfection mixture was removed and cells were washed with 70 µl 1X DPBS in order to 
remove cell debris or non-adherent cells. Silicone inserts were carefully removed with sterile 
tweezers and wells were filled with 2 ml serum-containing medium. Unused wells of the  
24-well plate were filled with Millipore water in order to ensure good humidity in the plate and 
to prevent cells from drying out. The plate was closed with a special lid, which allowed 
connecting the gas supply during observation. Plate and lid were sealed with an adhesive tape 
to reduce leaking gas and then placed onto the sample stage of the microscope. 
 
 
Figure 26│Schematic of 2D migration assay. After placing the culture inserts into well of a 24-well 
plate cells were seeded into the two wells of the silicone device. After 24 h, cells were transfected 
(4.37.8) for 4 h and subsequently the insert was removed, leaving a 500 µm gap. Migration of cell fronts 
was recorded over time. 
 
Long-term observation was conducted using a self-build microscopy setup (COB1) kindly 
provided by the soft matter physics division of the University of Leipzig. The homemade 
microscopy system mainly consisted of a temperature-controlled enclosure and a gas supply 
(5 % CO2/95 % air mixture) in order to control optimal measurement conditions similar to a 
standard cell culture incubator, an inverted Leica DM IRB phase contrast microscope (Leica 
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Microssystems GmbH, Germany), a motorized x-y sample stage (Leica DMSTC, Germany), 
an objective z-piezo positioner (PI P-721 PIFOC, Physik Instrumente GmbH & Co. KG, 
Germany), two homemade motorized illuminations shutters and a homemade motorized filter 
cube. Long-term observations were kindly supervised by Steve Pawlizak and Steffen Grosser 
(University of Leipzig), who built up the microscopy setup and the corresponding Multi 
Observation software. Migration of cells into the free gap was observed over 48 h and phase 
contrast pictures were recorded every 5 min. Image analysis was conducted with ImageJ and 
a special plugin, named MITOBO (4.12). This program detects cell-free areas and sets it to 
“white”, whereas areas where cells grew were set to “black”. By subtracting “white” from “black” 
areas, the percentages of areas covered with cells were calculated. 
4.40.4 3D Migration and invasion assay 
To gain better overview of the following 3D migration and 3D invasion assay, a schematic 
representation is shown in Figure 27. MDA-MB-231 cells (4.4.2) were seeded at 0.35 x 106 
cells/ml in 2 ml in 6-well plates and incubated overnight in the incubator. The next day, medium 
was removed, cells washed with 1X DPBS and starved with 1 ml Opti-MEM® 24 h prior to 
transfection. MDA-MB-231 cells were transfected (4.37.8) with 300 nM wLX as well as control 
samples and incubated for 4 h at 37 °C in 5 % CO2 humidified atmosphere. 
For 3D invasion assays, cell culture inserts (Cultrex® 24 Insert Cell Invasion / Migration 
Chamber, Biozol Diagnostica) were coated with 100 µl of 0.5X or 1X basement membrane 
extract (BME) solution. Therefore, Cultrex® 5X BME solution (Biozol Diagnostica) was diluted 
1 : 10 or 1 : 5 with 1X Coating buffer prepared from Cultrex® 10X Coating buffer (Biozol 
Diagnostica). BME-coated inserts were incubated for 4 h in the incubator to polymerize the 
natural extracellular matrix hydrogel, which forms a reconstituted basement membrane. During 
3D migration experiments, cell culture inserts were not coated with BME layer. 
After 4 h, transfection mixture was aspirated and cells washed with 1X DPBS. Cells were 
trypsinized (4.37.2) for 3 min by the addition of 200 µl 0.05 % Trypsin-EDTA. Eight hundred µl 
serum-containing MDA-MB-231 medium (4.5) were added and cell suspension spun for 5 min 
at 1150 rpm in a Centrifuge 5424 R (Eppendorf AG). The supernatant was discarded and cells 
resuspended in 800 µl Opti-MEM®. Cell count and viability was measured with Luna II™ 
automated cell counter (Biozym) as described in 4.37.4. Subsequently, cells suspensions were 
diluted to 1 x 106 cells/ml (for 3D invasion) and 0.5 x 106 cells/ml (for 3D migration) with  
Opti-MEM®. 
Before seeding, wells of the Cultrex® 24 Insert Cell Invasion / Migration plate were filled 
with 650 µl serum-containing MDA-MB-231 medium. Uncoated cell culture inserts were placed 
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into wells of the plate and 100 µl of 0.5 x 106 cells/ml transfected cells were seeded in order to 
investigate 3D migration. 
To study 3D invasion, BME-coated cell culture inserts were utilized. As mentioned for 3D 
migration, wells of the Cultrex® 24 Insert Cell Invasion / Migration plate were filled with 650 µl 
serum-containing MDA-MB-231 medium in advance and BME-coated inserts were placed into 
wells. Directly before seeding samples, 70 µl of excess BME solution were removed from 
individual inserts and 100 µl of a 1 x 106 cells/ml cell suspension was placed on top of the BME 
layer. Both, migration and invasion samples were incubated for 36 h - 48 h in the incubator. 
 
 
Figure 27│Schematic of 3D migration and 3D invasion assay. For 3D migration experiments (left), 
transfected cells were seeded in serum-free medium in culture inserts with an average pore size of 
8 µm. The insert was surrounded by serum-containing medium towards cells migrate over time and 
squeeze through pores. In terms of 3D invasion (right), cells in serum-free medium were seeded on top 
of a 0.5X – 1X basement membrane extract (BME) layer that they had to degrade in order to finally get 
through the pores to reach the serum-containing medium. Cells were incubated for 36 h - 48 h and cell 
count was determined using the cell permeable dye Calcein AM. 
 
The number of cells that have invaded or migrated was quantitated via Calcein AM 
(Thermo Fisher Scientific). Calcein AM is a cell-permeant dye whose acetomethylester (AM) 
gets cleaved by intracellular esterases. Generated, free Calcein fluoresces brightly, and this 
fluorescence may be used for quantification. 
Therefore, 50 µg Calcein AM was resuspended in 30 µl DMSO. For 1 ml of 
1X Calcein/CDS, 100 µl Cultrex® 10X Cell Dissociation Solution (Biozol Diagnostica) were 
mixed with 900 µl Millipore water and 1.2 µl Calcein AM stock were added. Inserts were taken 
out of the well using a sterile tweezer and put into an unused well. The supernatant from the 
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well was removed and well washed with 500 µl 1X DPBS. After that, 350 µl 1X Calcein/CDS 
were added and inserts placed back into the well. Subsequently, the supernatant of the insert 
was removed as well. The plate was placed back into the incubator for 1 h and sides of the 
plate were tapped after 30 min. Next, inserts were removed and 100 µl of the cell suspension 
were pipetted in triplicates into a black fluorescence 96-well plate (fluorotrac, Greiner Bio-One 
International GmbH). Fluorescence was read out with a TECAN Infinite® M1000 reader (Tecan 
Group AG) with an excitation of 485 nm and an emission of 520 nm. 
In order to determine cell count, a calibration curve was recorded. Untreated  
MDA-MB-231 cells were detached and spun as described before. The cell pellet was 
resuspended in 1X CDS solution and cell count was measured with Luna II™ automated cell 
counter. A dilution series of cells diluted in 1X CDS was prepared. Fifty µl of each cell 
concentration was pipetted in triplicates into a black fluorescence 96-well plate. Then, 50 µl of 
2X Calcein AM/CDS (2.4 µl Calcein AM stock/1 ml 1X CDS) were added to cell dilutions. The 
plate was incubated for 30 min at 37 °C in the incubator and fluorescence read out with an 
excitation of 485 nm and an emission of 520 nm. Known cell numbers of the dilutions as well 
as their corresponding fluorescence intensities were plotted and a linear standard curve was 
generated, which was used to calculate the cell count after invasion and migration. 
Additionally, the number of cells seeded into inserts was double checked via Calcein AM 
staining. Cell solutions of 1 x 106 cells/ml as well as 0.5 x 106 cells/ml were diluted 1 : 5 and 
1 : 2 in 1X CDS, respectively. Samples were also pipetted at 50 µl/well in triplicates and 50 µl 
2X Calcein AM/CDS solution was added. After an incubation of 30 min in the incubator, the 
fluorescence was measured as already mentioned. Cell count that was seeded into inserts for 
3D migration and 3D invasion was more precise and got incorporated into the later calculation 
of cells that finally passed through the micro-sized pores. 
4.40.5 EMT induction of MCF-10A cells 
MCF-10A cells (4.4.2) were seeded at 1.66 x 105 cells/ml in 300 µl into chamber slides 
(8-well on glass, detachable; Sarstedt) and incubated overnight in the incubator. The next day, 
cells were washed with 1X DPBS and starved with 300 µl Opti-MEM® for 24 h. Cells were 
transfected (4.37.8) for 6 h with 300 nM wLX and corresponding controls which were  
300 nM 60bp ds DNA and LipofectamineTM 3000 only treated cells. The transfection mixture 
was removed and cells washed with 1X DPBS. Subsequently, 300 µl Opti-MEM® 
supplemented with or without 10 ng/ml TGF-β that was previously solubilized in a 4 mM HCl, 
0.1 % (w/v) BSA solution at a final concentration of 4 µg/ml, was added. Samples were 
incubated for 48 h in the incubator. In order to assess MMP-2 and MMP-9 activity in EMT-
induced and -uninduced samples, a gelatin zymography assay of conditioned medium was 
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conducted230,231. Additionally, same samples were analyzed for E-cadherin and Snail levels by 
immunocytochemistry. Both methods are described in the following. 
4.40.5.1 Gelatin zymography 
Zymography is a simple, sensitive, quantifiable, and functional assay for analyzing 
proteolytic activity. It is already widely used for research on extracellular matrix degrading 
enzymes, in particular the matrix metalloproteinases (MMPs)232. Both gelatinase A (MMP-2, 
72 kDa) and gelatinase B (MMP-9, 92 kDa) are proteins that are secreted from cells. In order 
to determine differences in MMP-levels of samples, the supernatant of induced and uninduced 
cells was analyzed. In a first step, the supernatant of each individual sample was collected and 
spun for 2 min at 1150 rcf in order to pellet dead cells. The supernatant was transferred into a 
new 1.5 ml reaction tube and total protein content determined using Pierce™ BCA Protein 
Assay Kit (Thermo Fisher Scientific) according to manufacturers’ instructions. Three 
hundred ng total protein were mixed with 5X Non-reducing sample buffer (4.3) and loaded onto 
a 0.75 mm thick 10 % (v/v) SDS-PAGE233 gel containing 0.1 % (v/v) gelatin. For a better 
resolution of proteins, a 4 % (v/v) stacking gel was utilized. Typically, SDS-PAGE was run for 
1.5 h at room temperature and 130 V in 1X SDS running buffer (4.3). 
 
Separating gel (10 % (v/v), 8 ml) 
40 % (w/v) Acrylamide-bisacrylamide (29 : 1) 2 ml 
1 M Tris pH 8.8 3 ml 
dd H2O 2.6 ml 
2 % (w/v) Gelatin solution 0.4 ml 
10 % (w/v) SDS 80 µl 
10 % (w/v) APS 80 µl 
TEMED 8 µl 
 
Stacking gel (4 % (v/v), 5 ml) 
40 % (w/v) Acrylamide-bisacrylamide (29 : 1) 0.5 ml 
0.5 M Tris pH 6.8 1.25 ml 
dd H2O 3.25 ml 
10 % (w/v) SDS 50 µl 
10 % (w/v) APS 50 µl 
TEMED 5 µl 
 
After electrophoresis, gel was washed twice with washing buffer (4.3) for 30 min in order 
to remove SDS from the gel and thereby renature MMPs. Next, gel was rinsed for 10 min at 
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37 °C with incubation buffer (4.3) that contained cofactors necessary for the gelatinase 
reaction to occur. This buffer was subsequently replaced with fresh incubation buffer and gel 
incubated for 24 h at 37 °C. Gel was stained for 45 min with staining solution (4.3) and further 
incubated with destaining solution (4.3) until clear bands were seen. These bands indicate 
MMP activity. The molecular weight of the analyzed MMPs was compared to PageRuler™ 
Unstained Protein Ladder (Thermo Fisher Scientific) that was run as a protein standard on 
each gel. 
4.40.5.2 Immunocytochemistry staining for EMT markers 
Additionally, EMT-induced and -uninduced cells were stained for EMT markers such as 
E-cadherin and Snail using fluorochrome-conjugated antibodies provided within the Human 
EMT 3-Color Immunocytochemistry Kit (Bio-Techne Corporation). Intensity of fluorescence 
signal can give evidence of an up or down regulation of these proteins. After fixation with Roti®-
Histofix (4.1) and permeabilization with 1X PBS-T buffer (4.3), cells were treated with blocking 
solution (4.3) for 5 min at room temperature. Cells were incubated for 3 h at room temperature 
in the dark with anti-human snail NL557-conjugated goat IgG and anti-human E-cadherin 
NL637-conjugated goat IgG, which were diluted in blocking solution according to 
manufacturers’ instructions. Antibody staining solution was removed and cells washed three 
times for 2 min with 1X PBS-T. Cells were covered with Fluoroshield™ and sealed with a cover 
slip. Samples were imaged with confocal laser scanning microscopy (4.40.7). 
4.40.6 Real-time deformability cytometry (RT-DC) 
The mechanical phenotype of crosslinker-transfected MCF-10A cells, which were either 
treated without or with TGF-β in advance, was determined with real-time deformability 
cytometry (RT-DC)234. MCF-10A cells (4.4.2) were seeded at 2 x 105 cells/ml in 1.5 ml in  
6-well plates as triplicates and incubated overnight in the incubator. The next day, cells were 
washed with 1X DPBS and starved overnight with 2 ml Opti-MEM®. Cells were transfected 
(4.37.8) with 300 nM wLX as well as 300 nM 60bp DNA and Lipofectamine only that served as 
a control. After an incubation time of 6 h, the transfection mixture was removed and cells 
washed with 1X DPBS. In order to induce EMT, 2 ml serum-containing MCF-10A medium (4.5) 
supplemented with 10 ng/ml TGF-β were added. Control cells received serum-containing 
medium without TGF-β. After an incubation time of 48 h in the incubator, medium was removed 
and cells washed with 1X DPBS. Cells were trypsinized with 500 µl of 0.05 % Trypsin-EDTA. 
After 18 min, 900 µl serum-containing MCF-10A medium were added, cell suspension 
transferred into a 1.5 ml reaction tube and cells spun for 3 min at 2,000 rcf. The cell pellet was 
carefully resuspended in 100 µl Cell carrier buffer (Zellmechanik Dresden GmbH) without the 
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formation of air bubbles, which would interfere with the following measurement. Cells were 
measured with the AcCellerator (Zellmechanik Dresden GmbH) at a flow rate of 0.04 µl/s to 
0.12 µl/s in a 20 µm x 20 µm channel in triplicates. Measurements were kindly conducted by 
Christoph Herold (Zellmechanik Dresden GmbH). The evaluation of data was performed using 
analysis software ShapeOut, provided by Zellmechanik Dresden GmbH. 
4.40.7 Confocal laser scanning microscopy (LSM) 
Cells were imaged via confocal laser scanning microscopy (LSM) using a Zeiss 
LSM 710/AxioObserver and objectives Plan-Apochromat 63x/1.40 Oil DIC M27 or Plan-
Aprochromat 20x/0.8 M27 (Carl Zeiss Microscopy GmbH). Lasers, including Diode laser 
(405 nm), Argon laser (488 nm) and Helium-Neon laser (633 nm), were run at 60 % laser 
power. Images were recorded at a size of (xy) 50 µm x 50 µm to 700 µm x 700 µm and a 
resolution of 512 x 512 pixels. For some experiments, z-stacks of approximately 15 μm were 
taken in steps of 1.5 μm. Values for digital gain, offset, pinhole, scanning speed and laser 
power were set to standard values, but corrected until few specific pixels reached 
oversaturation. Image processing, including pseudo coloration, was conducted with Zen blue 
software (Carl Zeiss Microscopy GmbH). 
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5 Results and Discussion 
5.1 CPP-conjugated DNA nanostructures as carriers for biomolecules 
The first part of this work covers the usage of DNA nanostructures, i.e. DNA tetrahedra 
and DNA trimers, as a platform to covalently attach functional biomolecules, e.g cell-
penetrating peptides (CPP), to increase their cellular uptake without the utilization of 
transfection agents such as Lipofectamine™ 3000. 
5.1.1 Covalent conjugation of sC18 to DNA tetrahedra 
In a first approach, chains of CPP should be covalently coupled to DNA tetrahedra 
(4.26.1). Therefore, a tail of aminoallyl-dUTP (589.2 Da) was added to DNA tetrahedron 
sequences (Table 4) using TdT. This amino-tail was subsequently used to couple sulfo-SMCC 
(Figure 16), a heterobifunctional linker that firstly reacts via its NHS ester with the primary 
amine on the tail, and secondly via its maleimide group with a cysteine-containing CPP 
(Cys - sC18, Table 5). The whole conjugation process was monitored via 6 % (v/v) native 
PAGE and is shown in Figure 28. Depending on the ratio of used substrate, different lengths 
of amino-tails were obtained. In case of a molar ratio of 1 : 3 (DNA : aminoallyl-dUTP), shown 
in lane 1, the tail was shorter than using a ratio of 1 : 10, which can be seen in lane 2. After 
adding Sulfo-SMCC (436.37 Da), the small relative gain of molecular weight could not be 
resolved in the gel (lanes 3 and 4). Sulfo-SMCC-coupled DNA strands were mixed with CPP, 
incubated overnight and loaded onto 6 % (v/v) native PAGE next day. Samples did not enter 
into the gel (lanes 5 and 6), therefore detection of a successful conjugation was not possible 
in this case. 
Native PAGE separates molecules by their isoelectric point (pI). Since native PAGE is 
typically performed at pH 7 – 9, peptides with a high pI are positively charged at this pH. When 
samples are run from cathode to anode, highly positively charged molecules do not separate 
in the gel. Hence, it was assumed that if sC18, which is a highly positively charged peptide 
(2.2), reacted with a large number of maleimides of DNA strands, the overall charge of the 
DNA-peptide conjugate became too positive to run in the gel. 
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Figure 28│Functionalization of DNA tetrahedra with CPP chains. Tetrahedron sequences were first 
tailed with aminoallyl-dUTP in different ratios using TdT. Next, sulfo-SMCC was attached via NHS ester 
to primary amines of dUTPs. Finally, CPP (Cys – sC18) were coupled to maleimides of sulfo-SMCCs 
via its TCEP-reduced sulfhydryl groups. The conjugation process was monitored via 6 % (v/v) native 
PAGE and visualized by SYBR® Gold Nucleic Acid Gel Strain staining. M, GeneRuler™ Low Range 
DNA Ladder; U, unmodified DNA tetrahedra; 1 - 2, DNA tetrahedra with aminoallyl-dUTP tail (ratios 1:3 
and 1:10) via TdT; 3 - 4, DNA tetrahedra covalently conjugated to sulfo-SMCC via previously introduced 
NH2 groups, 5 - 6, DNA tetrahedra coupled to CPP (azide - sC18), which do not show up in the gel. 
 
 
 
Figure 29│Functionalization of DNA tetrahedra with CPP. Utilizing a SPAAC approach, DNA 
tetrahedra carrying single CPP modifications were obtained. Covalent conjugation of CPP was observed 
through 6 % (v/v) native PAGE and visualized by SYBR® Gold Nucleic Acid Gel Strain staining. 
M, GeneRuler™ Low Range DNA Ladder; U, unmodified DNA tetrahedra; 1 - 4, DNA tetrahedra with 
one, two, three and four azide - sC18 attached, respectively. 
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In order to drastically reduce the number of attached CPP and thereby the probably 
dominant positive charge, DNA tetrahedra were conjugated to single CPP molecules. 
Therefore, a copper-free click chemistry approach (SPAAC, 2.2.4) was utilized as explained in 
section 4.26.2. Figure 29 shows DNA tetrahedra covalently conjugated to one (lane 1), two 
(lane 2), three (lane 3) and four (lane 4) azide - sC18, respectively. Compared to DNA 
tetrahedra which were not functionalized with CPP, a band shift from left to right can be seen, 
which indicates the successful attachment of peptides. 
5.1.2 AFM imaging of CPP-conjugated DNA tetrahedra 
Direct visualization of DNA tetrahedra is rather difficult since the nanostructure is very 
small. One edge is only about 7 nm in length. Nonetheless, DNA tetrahedra were imaged via 
atomic force microscopy (AFM). As described in sections 4.30 and 4.30.1, samples were 
measured in alternating contact (tapping) mode in fluid utilizing an ultra-short cantilever  
(Table 6). AFM images of unmodified DNA tetrahedra, DNA tetrahedra with CPP-chains that 
were not visible in native PAGE gels, as well as DNA tetrahedra carrying single CPP 
modifications are shown in Figure 30. During AFM measurements, structures were flattened 
into 2D structures due to strong electrostatic interactions between the DNA frame and the mica 
surface. For this reason, unmodified DNA tetrahedra (Figure 30 A) appeared as triangular 
structures. The length of individual edges was in the range of 7 nm, from which it can be 
concluded that structures formed correctly. In contrast, DNA tetrahedra that were modified with 
CPP chains appeared as circular structures (Figure 30 B). The overall structure was twice as 
big as unmodified DNA tetrahedra. Nevertheless, the diameter of the formed hole in the middle 
of these structures was in the range of 7 nm to 9 nm, suggesting that DNA tetrahedra were 
surrounded by covalently coupled peptide chains. On the other hand, DNA tetrahedra 
conjugated to four individual CPP molecules, shown in Figure 30 C, did not appear as rounded 
structures. Even though the image quality was not as good as within the other images, the 
structures looked similar to those of unmodified DNA tetrahedra, displaying sharp edges rather 
than a circular configuration. 
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Figure 30│AFM images of CPP-functionalized and unmodified DNA tetrahedra. Height 
measurements of (A) unmodified DNA tetrahedra, (B) DNA tetrahedra with CPP chains as well as (C) 
DNA tetrahedra with single CPP functionalization were obtained by AFM imaging in tapping mode under 
aqueous buffer conditions (4.30.1). 
A 
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5.1.3 Separation of DNA tetrahedron monomers from aggregates 
Even if the covalent coupling of single CPP molecules as well as CPP chains to DNA 
tetrahedra was successful, a significant amount of aggregates formed. DNA tetrahedra were 
self-assembled according to Goodman et al. (2005)16 and as the step-wise formation in 
supplemental Figure S 1 shows, aggregates firstly occurred when three strands were mixed 
and hybridized (lane 3). This phenomenon was even stronger when all four strands were 
involved in the assembly (lane 4). In order to separate these aggregates from DNA tetrahedron 
monomers, size exclusion chromatography (SEC) was conducted as described in section 4.24. 
Several buffer conditions for isocratic sample elution were tested. The best separation of the 
aggregation peak from the monomer peak was obtained with an elution buffer containing 
10 mM Tris base pH 7.4, 450 mM NaCl2. An illustrative image of the SEC chromatogram as 
well as the corresponding peak fractions and fractions that were pooled and analyzed via 
native PAGE are shown in Figure 31. Whereas fractions 1.A.2 to 1.A.8 mainly contained 
aggregates, monomers appeared mostly in peak fractions 1.B.1 to 1.B.7. Unfortunately, 
separation of both peaks was not optimal and could not be further optimized during this work. 
However, all pooled fractions contained less aggregates after buffer exchange compared to 
unpurified DNA tetrahedron samples. 
 
 
Figure 31│Size exclusion chromatography (SEC) of DNA tetrahedra. In order to remove aggregates 
from DNA tetrahedron monomers, SEC was performed as described in 4.24. DNA structures were 
isocratically eluted and peak fractions collected at 260 nm. Fractions were analyzed via native PAGE, 
samples pooled, concentrated, and buffer exchanged to 1X TM buffer. (A) Elution of 1 µM sample and 
pooled fractions, that were partially (B) analyzed via 8 % (v/v) native PAGE and visualized by SYBR® 
Gold Nucleic Acid Gel Strain staining. M, GeneRuler™ Low Range DNA Ladder; 1.A.2 – 1.B.7, partial 
fractions of chromatography run. (C) Native PAGE analysis of pooled fractions. M, GeneRuler™ Low 
Range DNA Ladder; n.p., unpurified DNA tetrahedra, Pool1 - Pool3, SEC-purified fractions. 
C
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A complete separation of CPP-tetrahedron conjugates from aggregates was not at all 
possible under these buffer conditions. Several other harsh buffers (e.g. containing low 
concentration of acetonitrile) were tested but did not lead to a separation. In order to still 
investigate the effect of cellular uptake and localization, DNA tetrahedron-CPP complexes 
were therefore utilized in presence of remaining aggregates for cell culture experiments. 
5.1.4 Uptake and localization of CPP-conjugated DNA structures 
HeLa cells were treated with sC18-coupled FRETrahedra as well as unmodified 
FRETrahedra as described in 4.38. The intracellular localization of these structures after 24 h 
incubation is shown in Figure 32. The upper row shows Cy5 fluorescence of intact DNA 
structures (green), the middle row Cy3 fluorescence of partly digested or destroyed 
FRETrahedra (red) and the lower row an overlay of Cy5, Cy3 and CellTracker™ Blue CMAC 
fluorescence that was utilized to stain the cytosol (blue). Since the fluorescence signal is higher 
in Figure 32 A compared to Figure 32 B, one can assume that CPP-conjugated DNA tetrahedra 
internalize into cells better than unconjugated DNA tetrahedra. 
This phenomenon was also seen with CPP-conjugated DNA trimers, which were 
synthesized as described in 4.27, supplemental Figure S 2, and had additional PTO-caps on 
DNA ends to prevent the structures from degradation through exonucleases within cells. These 
DNA structures were added to HeLa cells for 2 h at a concentration of 400 nM, as explained 
in 4.38. The fluorescence signal in Figure 33 A, which shows DNA trimers covalently coupled 
to two sC18 molecules, was significantly higher than the fluorescence signal of the trimer 
control that did not carry CPP, shown in Figure 33 B. This result is consistent to what was 
observed for CPP-conjugated DNA tetrahedra. 
DNA tetrahedra enter cells via endocytosis and end up in lysosomes, as reported by 
Kichler et al. (2006)38. The same can be assumed for the trimeric DNA structure, since these 
co-localize with the lysosomal marker LysoTracker™ Deep Red, shown in Figure 33 C and D. 
An overly of Cy3-fluorescence of the PTO-capped DNA trimer and the fluorescence of 
lysosome marker can be seen in Figure 33 E and F. Both DNA tetrahedra as well as DNA 
trimers did not enter the nucleus, also when conjugated to CPP. The increased intracellular 
fluorescence of CPP-conjugated DNA tetrahedra could appear due to the presence of large 
aggregates. However, since CPP-coupled DNA trimers were not seen to aggregate 
(supplemental Figure S 2), it can be assumed that the effect can be at least partially attributed 
to an increased uptake. 
The utilized CPP sC18 was also previously described to enter cells via endocytosis and 
to end up in lysosomes58. As seen from fluorescence images, both, DNA tetrahedra and CPP 
in combination, did end up in lysosomes. In order to increase the uptake of DNA structures 
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through CPP but also mediate their release into the cytosol, CPP that promote endosomal 
escape or lysosome rupture could be used57. Neundorf et al. described a chimeric version of 
sC18, named N-E5L-sC18 that was coupled to a short modified sequence of influenza virus 
hemagglutinin subunit HA2. Since these N-terminal fragments are able to disrupt endosomal 
membranes they were reported to be used for endosomal release of biologically active 
substances into the cytosol after encapsulation into endosomes235,236. Neundorf et al. found 
that these chimeric CPP also enter cells via endocytosis but showed an increased cytosolic 
distribution. However, this peptide also showed intrinsic cytotoxic effects against certain cell 
lines58. While not pursued in the context of the work presented here, the utilization of peptides 
permitting endosomal escape and cytosolic translocation of DNA nanostructures would be 
interesting for future applications, as they could act as carrier platforms, which would be rapidly 
uptaken and additionally could target specific molecules in the cytosol. 
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Figure 32│Localization of CPP-functionalized and unmodified DNA tetrahedra in HeLa cells. 
(Left) DNA tetrahedra containing a FRET pair (Cy3/Cy5) were covalently coupled to two CPP 
(azide - sC18) via SPAAC (2.2.4). (Right) DNA tetrahedra without CPP functionalization served as 
control. DNA samples were diluted to 200 nM in Opti-MEM® and cells incubated for 24 h to internalize 
structures. Staining the cytosol using CellTracker™ Blue CMAC, shown in blue, was performed as 
described in 4.37.6. LSM images show (A, B) Cy5 fluorescence of intact DNA tetrahedra (green),  
(C, D) Cy3 fluorescence of degraded DNA structures (red) and (E, F) an overlay. Equal laser intensities 
and gains were applied. Images were pseudo colored using ZEN blue software and scale bars set to 
20 µm. 
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Figure 33│Localization of CPP-functionalized and unmodified PTO-capped DNA trimers in HeLa 
cells. (Left) PTO-trimers labeled with a Cy3 dye and conjugated to two CPP (azide - sC18) via SPAAC 
(2.2.4). (Right) Unmodified PTO-trimers labeled with a Cy3 dye. DNA samples were diluted to 400 nM 
in Opti-MEM® and cells incubated for 2 h for cellular uptake. Staining nuclei using Hoechst® 33342 (blue) 
and lysosomes using LysoTracker™ Deep Red (red), was performed as described in 4.37.6.1. LSM 
images show (A, B) localization of DNA trimers (A) with CPP and (B) without CPP functionalization,  
(C, D) subcellular localization of lysosomes of cells treated with DNA trimers (C) conjugated with CPP 
and (B) without functionalization. (E, F) Overlay of trimer and lysosome localization. Equal laser 
intensities and gains were applied. Images were pseudo colored using ZEN blue software and scale 
bars set to 20 µm. 
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5.2 Synthetic actin crosslinkers 
As previously mentioned, natural occurring actin crosslinkers, due to their empirical 
nature and complexity, do not allow systemic studies, where different key parameters can be 
decoupled from each other and individually varied in a systematic manner. This natural 
limitation was resolved in this work by engineering purely synthetic actin crosslinkers (4.28), 
whose core building block is a 20 nm long, double-stranded DNA which can be covalently 
coupled to actin-binding peptides on both sides via a copper-free click chemistry approach 
(SPAAC, 2.2.4). Thus, the basic geometry of the crosslinkers are conserved while properties 
such as binding affinity towards actin can be tuned independently by varying the attached 
actin-binding peptides. The following part of this work addresses the development of synthetic 
actin crosslinkers, i.e. the weakly-binding LifeAct® crosslinker (wLX) and the strongly-binding 
Phalloidin crosslinker (sPX) as the means to mimic the behaviors of α-actinin (2.5.1) or fascin 
(2.5.2), respectively, and the in vitro characterization of both reconstituted actin networks as 
well as living cells. 
5.2.1 Generation of wLX and sPX 
Synthetic actin crosslinkers were produced as described in 4.28 and the engineering 
process analyzed via native PAGE (4.15.2), depicted in Figure 34. Different kind of crosslinkers 
were generated: wLX (Figure 34 A, lane 2), sPX (Figure 34 A, lane 6), Cy3-labeled wLX (Figure 
34 B, lane F), as well as full-PTO protected wLX (Figure 34 C, lane S). Additionally, 60bp DNA 
conjugated to only one LifeAct® (Figure 34 A, lane 4) or Phalloidin (Figure 34 A, lane 8) served 
as control. wLX, sPX and Cy3-wLX were generated in high yields as monomer bands were 
only slightly visible. Only for the generation of full-PTO-wLX side products, i.e. only one 
coupled LifeAct® instead of two, were observed. However, these samples were nevertheless 
utilized for shear rheology measurements, cell based assays as well as confocal laser 
scanning microscopy. 
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Figure 34│Analysis of synthetic actin crosslinker production. The engineering process of synthetic 
actin crosslinkers was stepwise monitored via (A) 10 % (v/v), (B) 12 % (v/v), (C) 10 % (v/v) native PAGE 
and visualized by SYBR® Gold Nucleic Acid Gel Strain staining. M, GeneRulerTM Low Range DNA 
Ladder; U, 60bp hybridized DNA; 1 and 5, two-fold DBCO-functionalized 60bp DNA; 2, 60bp wLX; 
3 and 7, one-fold DBCO-functionalized 60bp DNA; 4, 60bp DNA coupled to one LifeAct®; 6, 60bp sPX; 
8, 60bp DNA coupled to one Phalloidin; F, Cy3-labeled wLX that was used for staining of actin structures 
within cells (Figure 46); P, full PTO-modified 60bp DNA; S, full-PTO wLX that was utilized in cell-based 
experiments. 
 
5.2.2 Stability of DNA structures 
Besides the synthesis of crosslinkers, the general stability of two-armed as well as three-
armed DNA structures towards endo- and exonucleases was investigated. In a first test, 60bp 
DNA, either with PTO-modifications for all nucleotides or unmodified (Table 4), were incubated 
with DNase I or Exonuclease III as explained in 4.29. As shown in Figure 35, DNA that was 
not fully protected through PTO-modifications did not resist nuclease degradation, whereas 
PTO-protected 60bp DNA was not degraded (Figure 35 A, lanes D and E). An incubation of 
DNA with Opti-MEM® I Reduced-Serum Medium (Figure 35 A, lanes O) or Millipore water 
(Figure 35 A, lanes N) did not cause degradation.  
In addition, DNA trimers that were capped by five PTO-nucleotides each and were 
incubated for up to 30 min with Exonuclease III, and their resistance against digestion was 
compared to those of uncapped DNA trimers. As Figure 35 B indicates, PTO-capped DNA 
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trimers were stable against Exonuclease III over 30 min whereas unprotected DNA trimers 
were already digested within one minute, as trimer bands disappeared in the native PAGE gel. 
 
 
Figure 35│Stability of PTO-modified and unmodified DNA structures in presence of nucleases. 
(A) 60bp DNA, either without PTO-modifications or as full PTO-DNA, was incubated for 30 min at 37 °C 
in (N) dd H2O, (O) Opti-MEM® I Reduced-Serum Medium, with (D) DNase I or (E) Exonuclease III. 
Samples were analyzed via 12 % (v/v) native PAGE and visualized by SYBR® Gold Nucleic Acid Gel 
Strain staining. M, GeneRulerTM Low Range DNA Ladder. (B) PTO-capped DNA trimers as well as 
trimers without PTO modifications were incubated for indicated times in presence of Exonuclease III. 
Samples were analyzed via 10 % (v/v) native PAGE and stained as described above. The experimental 
setup is to be found in 4.29. 
 
In a second approach, the stability of unprotected 60bp DNA as well as PTO-capped 
DNA trimers, both coupled to a fluorophore-quencher pair (i.e. Cy3 and black hole quencher 2 
(BHQ2)) was investigated, as explained in 4.29. As long as DNA is hybridized and not 
degraded, Cy3 is close enough to have its fluorescence emission quenched by BHQ2. 
However, when degraded by nucleases, the Cy3 molecule is no longer quenched and its 
fluorescence emission can be detected. 
First, 60bp DNA, without PTO-protected nucleotides but with a Cy3-BHQ2 pair, was 
incubated with DNase I, Exonuclease III or without any nucleases. The fluorescence emission 
at 570 nm was recorded over 30 min for individual samples, respectively. As plotted in Figure 
36 A, degradation of unprotected 60bp DNA through DNase I started immediately after 
pipetting the enzyme since the fluorescence signal directly increased at the beginning. After 
about 15 min, the fluorescence signal reached a plateau, indicating that all DNA was degraded. 
Similar results were observed for DNA incubated with Exonuclease III. In this case, the 
fluorescence signal strongly increased after about 8 min and reached a plateau after 
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approximately 20 min. 60bp DNA that was not incubated with nucleases did not show an 
increase of fluorescence signal over 30 min, indicating that DNA remained intact. 
 
Figure 36│Degradation of unmodified and PTO-capped DNA structures in presence of nucleases. 
(A) 60bp DNA with a Cy3-BHQ2 pair (fluorophore-quencher pair) but without PTO-modification was 
incubated w/ DNaseI, w/ Exonuclease III or w/o both nucleases. (B) PTO-capped DNA trimers carrying 
a Cy3-BHQ2 pair were also incubated w/ DNaseI, w/ Exonuclease III or with none of these enzymes. 
The increase of relative fluorescence at 570 nm due to enzymatic degradation of DNA was analyzed 
over time using a TECAN Infinite® M1000 with an excitation of 550 nm. 
 
Cy3 - BHQ2 DNA trimers, capped by five PTO-nucleotides, were also incubated with 
either DNase I, Exonuclease III or none of these nucleases. Again, the fluorescence intensity 
was measured at 570 nm over time. As depicted in in Figure 36 B, DNA trimers incubated with 
DNase I showed the same rapid degradation as previously seen for 60bp DNA, since the 
fluorescence signal increased right after initiating the experiment. In contrast, PTO-capped 
trimers resisted digestion through Exonuclease III. The fluorescence signal did not increase 
over time, as seen for the control that was not incubated with a nuclease. However, for DNA 
trimers incubated with DNase I, the fluorescence signal decreased over time. This is probably 
due to bleaching of the fluorophore Cy3, although anti-bleaching agents were utilized. 
As reported by Putney et al. in 1981, DNA can be protected from degradation through 
nucleases by PTO-modifications of the DNA backbone237. As seen from previously described 
experiments, DNA structures that were only PTO-capped were stable against exonucleases 
but not endonucleases. When the DNA structure consisted of strands that were fully modified 
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with PTO-nucleotides it was stable against both, endo- and exonucleases. This result as well 
as the fact that the full-PTO structures were also producible in high yields, was thought to be 
of importance for subsequent cell culture experiments, since it meant that the full-PTO wLX 
could longer stay intact within the cytosol that contains both exo- and endonucleases, and 
therefore could cause the most possible impact on cellular functions. 
5.3 Functional effects of wLX and sPX on reconstituted actin networks 
In order to investigate the effect of these synthetic crosslinkers on reconstituted actin 
networks in a quantitative manner, dynamic shear rheology (4.32) was employed. A broad 
range of crosslinker concentrations were tested in viscoelastic actin filament networks. These 
ratios are given as R = ccrosslinker/cactin in the following. 
5.3.1 Mechanical fingerprints of wLX and sPX  
In a first approach, actin polymerization was measured with a bulk shear rheometer in 
presence of different concentrations of wLX. Therefore, monomeric actin was enriched w/ or 
w/o wLX, polymerization induced by the addition of 20X KME and rheological measurements 
were immediately started. Corresponding values for the elasticity (G´) were plotted over time 
and are shown in Figure 37. Actin polymerization w/o wLX (black curve) showed a monotonic 
increase of G´ over time, indicating elongating filaments arranged into an entangled, 
viscoelastic network. Once the steady state of actin polymerization was reached the elasticity 
remained stable. These qualitative characteristics were also obtained when actin was 
polymerized in presence of the weakly-binding wLX (differently shaded red curves). However, 
additional crosslink-dependent effects emerged as wLX caused an increase of G´ in a 
concentration-dependent manner. For the highest wLX concentration, i.e. 2.4 µM (R = 0.1, 
dark red), the overall elasticity was 6-times higher compared to pure actin. This illustrates the 
effect of physically, albeit transiently connecting individual filaments. This has also been 
previously described for the weakly-binding natural occurring crosslinker α-actinin (2.5.1)140,238. 
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Figure 37│Evolution of the elasticity during actin polymerization in presence of wLX over time. 
Actin polymerization in presence of wLX was investigated via dynamic shear rheology. The elastic 
modulus G´ of pure actin (24 µM, black) enriched with different concentrations of wLX 
(R = 0, 0.001, 0.01, 0.1, red shaded curves) was measured over time as explained in 4.32. 
 
A similar behavior, at comparatively lower concentrations, was observed for the strongly-
binding sPX. As Figure 38 A illustrates, a 6-fold increase of G´ was observed at a molar ratio 
of R = 0.01 (blue curve), which is about 10 % of the wLX concentration required to reach a 
similar magnitude of elasticity. The corresponding phase angles at R = 0.01 and 0.0025, 
depicted as blue curves in Figure 38 B, were shifted to lower values, indicating their increasing 
elastic response. Pure, viscoelastic actin networks in contrast, displayed a phase angle around 
40 °. Again, equivalent behavior was reported for human fascin, the natural analogue to sPX, 
where the described signatures of gelation have been shown for similarly low ratios140. 
However, at higher sPX concentrations, i.e. R = 0.1 and 0.02, the elasticity increased non-
monotonically. Initially, G´ drastically increased until reaching a peak, which suddenly relaxed 
to a more viscous dominated state, shown in Figure 38 A (green curves). This time evolution 
is referred to as the “elasticity burst”140. The nature of this elasticity burst with its subsequent 
exponential decay was further revealed through the concurrent evolution of the phase angle δ 
over time. As seen in Figure 38 B (green curves), before the peak of G´ is reached, δ remained 
stably low indicating a predominantly elastic system. During the subsequent decay of G´, the 
phase angle monotonically increased and finally reached a stable plateau, representing a 
correspondingly viscoelastic response. For the highest sPX concentration tested, i.e. R = 0.1 
(Figure 38 B, dark green curve) the system predominantly behaved as a viscous fluid, since δ 
values were significantly higher compared to purely entangled actin filaments (Figure 38 B, 
black curve).  
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Figure 38│Evolution of the elasticity during actin polymerization in presence of sPX over time. 
Actin polymerization in presence of wLX was investigated via dynamic shear rheology. (A) The elastic 
modulus G´ of pure actin (24 µM, black) enriched with different concentrations of sPX 
(R = 0, 0.0025, 0.01, 0.02, 0.1, different shades of blue and green referring to monomeric increase vs. 
elastic burst, respectively) was measured over time as explained in 4.32. (B) Shows the corresponding 
phase angles δ defined as the arctangent of the ratio G’’/G’, where G’’ and G’ are the frequency 
dependent viscous and elastic shear moduli, respectively, with 0° being a purely elastic (solid-like) 
response and 90 ° being a purely viscous response (colours refer to the same concentrations as in 
Figure 38 A). 
 
This mechanical fingerprint was also seen in experiments with the strongly-binding 
natural occurring actin crosslinker fascin (supplemental Figure S 4), confirming the already 
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reported behaviors139,140. Lieleg et al. reported in 2011 that simultaneous polymerization with 
strong crosslinking leads to the generation of pre-stressed structures that are bent beyond 
their equilibrium configuration139. As a result, formed actin networks build up internal 
stress139,178. This occurs due to the fact that polymerization is faster than unbinding of the 
strong crosslinker, i.e. the typical filament elongation rates (~10 µM–1 s–1)186 far exceed the off 
rates of the actin-binding domains (0.12 s-1 for fascin187, 0.00026 s-1 for phalloidin164). In this 
situation, the buildup of stress within the network can occur since fast filament growth can lead 
to sterically trapped configurations, where relaxation is limited by the slow unbinding rates of 
crosslinkers. As seen in Figure 38 the build-up pre-stress subsequently relaxed and therefore 
the system became more viscous. As actin filaments are subjected to significant bending 
forces, they could break at some point which would lead the system to become more 
viscous188. Moreover, the subsequent age-dependent relaxation could be partially induced by 
glassy dynamics aiming to release the stress towards equilibrium139. 
5.3.2 Concentration-dependent stiffening of actin networks 
Since naturally occurring actin crosslinkers, such as α-actinin and fascin, were reported 
to stiffen reconstituted actin networks in a concentration-dependent manner140, actin/wLX and 
actin/sPX networks were rheologically examined over a broad concentration spectrum. As 
depicted in Figure 39, both wLX (red curve) and sPX (green curve) showed a qualitatively 
similar, non-monotonic, concentration dependent behavior of the network elasticity. For the 
lowest respective concentrations, G’ was slightly lower compared to purely entangled actin 
networks. This could be due to local heterogeneities induced by the crosslinker, which caused 
a global softening of the network150,239. With increasing crosslinker concentrations, as the 
networks became progressively more percolated, the elasticity rose as demonstrated by the 
positive slopes in Figure 39. However, the slope for sPX was higher than for wLX, i.e. 
displaying a power law exponent of 0.62 compared to 0.21 for the weaker case. This indicated 
that sPX stiffened the network much more efficiently compared to wLX, which also correlates 
with the binding affinities of Phalloidin and LifeAct® for actin. Excitingly, both cases exhibited a 
local maximum of G’, which subsequently decreased to a minimum and rose again with a 
different exponential behavior for the highest concentrations. Although the onset of the 
different regimes varied, the qualitative curve progression for both binding strengths resembled 
each other in appearance. 
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Figure 39│Concentration-dependent elasticity of actin networks enriched wLX and sPX. Elastic 
moduli of actin networks were investigated for different concentrations of wLX (red curve) and sPX 
(green curve) via dynamic shear rheology (4.32). Power law fits are shown in black with according power 
law exponents in the corresponding color next to the graph. 
 
5.3.3 Different structural morphologies of actin networks 
As reported by Lieleg et al. in 2010, the natural actin crosslinker α-actinin induced 
different structural morphologies in a concentration-dependent manner150. Since both wLX and 
sPX caused a non-monotonic behavior of the network elasticity with increasing concentration, 
actin networks enriched with different concentrations of synthetic crosslinkers were 
investigated concerning their morphology in the next step. For this purpose, light scattering 
(4.33, Figure 40) as well as spinning disc confocal microscopy (4.34, Figure 41) were 
conducted and additionally correlated to the corresponding elastic moduli. 
As seen in Figure 40 (blue curve), the scattering intensity remained constant below a 
wLX concentration of R ≤ 0.01. In addition, microscopy images revealed that actin filaments 
were arranged in a weakly crosslinked network (Figure 41 A). However, above a threshold 
concentration (R = 0.01), the scattering intensity increased while simultaneously G´ (red curve) 
decreased. Fluorescence images taken at a wLX concentration of R = 0.01 (Figure 41 B) 
showed the existence of a few actin bundles in a crosslinked actin network. With further 
increases to the wLX concentration, the scattering intensity as well as the network elasticity 
rose. Corresponding images taken at wLX concentration of R = 0.33 showed a bundled actin 
network (Figure 41 C).  
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These mechanical characteristics can be attributed to three different phases of 
morphologies, i.e. (I) crosslinked actin network, (II) coexistence network and (III) bundle 
network, as illustrated in grey shaded parts in Figure 40. In the first regime (I) actin filaments 
are isotropically arranged in a weakly crosslinked network. Above a certain threshold 
concentration, the network enters the coexistence regime (II), in which higher wLX 
concentrations increasingly favor alignment of filaments, yielding a coexistence of bundles 
within an isotropic background network. In this regime (0.01 < R ≤ 0.08) bundles can be 
considered as local anisotropies, hence the effective actin concentration in the percolated 
background network is reduced which results in a weakening of the overall structure and 
resulting in the observed decrease of G’. It was previously suggested in simulation studies that 
bundled structures occupy more crosslinkers than their isotropic counterparts suggesting that 
this increasing anisotropy comes at the cost of overall network percolation240. The combination 
of both, a reduced percolation in the background network and concurrently a reduced effective 
actin concentration might be the reason for the drastic decrease of the elasticity to values even 
below those found for much smaller crosslinker concentrations240. In the third regime (III), 
bundles assembled to form a percolated bundle network, illustrated by the dominating elastic 
response of the system. With rising crosslinker density, percolation is increased and therefore 
the network further stiffened.  
 
 
Figure 40│Structural phases of actin networks crosslinked by wLX. Actin networks were 
investigated in presence of different concentrations of wLX via light scattering (4.33). Light scattering 
intensities are shown in blue with error bars indicating standard deviations of the mean values. 
Corresponding elastic moduli (same as in Figure 39) are additionally given in red. 
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Figure 41│Structural phases of actin networks polymerized in presence of wLX. Actin was 
polymerized at 3 µM in presence of wLX at (A) R = 0.001, (B) R = 0.01 and (C) R = 0.333, respectively. 
Actin was mixed with TRITC-Phalloidin at a molar ratio of 3 : 1 for visualization with spinning disc 
confocal microscopy. The detailed experimental setup is explained in 4.34. 
 
 
B 
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This qualitative structural trend was also seen in actin networks containing sPX. 
However, light scattering analysis of sPX crosslinked actin networks was not suitable due to 
the time dependent evolution of structural anisotropies described in section 5.3.1. However, 
clear differences became apparent when samples were investigated with fluorescence 
microscopy (supplemental Figure S 5). 
The observed tri-phasic behavior was described for actin networks containing the 
weakly-binding synthetic crosslinker wLX. However, it can be expected, as prior findings 
indicate89,150, that the characteristics will be generally valid for other synthetic and natural actin 
crosslinkers. 
5.3.4 Reversibility of crosslinking induced by an enzymatic switch 
In addition to mimicking natural mechanical signatures, the modular, DNA-based design 
of the synthetic crosslinkers also allows the integration of simple regulatory mechanisms in the 
form of orthogonal state-switches. Here, the sequence of the DNA spacer included a 
recognition site for the restriction enzyme EcoRV so that the crosslinker could be cleaved into 
two segments, thereby effectively "breaking" the link between filaments. Therefore, the time-
dependent elasticity of actin polymerization was studied either in presence of intact sPX, 
EcoRV-HF®-cleaved sPX or EcoRV-HF® only. For this purpose, sPX concentrations below the 
threshold of the elastic burst were chosen (i.e. R = 0.01; c = 0.24 µM). As Figure 42 A 
demonstrates, a cleavage of sPX through EcoRV-HF® prior to measurement (light green curve) 
led to a drastic decrease of G´ compared to intact sPX (dark green curve) and reached values 
close to the actin control (black curve) that was incubated with EcoRV-HF® but without 
crosslinkers. Still EcoRV-HF®-cleaved sPX showed a slightly higher elasticity than the actin 
control which likely could be resulting from few numbers of undigested crosslinkers, as it was 
confirmed by native PAGE analysis (supplemental Figure S 3). 
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Figure 42│Reversibility of synthetic actin crosslinkers. Time-dependent elasticity of actin 
polymerization in presence of intact sPX (dark green, c = 0.24µM (R = 0.01)), EcoRV-HF®-cleaved sPX 
(light green, c = 0.24 µM (R = 0.01)) and actin which was incubated with just EcoRV-HF® (black) was 
investigated via shear rheology. The actin concentration was 24 µM for all experiments and the cleavage 
of sPX through EcoRV-HF® was additionally verified via native PAGE (supplemental Figure S 3). 
 
Moreover, the mechanical impact of crosslinker-induced stiffening and enzyme-based 
regulation of actin networks could be also seen in macroscopic gels. As explained in section 
4.35, TRITC-Phalloidin-labeled actin was polymerized in a cuvette in presence of intact sPX, 
EcoRV-HF®-cleaved sPX as well as without any crosslinker for 40 min. Right after, the cuvette 
with the respective sample was placed on an inclined plane with a 20 ° angle. The flow down 
of the samples over time is illustrated in Figure 42 B. Purely entangled, viscoelastic actin flowed 
down the gradient within seconds (left column) whereas an addition of intact sPX resulted in a 
more than five-fold slowing of the flow (middle column) indicating the increased elastic behavior 
of the system. However, the inclusion of enzyme-cut crosslinkers (right column) restored the 
dominance of the fluid-like behavior as the flow rate was undistinguishable from the actin only 
control. 
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Figure 43│Reversibility of synthetic actin crosslinkers. Macroscopic behavior of actin in an inclined 
cuvette over time. Actin was polymerized at 24 µM (left) w/o actin crosslinkers, (middle) with 9.6 µM 
sPX and (right) 9.6 µM sPX pre-incubated with 300 U EcoRV-HF®. 
 
 
Results and Discussion 
112 
 
5.4 Interaction of synthetic crosslinkers with actin filaments 
5.4.1 Polymerization / Depolymerization of actin filaments (pyrene assay) 
A well-established method to monitor actin polymerization and depolymerization in vitro 
is the standard pyrene assay, in which the fluorescence intensity is a measure for the degree 
of polymerization170,241. Schmoller et al. reported that natural occurring crosslinking proteins, 
such as fascin, suppress actin depolymerization in a concentration dependent manner and that 
this would be a generic effect for all actin-binding proteins which simultaneously bind to two  
F-actin subunits241. 
In order to investigate the effect of synthetic actin crosslinkers on in vitro polymerization 
and depolymerization, a pyrene assay was conducted as explained in section 4.36. Pyrene-
actin was polymerized at 6 µM in presence of different concentrations of wLX (i.e. R = 1, 
R = 0.2, R = 0.1, R = 0.08, R = 0.02 and R = 0.01) as well as the LifeAct® peptide only (R = 1). 
These results were compared to the polymerization of pyrene-actin alone. Actin 
depolymerization was induced after 90 min by the addition of latrunculin B (latB), which 
sequesters monomeric actin and thus causes a depolymerization at both the barbed and 
pointed ends241. Corresponding fluorescence intensities at 407 nm were recorded over time 
and are plotted in Figure 44. Typically, fluorescence intensity increases over time and reaches 
a plateau. When latB is added, this plateau suddenly drops and actin depolymerizes. Here, 
fluorescence intensities of all samples increased until reaching a peak after about 30 min but 
without the addition of latB, fluorescence intensity suddenly decreased over time. This could 
be due to bleaching effects and the rather low amount of pyrene-actin used. However, it could 
be clearly observed that wLX inhibited polymerization rates in a concentration-dependent 
fashion. At a wLX concentration of R = 1 polymerization was suppressed the most, and at the 
lowest concentration of R = 0.01 polymerization was almost similar to that of pyrene-actin 
alone. LifeAct® by itself did not cause an inhibition of polymerization rate when used at the 
same high concentration as wLX (R = 1), which is coincident to the findings of Riedl et al.161. 
After 90 min, latB was added and depolymerization of pyrene-actin induced. 
Unfortunately, since fluorescence signal already had dropped, no clear differences between 
samples were observed. Still, a slight concentration dependency might be assumed as wLX at 
R = 1 showed the lowest fluorescence signal compared to wLX at R = 0.01, which is again in 
the range of pyrene-actin alone. However, it not possible to conclude from these results that 
synthetic crosslinkers also inhibit depolymerization rates as Schmoller et al. found for naturally 
occurring actin crosslinkers241. 
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Figure 44│Polymerization and depolymerization of actin in presence of LifeAct® and wLX. 
Polymerization and depolymerization of pyrene-actin (6 µM) in presence of LifeAct® as well as different 
ratios of wLX (R = 1, R = 0.2, R = 0.1, R = 0.08, R = 0.02 and R = 0.01) was monitored over time. 
Polymerization was induced by the addition of 20X KME buffer (4.3). After 90 min, depolymerization was 
initiated by the addition of Latrunculin B to a final concentration of 200 µM. Emitted fluorescence was 
measured at 407 nm. A detailed experimental setup is described in 4.36. 
 
5.4.2 Impact of wLX on actin remodeling dynamics in cells 
The actin cytoskeleton is highly dynamic, with ABP attaching and detaching from the 
actin meshwork and the constituent actin filaments turning over due to addition and removal 
of monomers at the filament ends242. As it was shown that wLX impact the actin polymerization 
in vitro, it is was of great interest whether synthetic crosslinkers also interfere with the actin 
remodeling dynamics inside of cells. Therefore, the influence of wLX on the actin dynamics 
were investigated the via fluorescence recovery after photobleaching (FRAP) with collaborator 
Tobias Zech (Cellular and Molecular Physiology, University of Liverpool). Normal mouse 
mammary gland epithelial cells (NMuMG) were transfected for 24 h with EGFP-actin and either 
50 nM wLX or, as a control, 50 nM single LifeAct® 60bp DNA using Lipofectamine 2000 
(Invitrogen) according to manufacturers’ instructions. After transfection, EGFP fluorescence of 
actin in regions of interest (ROI) were imaged using a spinning disk confocal microscope and 
bleached with a brief pulse of 405 nm Diode laser. The recovery of the EGFP-fluorescence 
was recorded over time and is depicted in Figure 45. The control sample, i.e. 50 nM single 
LifeAct® 60bp DNA, which should not interfere with actin dynamics as it is not able to connect 
actin filaments, showed a fast increase up to 20 % of recovered fluorescence within half a 
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minute. In contrast, the actin-EGFP-fluorescence did not even recover to 5 % within the same 
time in wLX-transfected cells, which indicates that wLX is capable of slowing down actin 
remodeling dynamics. Still it remains unclear whether this effect can be attributed to a slowed 
down actin polymerization/depolymerization or an interference with either diffusion or myosin 
transport due to an enhancement of glassy characteristics in the networks. However this will 
be further investigated in future experiments. 
 
Figure 45│Influence of wLX on actin remodeling dynamics in NMuMG cells. Normal mouse 
mammary gland epithelial (NMuMG) cells were co-transfected with EGFP-actin and either 50 nM wLX 
or, as a control, 50 nM single LifeAct® 60bp DNA using Lipfecamine 2000 (Invitrogen) according to 
manufacturers’ instructions. Cells were imaged 24 h after transfection with a Marianas spinning disk 
confocal microscope (3i) using a 63 x 1.4NA or 10x 0.45NA Zeiss Plan-Apochromat lens. EGFP 
fluorescence in regions of interest (ROI) was bleached with a brief pulse of 405nm laser and recovery 
was recorded over time. Slidebook software (3i) was used to analyze the fluorescence recovery in ROIs 
and to deduct background bleaching of rest of cell with a control non-bleach ROI. The experiment was 
conducted and data kindly provided by Tobias Zech (University of Liverpool). 
 
5.4.3 Labeling of actin filaments within cells 
Synthetic wLX were extensively studied in in vitro experiments. Additionally, it was of 
general interest to see where fluorescently labeled wLX, i.e. Cy3-wLX, localize within cells and 
if it is possible to stain single actin filaments, as it was shown for LifeAct®-GFP fusions161. Cy3-
wLX were generated as described in section 4.28 and, as already discussed (5.2, Figure 34), 
produced at high yields.  
To compare localization of fluorescently labeled wLX, a LifeAct-GFP fusion, encoded on 
pTag-LifeAct-GFP-N (4.7), was generated as described in sections 4.18 to 4.21. The 
hybridized LifeAct®-DNA fragment was inserted into previously linearized 4.73 kb pTagGFP-N 
(supplemental Figure S 6 A) and subsequently E. coli DH5α cells were transformed with the 
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ligation mixture. Four of five picked clones were identified as positive clones, since these 
showed the estimated PCR product of 325bp (supplemental Figure S 6 B and Figure S 7). 
Additional sequence analysis verified the correctness of the sequence (not shown).  
To visualize intracellular actin structures, HeLa cells were transfected (4.37.8) for 6 h 
with Cy3-wLX or pTag-LifeAct-GFP-N as described in 4.39. Corresponding LSM images, 
shown in Figure 46, illustrate that filamentous actin structures were stained with Cy3-wLX, 
comparable to staining with conventional LifeAct®-GFP fusions161, depicted in Figure 46 B, D 
and F. Figure 46 A and E nicely show the Cy3-wLX staining of lamellipodia that appear as 
branched ‘‘dendritic’’ actin filament networks or quasi 2D actin mesh at the front, leading edge 
of the cell243. Filopodia (also known as microspikes), which are exploratory extensions from 
the plasma membrane that contain parallel bundles of actin filaments244, were visualized within 
all Cy3-wLX transfected cells. 
Additionally, some vesicular structures were noticeable. These vesicles presumably 
were Lipofectamine/Cy3-wLX complexes, which were up taken by endocytosis. However, 
since Cy3-labeled wLX were able to actively stain the actin cytoskeleton, it can be assumed, 
that most of these complexes were released from endosomes and translocated into the 
cytosol. This is consistent to what Cardarelli et al. recently found. They observed that 
Lipofectamine/DNA complexes enter cells by endocytosis and that a significant number of 
these complexes are released into the cytosol as they did not show a co-localization with 
lysosomal markers245.  
Since synthetic crosslinkers are both, peptide- and DNA-based, Cy3-wLX were 
additionally investigated for co-localization with 4',6-diamidino-2-phenylindole, short DAPI. 
DAPI is a DNA-specific probe which forms a fluorescent complex by attaching in the minor 
grove of A-T rich sequences of DNA246. Thus DAPI is extensively used as DNA-specific probe 
for flow cytometry, chromosome staining, DNA visualization as well as quantitation in 
histochemistry and biochemistry. Here, DAPI was applied to stain the nuclei of Cy3-wLX-
transfected as well as untreated, FITC-Phalloidin stained HeLa cells (Figure 47). Interestingly, 
when increasing the gamma of DAPI signal to 0.01 during image processing, afore mentioned 
F-actin structures could be visualized with DAPI in Cy3-wLX transfected cells, seen in Figure 
47 B. In contrast, actin structures stained with FITC-Phalloidin did not co-localize with DAPI in 
control cells (Figure 47 D). This phenomenon served as an extra proof, that fluorescently 
labeled synthetic crosslinkers bound to actin structures within cells. 
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Figure 46│Labeling of actin filaments within HeLa cells. (Left) Labeling of intracellular actin 
structures with Cy3-labeled wLX was compared to (Right) conventional staining with LifeAct-GFP 
through plasmid transfection with pTag-LifeAct-GFP-N (4.18). HeLa cells were transfected with 
(A) 75 nM, (C) 150 nM and (E) 300 nM Cy3-wLX for 6 h. (B, D, F) HeLa cells were transfected with 
1000 ng pTag-LifeAct-GFP-N plasmid DNA for 6 h. Cells were fixed and nuclei were stained with DAPI 
(shown in blue). Equal laser intensities and gains were applied. LSM Images were pseudo colored using 
ZEN blue software and scale bars set to 20 µm. 
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Figure 47│Co-localization of DNA and actin structures in HeLa cells transfected with wLX. (Left) 
HeLa cells were transfected with 300 nM Cy3-labeled wLX for 6 h and fixed prior to LSM imaging. 
(Right) As a control, untreated cells were stained with 100 nM FITC-Phalloidin after fixation. In order to 
determine whether DNA-based Cy3-wLX (green fluorescence) merge with DNA staining (DAPI), gamma 
of blue channel was upregulated to 0.01 during image processing with ZEN blue software. (A, B) shows 
green fluorescence of (A) Cy3-wLX and (B) FITC-Phalloidin, (C, D) fluorescence of DAPI staining (blue), 
(E, F) merged pictures. LSM Images were pseudo colored and scale bars set to 20 µm. 
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5.5 Functional effects of wLX on cells 
After having shown that synthetic crosslinkers strongly interact with actin in vitro, e.g. 
inhibition of actin polymerization rates as well as stiffening of reconstituted actin networks, and 
that they specifically interact with actin filaments within cells, it was of strong interest, to 
investigate the functional effects of crosslinkers on cells stemming from these interactions. 
Obviously, actin-dependent processes such as proliferation, migration and invasion were in 
focus at the beginning. Additionally, the cytotoxic effect of these synthetic constructs was 
examined. 
5.5.1 Proof of concept 
As a first proof of principal, the effect of synthetic crosslinkers on the migration of HeLa 
cells was tested. The process of cell migration is extremely dependent upon actin dynamics, 
as the rapid polymerization of actin at the barbed end of a branch in lamellipodia pushes the 
cell forward and therefore mediates migration (2.4). Since synthetic crosslinkers were shown 
to inhibit actin polymerization rates in vitro, it was of great interest to study migratory processes 
within cells. The two-dimensional migration of HeLa cells was investigated performing a simple 
wound healing or scratch assay, as described in section 4.40.3. HeLa cells were either treated 
with Lipofectamine™ 3000 only, or transfected with 300 nM 60bp DNA, 300 nM wLX or 300 nM 
sPX, respectively. After removing the culture insert, cell migration into the free gap was 
microscopically monitored over 48 h and a typical experimental run is shown in Figure 48 A. 
Whereas Lipofectamine as well as 60bp DNA control cells closed the gap within 48 h, cells 
treated with wLX and sPX moved slower and cell fronts did not reach each other within the 
same time. In order to gain a better understanding of the relative areas that are covered with 
cells during the process, images were quantitatively analyzed with the ImageJ plugin MITOBO. 
Figure 48 B shows the percentages of cells migrated into the cell-free area over 36 h. Cells 
treated with 300 nM wLX showed up to a 30 % decrease in migration over 36 h compared to 
the Lipofectamine control. Similar results were achieved for sPX: cells treated with 300 nM 
sPX migrated approximately 25 % slower than control cells. DNA-treated cells showed similar 
migratory course to Lipofectamine-treated cells. This observation nicely matches the findings 
Glück et al. reported in 1994. They found that modulations in the expression of α-actinin, one 
of the previously introduced natural occurring actin crosslinkers (2.5.1) that were to be 
mimicked by wLX, were reported to have a major effect on the motile and tumorigenic 
properties of a cell. An overexpression of α-actinin in 3T3 fibroblasts showed a significant 
reduction in cell motility, as seen by their slower movement into the cell free area of a standard 
wound healing assay. In contrast, a downregulation of α-actinin led to an increased cell 
motility137.  
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Figure 48│2D migration of crosslinker-transfected HeLa cells into cell-free area over time.  
(A) HeLa cells were transfected with 300 nM wLX, 300 nM sPX, 300 nM 60bp DNA as well as 
Lipofectamine only for 4 h. The time-dependent migration into the cell-free gap was imaged with an 
inverted Leica DM IRB phase contrast microscope. (B) Subsequent image analysis was conducted 
using ImageJ plugin MITOBO and received sample values were plotted against time. The experimental 
setup is described in 4.40.3. 
 
Two-dimensional migration behavior is a combination of cells moving into the cell-free 
gap as well as cells proliferating to create the confluent layer. Since synthetic crosslinkers were 
shown to slow down cell migration in HeLa cells, it was of great interest whether the observed 
phenomenon simply occurred due to decreased proliferation or alternatively cell death and 
moreover, how wLX effects migration and invasion in 3D. However, HeLa cells are not suitable 
for invasion assays since they are noninvasive tumor cells. Thus, MDA-MB-231 cells, which 
are highly invasive and also considered a model system for cells that have undergone the 
process of epithelial-mesenchymal-transition (EMT), were utilized for the following 
experiments. 
5.5.2 Impact of wLX on vital functions of cells 
Initially, the proliferation of MDA-MB-231 cells, as described in 4.40.2, was investigated. 
WST-1 proliferation agent was added 24 h, 48 h and 72 h post transfection with wLX and 
corresponding controls. Results are plotted in Figure 49. Since DMSO is cytoctoxic and cells 
did not proliferate any more after its addition, this was used as a suitable positive control. After 
three days, most of the DMSO-treated cells died, seen as red bars. After 72 hours, cells that 
were either transfected with 150 nM or 300 nM wLX showed a negligibly decreased 
A B 
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proliferation activity compared to control samples with single-LifeAct® 60bp DNA, and a slightly 
decreased proliferation compared to the 60 bp DNA connector strand without any peptides 
(Figure 49 C). Cells, which were treated w/ and w/o Lipofectamine™3000, did show the highest 
proliferation rates. In general, any differences in the proliferation of cells treated with wLX 
compared to control cells were effectively negligible, and would not be expected to lead to 
functional changes as significant as those reported in the previous section. 
 
Figure 49│Proliferation of crosslinker-treated MDA-MB-231 cells. MDA-MB-231 cells were 
transfected for 4 h with different concentrations of 60bp DNA, half-PTO 60bp DNA, wLX and full-PTO 
wLX, as well as Lipofectamine only. Proliferation was measured with WST-1 proliferation agent (A) 24 h, 
(B) 48 h and (C) 72 h post transfection. Cells treated with 7 % (v/v) DMSO served as positive control. 
Proliferation analysis was conducted as described in 4.40.2. 
A 
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Corresponding apoptosis analysis, as described in 4.40.1, is depicted in Figure 50. As 
seen in Figure 50 A, 60bp DNA as well as single LifeAct® 60bp DNA control showed very 
similar amounts of apoptotic cells compared to 150 nM and 300 nM wLX transfected cells. All 
of them were in the range of about 80 % to 85 % of vital cells, and showed approximately 10 % 
early apoptotic as well as 5 % to 7 % late apoptotic cells. However, non-treated cells, as well 
as cells treated only with Lipofectamine, showed a slightly lower apoptosis rate, with vitality 
rates of about 90 %, early apoptotic cells of 6 % to 7 % and late apoptotic cells of 3 % to 4 %. 
The DMSO control sample, shown as red bar, showed about 20 % early and more than 55 % 
late apoptotic cells after 24 h incubation. Only approximately 23 % cell incubated with 7 % 
DMSO were vital. In summary, it can be assumed, that synthetic crosslinkers do not initiate 
any significant amount of apoptosis in MDA-MB-231 cells and are not cytotoxic at those 
concentrations that were applied. 
 
Figure 50│Apoptosis assay of crosslinker-treated MDA-MB-231 cells. MDA-MB-231 cells were 
transfected for 4 h with different concentrations of 60bp DNA, half-PTO 60bp DNA, (A) wLX and (B) full-
PTO wLX, as well as Lipofectamine only and incubated another 24 h prior to flow cytometry analysis. 
Cells treated with 7 % (v/v) DMSO served as positive control. Apoptosis analysis was conducted as 
described in 4.40.1. 
A 
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Since PTO-modified DNA is known to be more stable against nuclease degradation237, 
two types of PTO-protected spacer segments were used in the cell culture experiments 
described in the following. Half-PTO 60bp DNA consisted of one fully protected strand and an 
unmodified complement, with no peptide modifications, and were used as a control. Full-PTO 
wLX were also used, where both strands were fully protected. These structures were 
investigated to assess influence of PTO modifications on apoptosis247. The results of this 
apoptosis assay, conducted similarly to the previously described apoptosis assay, are plotted 
in Figure 50 B. Compared to cells that were transfected with 300 nM and 600 nM 60bp DNA 
w/o PTO-modification, which showed vitality rates of about 80 %, cells transfected with either 
300 nM or 600 nM half-PTO protected 60bp DNA as well as 300 nM and 600 nM full-PTO wLX 
showed about 20 % less vital cells. This included up to 24 % early and up to 20 % late apoptotic 
cells. Similarly, the half-PTO modified 60bp DNA also caused this significant effect. Due to the 
apparent and significant triggering of apoptosis from even a single PTO-protected strand, 
synthetic fully-PTO-protected crosslinkers were considered to be unsuitable for further cell 
experiments as they are more cytotoxic than unmodified DNA.  
5.5.3 Effect of wLX on motile functions and invasiveness of cells 
Migration of MDA-MB-231 cells was investigated in 3D utilizing a simple Boyden-
chamber248 approach, where cells squeeze through micron-sized pores at the bottom of the 
chamber towards a chemoattractant, in this case serum-containing medium. The full 
experimental setup is explained in section 4.40.4. Here, the 3D migration of cells after being 
treated for 48 h with only Lipofectamine was compared to cells transfected with either 300 nM 
60bp DNA, 300 nM wLX, or 300 nM full-PTO wLX. Figure 51 A shows the percentages of cells 
that migrated through pores including the number of seeded cells. The data was normalized 
according to the cells treated with only Lipofectamine, which were set to 100 % in the presented 
data. All other samples were scaled according to this control. MDA-MB-231 cells, transfected 
with 300 nM wLX showed a decrease in 3D migration of around 12 % compared to 
Lipofectamine treated control cells. Full-PTO-protected wLX treated cells in contrast did not 
show a decrease in migration, and migrated similarly to control cells. However, cells that were 
transfected with unmodified 60bp DNA showed a decreased migration of around 12 %, similar 
to those described above that were treated with wLX.  
Initial, earlier experiments had shown a decreased 3D migration of about 25 % of MDA-
MB-231 cells treated with 300 nM wLX compared to cells that were treated either with only 
Lipofectamine or 300 nM single LifeAct 60bp DNA (supplemental Figure S 8 A). However, 
since the experimental setup was not exactly the same, those results are rather difficult to 
compare. 
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The initial response of a cell to a migration-promoting agent or trigger is polymerization 
and extension of protrusions towards the direction of migration. These protrusions can be 
large, broad lamellipodia or spike-like filopodia, are usually driven by actin polymerization, and 
are stabilized by adhering to the extracellular matrix (ECM) or adjacent cells via 
transmembrane receptors linked to the actin cytoskeleton. These adhesions serve as traction 
sites for migration as the cell moves forward over them, and they are disassembled at the cell 
rear, allowing it to detach83. In order to drive membrane protrusion and therefore initiate 
migration, actin filaments are polarized with fast-growing “barbed” ends and slow-growing 
“pointed” ends83 as described in section 2.4. Additionally, it was reported that several actin-
binding proteins regulate the rate and organization of actin polymerization in protrusions by 
affecting the pool of available monomers and free ends100,249. As seen in the pyrene assay, 
reported in 5.4.1, wLX caused an inhibition of polymerization rates in a concentration-
dependent manner. Since actin polymerizes at the edge of a cell and thus promotes migration, 
an inhibition or decrease in polymerization could be an explanation why cells transfected with 
wLX migrated slower, both in 2D (Figure 48) and 3D (Figure 51 A and supplemental Figure S 
8 A). For both, sPX and full-PTO wLX, pyrene assays are still lacking. Since it is unknown 
whether they inhibit or reduce actin polymerization rates as well, it is rather difficult to make 
conclusions about the cause for their previously observed effect on migrative behavior. 
 
Figure 51│3D migration and 3D invasion of crosslinker-transfected MDA-MB-231 cells.  
(A) MDA-MB-231 cells were transfected with 300 nM 60bp DNA, 300 nM wLX, 300 nM full-PTO wLX, 
as well as Lipofectamine only for 4 h. Cells were detached and seeded into (A) uncoated culture wells 
to investigate 3D migration and (B) 0.5X BME-coated culture wells to analyze 3D invasion. Cells were 
incubated for 48 h and migrated and invaded cells subsequently stained via Calcein AM fluorescent dye. 
Under consideration of a Calcein AM standard curve as well as the seeded cell count, the number of 
cells was calculated from measured fluorescence intensities. The detailed experimental setup is to be 
found in 4.40.4. The percentage of migrated and invaded cells that were treated with Lipofectamine only 
was set to 100 %. All other samples were normalized to this control, respectively.  
A B 
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Similarly to 3D migration, a 3D invasion assay was conducted. Here, cells were seeded 
into chamber inserts that were additionally coated with a basement membrane extract (BME) 
layer. Only invasive cells that are able to degrade this BME layer with special, secreted 
enzymes (e.g. matrix metalloproteinases, short MMPs) are finally able to cross the barrier and 
reach the serum-containing medium on the other side. The detailed experimental setup is 
described in section 4.40.4. Figure 51 B shows the percentages of cells that successfully 
invaded through the BME layer and pores, which were either treated with Lipofectamine only 
or transfected with 300 nM 60bp DNA, 300 nM wLX or 300 nM full-PTO-protected wLX, 
respectively. Again, the percentages of invaded cells that were only treated with Lipofectamine 
were set to 100 % and all other samples normalized to this control. Transfection of  
MDA-MB-231 cells with 300 nM wLX led to nearly 25 % decreased invasiveness, compared to 
Lipofectamine control. Also full-PTO wLX-treated cells invaded approximately 10 % less than 
the corresponding control. However, this result might also be an effect of increased apoptosis 
rates, as seen previously (Figure 50 B). Unexpectedly, 60bp DNA treated cells showed an 
increased invasiveness of more than 25 % compared to the Lipofectamine control. However, 
the standard deviation was also rather high in this case.  
Earlier 3D invasion studies, depicted in supplemental Figure S 8 B, had shown an 
inhibition of invasion of more than 90 % in wLX-treated MDA-MB-231 cells compared to 
corresponding controls. However, since different BME batches and BME concentrations were 
used as well as experiments were conducted in a self-made setup several months apart, larger 
differences in the very basic parameter of BMD layer thickness are expected. These 
preliminary results indicate that invasion is inhibited, however it requires further investigation 
to reveal to which extend it is inhibited. In order to better quantify the effect, future experiments 
need to be repeated on a standardized setup and a single BME batch. 
Since 3D migration and invasion experiments were only performed once (in triplicates) 
with this particular setup, it was not possible to define whether differences in migration and 
invasion were significant compared to control cells. This could be determined in future 
experiments as well. 
5.5.4 Possible impact of synthetic crosslinkers on EMT 
The results of the 3D invasion assays inevitably raised the question as to why wLX-
treated cells showed a decreased invasiveness (e.g. decreased mesenchymal characteristic) 
through the BME layer as compared to the respective control cells. As described in section 
2.9, the mesenchymal transformation of cells is not only associated with cancer, but generally 
with natural development and non-oncogenic diseases such as tissue fibrosis. Therefore, the 
potential inhibitory effect that these constructs generally have upon the epithelial to 
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mesenchymal transition (EMT) was explored in preliminary experiments in conjunction with the 
collaborating group of Judith West-Mays (McMaster University, Hamilton, Canada). Here, 
synthetic crosslinkers were applied to a model system of human lens epithelial primary cells 
(FHL-124)250, which are often used as a model system for fibrosis-derived secondary cataracts. 
It is possible to induce epithelial-mesenchymal-transition (EMT) through stimulation with 
transforming growth factor beta (TGF-β) in those cells (2.9). It was found that cells, which were 
treated with 300 nM wLX for 3 h before stimulation with TGF-β for 48 h, did not form criss-
cross stress fibers, a key signature of EMT. The staining for F-actin, depicted in Figure 52, 
revealed that stress-fiber formation strongly increased in control cells treated with 300 nM 60bp 
DNA as well as buffer only before TGF-β stimulation, indicating EMT was induced in those 
cells. Same was reported to happen for sPX-treated cells (data not shown). This observation 
can also be correlated to the previously described findings from FRAP experiments of wLX- 
transfected NMuMG cells, as it was shown that wLX slowed down actin remodeling dynamics 
(5.4.2), which is important for stress fiber formation. 
 
 
Figure 52│Influence of wLX on EMT induction in human lens epithelial cells (FHL-124). Human 
lens epithelial cells (FHL-124) were either treated with buffer or transfected with 300 nM 60bp DNA or 
300 nM wLX prior to treatment w/ or w/o transforming growth factor beta (TGF-β) for 48 h. Cells were 
fixed and stained for F-actin using Rhodamine-Phalloidin (red). Images were pseudo colored during 
image processing. Scale bars were set to 10 µm. Experiments were conducted and pictures kindly 
provided by Aftab Taiyab, Post-Doctoral Fellow of the group of Judith West-Mays (McMaster University, 
Hamilton, Canada). 
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Motivated by these experiments, wLX were investigated concerning their possible role 
within the process of EMT (2.9). Since Kim et al. showed that TGF - β induced EMT, invasion 
and migration in MCF-10A cells251, this human breast epithelial cell line (4.4.2) was utilized for 
these purposes. As a first anchor point, the influence of wLX on matrix metalloproteinase 
(MMP) expression was investigated. MMPs are calcium-dependent zinc-containing 
endopeptidases which are responsible for the tissue remodeling and degradation of the 
extracellular matrix252. Moreover, MMPs were reported to be connected to metastatic behavior 
in vivo and associated in breast cancer progression253. 
Since wLX-treated cells showed a decreased 3D invasion, one possible explanation 
would be that wLX somehow mediated the downregulation of MMP expression levels and thus 
cells were less able to degrade the utilized Cultrex® BME layer, which mainly contained 
laminin, collagen IV, entactin, and heparan sulfate proteoglycan. Several MMPs are capable 
of degrading components of the BME layer. However, since both MMP-2 (gelatinase A, 
72 kDa) and MMP-9 (gelatinase B, 92 kDa) are able to degrade collagen IV and gelatin, and 
were additionally reported to be upregulated in TGF - β stimulated MCF-10A cells251,252, a 
gelatin zymography assay was conducted. Gelatin zymography is a very simple assay to 
specifically detect gelatinase activity in conditioned medium. As reported in sections 4.40.5 
and 4.40.5.1, MCF-10A cells were transfected with Lipofectamine only, 300 nM 60bp DNA or 
300 nM wLX for 6 h and subsequently stimulated w/ or w/o TGF-β for 48 h. The received 
gelatin zymogram is depicted in Figure 53. 
 
Figure 53│Detection of MMP-2 and MMP-9 levels via gelatin zymography. Conditioned medium of 
MCF-10A cells stimulated for 48 h with or without 10 ng/ml TGF-beta after transfection for 6 h with  
(C) Lipofectamine only, (wLX) 300 nM wLX or (D) 300 nM 60bp DNA was analyzed for MMP activity. 
Samples were run on 10 % (v/v) SDS-PAGE containing 0.2 % (v/v) gelatin. M, PageRuler™ Unstained 
Protein Ladder. The detailed experimental setup is described in 4.40.5 and 4.40.5.1. 
 
Conditioned medium of MCF-10A cells, which were not stimulated with TGF-β for 48 h, 
did not show bands for MMP-2 and MMP-9 in the gelatin zymogram (lane C, - TGF-β). In 
contrast, conditioned media of cells which were stimulated with TGF-β for 48 h showed bands 
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for both MMP-2 and MMP-9. This nicely fits with what Kim et al. found in 2004, as they reported 
an upregulation of MMP-2 and MMP-9 expression in TGF-β-stimulated MCF-10A cells251. Band 
intensities of MMP-2 and MMP-9 were almost equal in media of stimulated cells pretreated 
with Lipofectamine only as well as 300 nM 60bp DNA (lanes C and D, + TGF-β). The media of 
stimulated cells which were previously transfected with 300 nM wLX showed a slightly less 
intense MMP-9 band (lane wLX, + TGF-β). However, this effect is, if at all, very minor and 
would require further investigations. The MMP-2 level of stimulated cells that were treated with 
wLX was similar to controls which were also TGF-β-stimulated. 
Besides the analysis of MMP expression levels of TGF-β-stimulated, wLX-treated cells, 
MCF-10A cells were also investigated regarding their up- or downregulated expression of 
several typical EMT markers. As described in sections 4.40.5 and 4.40.5.2, MCF-10 cells were 
transfected with Lipofectamine only, 300 nM 60bp DNA or 300 nM wLX and further treated w/o 
or w/ TGF-β for 48 h. Prior to LSM imaging, cells were immunocytochemically stained for  
E-cadherin and snail. Corresponding results are shown in Figure 54. MCF-10A cells which 
were not stimulated with TGF-β grew in a mosaic-like, epithelial fashion, as seen Figure 54 
A - C. In comparison, cells which were TGF-β-stimulated (Figure 54 D - L) did not grow in this 
previously mentioned pattern and appeared as more spindle-like cells with fewer cell-cell 
contacts, indicating the transition from an epithelial to a mesenchymal phenotype. 
Furthermore, those cells appeared larger compared to unstimulated cells. The fluorescence 
signal of E-cadherin was higher in unstimulated cells, compared to TGF-β-treated cells. Snail 
staining in contrast, showed slightly increased intensities in TGF-β-stimulated MCF-10A cells. 
It was reported that transcription factors, such as Snail, are induced by TGF-β exposure and, 
once expressed, repress E-cadherin expression254. This would match the previously described 
observations, yet the differences in expression observed here were rather minor. Furthermore, 
there was no evidence for differences in E-cadherin and Snail expression of stimulated cells 
pretreated with either Lipofectamine only, 60bp DNA or wLX. 
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Figure 54│Immunocytochemistry staining for EMT markers after induction with TGF-β. MCF-10A 
cells were transfected with (J – L) 300 nM wLX, (G – I) 300 nM 60bp DNA as well as (A – F) 
Lipofectamine only for 6 h prior to stimulation w/ and w/o 10 ng/ml TGF-β for 48 h in serum-free medium. 
Cells were fixed, permeabilized and stained for EMT markers E-cadherin and Snail utilizing 
fluorochrome-labeled antibodies (4.40.5.2). LSM images were pseudo colored using image processing 
software ZEN blue and scale bars set to 100 µm. 
 
In recent years, the elastic properties of non-cancerous, non-motile breast epithelial 
MCF-10A, cancerous but non-metastatic MCF-7 as well as highly invasive, motile  
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MDA-MB-231 cells have been investigated by various whole-cell rheology methods.  
Guck et al. reported in 2005 that non-cancerous MCF-10 cells deformed less than cancerous 
MCF-7 cells255. Furthermore is was reported that the elastic moduli of non-metastatic MCF-7 
cells were significantly higher than those of metastatic MDA-MB-231 cells256. Since EMT was 
reported to be associated with cancer progression and metastasis189, unstimulated or TGF-β-
stimulated MCF-10A cells, which were pretreated with wLX as well as the corresponding 
controls, were investigated regarding their elastic moduli. On one hand, it was of great interest 
whether wLX have a direct influence on the cell mechanical properties by itself by stiffening 
the underlying actin network through crosslinking, while on the other hand, whether they 
somehow interfere with the biochemical process of EMT was also a valid line of inquiry. In this 
regard, cells were either pretreated with Lipofectamine only, 60bp DNA or wLX and were 
stimulated for 48 h with TGF-β. The whole-cell elasticity was measured by microfluidic 
squeezing, i.e. real-time deformability cytometry (RT-DC)234, as described in section 4.40.6. 
The corresponding averaged Young´s moduli are plotted in Figure 55, whereby the Young´s 
modulus E is defined as the ratio of tensile stress to tensile strain. 
 
 
Figure 55│Mean elastic moduli of MCF-10 treated w/ or w/o TGF-β post transfection with wLX 
and corresponding controls. MCF-10A cells stimulated for 48 h with or without 10 ng/ml TGF-β after 
transfection for 6 h with Lipofectamine only, 300 nM 60bp DNA or 300 nM wLX were analyzed via  
RT-DC234 at a flow rate of 0.04 µl/s. Mean Young´s moduli were calculated using ShapeOut software 
provided by Zellmechanik Dresden GmbH. A detailed experimental setup is to be found in 4.40.5 and 
4.40.6. 
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Looking at the direct influence of the synthetic crosslinker on unstimulated MCF-10A 
cells, wLX did not appear to stiffen the cells. While the bar (light blue) is in fact slightly 
increased, it is within the corresponding error bar. Cells treated with 60bp DNA showed an 
equal elasticity compared to the Lipofectamine control. Interestingly, cells which were 
stimulated for 48 h with TGF-β showed an increased whole-cell elasticity compared to 
uninduced cells. Whereas the elasticity of Lipofectamine only and 300 nM 60bp DNA 
transfected cells increased of 11.6 % and 10.4 %, respectively, wLX-treated cells in showed a 
smaller increase of only 3.5 %. This result nicely correlates with the earlier described findings 
(5.5.4) where FHL-124 cells that were treated with wLX prior to TGF-β stimulation showed a 
lack of stress fibers (Figure 52). This lack of the formation of cell-stabilizing criss-cross stress 
fibers in wLX-treated, TGF-β-stimulated FHL-124 cells might be an explanation for the 
significantly smaller increase in elasticity compared to control cells. Corresponding contour 
plots also revealed that cells which were treated with TGF-β were slightly bigger as curves 
were shifted to the right compared to unstimulated MCF-10A cells (supplemental Figure S 9), 
as also observed in previously discussed LSM images (Figure 54). 
5.6 Hypotheses of how wLX effect actin-correlated processes 
It still remains unclear exactly how wLX caused previously described effects such as a 
decreased migration and invasion as well as a decreased elasticity in EMT-induced cells. 
Some hypotheses of how wLX possibly acts within cells are given in the following.  
5.6.1 Interference with signaling pathways 
One possible assumption is that the interaction of wLX with actin filaments interferes with 
actin-correlated signal pathways, schematically illustrated in Figure 56. It has been 
demonstrated that, for example, MMP-9 expression is linked to the myocardin-related 
transcription factor (MRTF) - serum-response factor (SRF) signaling pathway, which itself is 
dependent on actin polymerization and depolymerization processes201 (2.9, Figure 15). High 
levels of G-actin retain the SRF cofactor protein MRTF in the cytosol. The incorporation of  
G-actin into the F-actin filament, i.e. actin polymerization, liberates MRTFs to enter the nucleus 
and interact with the transcription factor SRF205. This triggers the expression of a subset of 
SRF target genes, including MMP-9201. As wLX was shown to inhibit actin polymerization 
in vitro, it could possibly inhibit or reduce the nuclear translocation of MRTF, since more MRTF 
could probably remain bound to G-actin, and therefore decrease or suppress the expression 
of MMPs. A reduction of MMP levels could possibly explain the reduced migratory as well as 
invasive behavior of MDA-MB-231 cells. However, when MCF-10A cells were stimulated with 
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TGF-β in order to induce EMT, MMP-9 levels of cells which were previously transfected with 
wLX only showed a minor, if any reduction. Further insights could be gained through the 
analysis of several other MMPs on the mRNA or protein level, also decoupled from TGF-β 
stimulation.  
Moreover, a downregulation of E-cadherin caused by an upregulation of snail was not 
conclusively detectable. However, wLX-transfected FHL-124 cells showed a suppression of 
criss-cross stress fibers, which are a signature of EMT. In addition to that, wLX-transfected, 
TGF-β-stimulated MCF-10A cells were softer than control cells, which might be an indicator 
that wLX indeed interact with EMT-related processes.  
 
 
Figure 56│Possible influence of wLX in MRTF-mediated SRF signal transduction during EMT. 
The synthetic actin crosslinker wLX showed a concentration-dependent inhibition of actin polymerization 
in vitro, which could also impact the MRTF-dependent SRF signal transduction of cytoskeletal target 
genes (2.9). Moreover, wLX caused a decreased migration and invasion as well as a lack of stress fiber 
formation in lens epithelial cells, which indicates a possible impact of wLX on EMT. Whether wLX indeed 
interferes with EMT, for instance, in the expression level of MMP-9 or the up- and downregulation of 
mesenchymal markers, however still requires further investigation. 
 
More information could be achieved through investigations of other EMT markers such 
as vimentin, α-smooth muscle actin, N-cadherin including immunocytochemistry staining as 
well as western blot analysis of wLX treated cells. In order to attain information, which genes 
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are possibly influenced by wLX application, microarrays could be conducted as well. Beyond 
this, it could be the case that wLX do not affect MRTF-SRF pathways; instead, they could also 
impact other actin-dependent signal transduction pathways or impact cell behavior by a 
different mechanism. 
5.6.2 Mechanical influence of wLX on cells 
Another assumption could be that crosslinkers directly influence cell behavior through a 
primarily mechanical effect as they possibly stiffen cells through linkage of actin filaments. This 
hypothesis is supported by the stiffening of reconstituted actin networks discussed in section 
5.3. In 2008, furthermore, Jackson et al. reported that an α-actinin overexpression in human 
osteoblasts led to an increased whole-cell stiffness, as measured by AFM indentation257. 
Moreover, Ehrlicher et al. reported that α-actinin mutants, which had a three-fold higher affinity 
for actin due to a point mutation in the actin-binding domain, displayed slowed down 
intracellular dynamics as internalized micron-sized particles moved slower. Additionally, they 
found that these mutants generated higher contractile forces1 compared to wild type cells. 
However, an increased elasticity of MCF-10A cells treated with wLX could not be conclusively 
proven with RT-DC measurements in this work. Future experiments will aim to provide insights 
into whether wLX as well as sPX connect actin filaments by their crosslinking properties and 
therefore intrinsically stiffen the whole cell. The influence of synthetic crosslinkers on adhesion 
forces as well as contractile forces could also be investigated via AFM and traction force 
microscopy, respectively. 
5.6.3 Steric interference of actin dynamics caused by wLX 
One final hypothesis is that since wLX interfere with actin polymerization and 
depolymerization, they generally slow down actin dynamics. This could be one reason for the 
observed decreased migration and invasion of MDA-MB-231 cells or the lack of the formation 
of criss-cross stress fibers in wLX-treated TGF-β-stimulated FHL-124 cells. As already 
mentioned, wLX was seen to suppress actin polymerization in a concentration-dependent 
fashion in vitro. Since polymerization was inhibited, it was not possible to clearly state the 
influence of wLX on actin depolymerization. However, depolymerization was reported to be 
inhibited by natural crosslinkers such as fascin241. Thus it could be possible that synthetic 
crosslinkers interfere with both actin polymerization and depolymerization, which are two of 
the primary cellular processes that comprise the engine of cell motion and force generation. 
Assuming that wLX could decrease polymerization at the barbed ends and depolymerization 
at the pointed ends, the actin retrograde flow could be slowed down which in turn could have 
led to previously stated phenomena. Since MRFT-SRF signaling is related to actin 
Results and Discussion 
133 
 
polymerization and depolymerization as well, the effect of wLX on filaments could also interfere 
with this pathway due to generally slowed down actin dynamics, which was indeed shown by 
FRAP experiments. 
Further experiments could provide insights into how synthetic crosslinkers affect actin 
kinetics in vitro. These could be investigated by changing the actin binding peptide and/or the 
geometry of the DNA structure, e.g. increasing the number of binding sites for actin. Moreover, 
actin retrograde flow could be imaged and analyzed. 
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6 Conclusion and Outlook 
One general aim of this work was to establish an efficient method to covalently link 
peptides to DNA nanostructures. Therefore, different conjugation methods were tested in 
which the copper-free click chemistry approach (SPAAC) was the most powerful tool as it gave 
the highest yields of the final product.  
Within a smaller subproject, DNA nanostructures should serve as carrier platforms for 
functional biomolecules. In order to increase their cellular uptake, so-called cell-penetrating 
peptides were covalently conjugated to both structures. The utilized CPP sC18 is strongly 
cationic and enters cells via endocytotic pathways. It was shown that CPP-coupled DNA 
structures were internalized more efficiently than unconjugated controls. Additionally, it was 
demonstrated that CPP retain their functionality when they were bound to DNA structures, 
which was one of the main aims of this study. Both DNA tetrahedra and DNA trimers ended 
up in endosomes when they were conjugated to CPP as well as unconjugated, albeit to a 
lesser degree. However, to use them as a carrier platform for biomedical applications, it would 
be necessary to release them from endosomes following their initial uptake. In order to mediate 
the translocation into the cytosol, CPP that promote endosomal escape such as the chimeric 
version of sC18, named N-E5L-sC18, could be attached. In case an effective translocalization 
in the cytosol is warranted, these structures could be developed further and also functionalized 
with other biomolecules or therapeutic agents to serve as multifunctional carriers. 
The fact that biofunctional molecules, such as peptides, retain their functionality when 
they are covalently attached to DNA structures, was also shown for the second subproject, in 
which actin crosslinkers such as α-actinin or fascin were mimicked by purely synthetic actin 
crosslinkers fabricated from DNA and peptides. This was done due to the fact that naturally 
occurring actin crosslinkers, attributable to their empirical nature and complexity, do not allow 
systemic studies, in which different key parameters (e.g. affinity) can be varied in a decoupled 
fashion. By using synthetic crosslinkers, this natural limitation was resolved: whereas the basic 
geometry was kept constant, the affinity of the crosslinker was tuned independently by either 
attaching a weak (LifeAct®) or a strong (Phalloidin) actin-binding peptide on both sites of the 
20 nm DNA spacer, referred as to wLX and sPX, respectively. High yields of both wLX and 
sPX as well as fluorescently labeled or PTO-protected alternatives were achieved by utilizing 
a SPAAC approach.  
One of the major questions was also whether peptide-DNA conjugates could be applied 
to tune reconstituted biological systems. For this purpose, the impact of synthetic actin 
crosslinkers on reconstituted actin networks was investigated. Studies of actin polymerization 
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and depolymerization (via pyrene assay) revealed that actin polymerization was inhibited by 
wLX in a concentration-dependent manner. A reliable assumption as to whether 
depolymerization was also impacted by wLX could not be made, even though naturally 
occurring crosslinkers have previously been shown to inhibit depolymerization. Interestingly, 
both wLX and sPX displayed the same mechanical fingerprint as α-actinin and fascin within 
rheological measurements. Moreover, both synthetic crosslinkers induced different structural 
morphologies within actin networks dependent on the crosslinker concentration applied. 
Thereby, it is noteworthy that the threshold bundle concentration was reduced for actin/sPX 
networks compared to actin/wLX networks due to a higher affinity of sPX towards F-actin. 
Furthermore, it was shown that crosslinking can be switched. A switching mechanism based 
on severing the DNA linker segment by the enzyme EcoRV clearly reversed the stiffening of 
actin/sPX networks, and the system became softer. This was nicely illustrated on the 
macroscopic scale within the inclined cuvette, as actin/EcoRV-cleaved sPX networks flowed 
out of the cuvette way faster than networks enriched with the intact sPX. The ability to switch 
crosslinkers from an "on" to an "off" state represents a promising feature, which could be further 
developed in future experiments. Moreover, it would be of great interest to explore the impact 
of different DNA spacer lengths as well as number of binding domains on in vitro actin 
networks. Altogether, these experiments indicate how effectively reconstituted actin networks 
can be manipulated in their biomechanical properties by using synthetic actin crosslinkers. 
The last major aim of this dissertation was to investigate whether functionalized DNA-
based biomimetic structures can function on specific target systems inside of living cells. One 
aspect was to ensure that synthetic crosslinkers are released into the cytosol after transfection 
to interfere with the actin cytoskeleton. As Cy3-labeled wLX were able to stain filamentous 
actin structures within cells similar to conventional staining methods using LifeAct®-GFP 
conjugates, it can be assumed that synthetic crosslinkers act in the cytosol. This assumption 
can be further strengthened by the results of actin remodeling dynamics experiments, as it was 
shown that the intracellular actin dynamics was slowed down by wLX. However, since actin 
remodeling in cells is a combination of polymerization, depolymerization, diffusion and myosin-
driven translocation, a slowed down actin dynamics cannot be simply attributed to the inhibited 
polymerization that was shown for wLX in in vitro pyrene assays. Other factors, such as an 
increased crosslinking between actin structures would for instance inhibit diffusion and myosin 
translocation. Further fluorescence recovery after photobleaching (FRAP) experiments could 
gain insights in which of the named factors leads to a decrease in actin remodeling dynamics. 
Therefore, it would be of importance to compare the velocities of processes such as retrograde 
flow and myosin-based translocation/remodeling of actin filaments to those of fluorescence 
recovery. Moreover, in order to conclusively state that the slowed actin remodeling dynamics 
can be attributed to slowed polymerization/depolymerization, myosin II-inhibiting drugs like 
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blebbistatin could be used to determine whether the recovery dynamics are affected by the 
crosslinkers without the influence of the motor protein. 
The impact of synthetic crosslinkers on actin-driven cellular processes such as migration, 
invasion or proliferation were investigated as well. Within a first “proof of concept” experiment, 
both wLX and sPX-transfected HeLa cells were observed to migrate slower into the cell-free 
gap of a simple 2D wound-healing assay. However, it still needed to be investigated in more 
detail whether this resulted from a decreased proliferation and/or increased apoptosis rates. 
In order to be also capable of studying 3D migration and invasion, a highly invasive breast 
tumor cell line (MDA-MB-231) was utilized for the following experiments. Both proliferation and 
apoptosis were not affected by wLX. However, PTO-modified wLX induced apoptosis and 
were, even though they were more stable against endo- and exonucleases in previous 
experiments, therefore excluded from further cell culture experiments. Furthermore, the 3D 
migration and invasion of wLX-transfected MDA-MB-231 cells was slowed down. The gain of 
invasive properties is associated with the process of epithelial-mesenchymal-transition (EMT), 
which involves signaling pathways that rely on the status of actin polymerization and 
depolymerization. Together with a collaborating group in Canada, who specialize in studying 
EMT during fibrosis, the synthetic crosslinkers were tested on a lens epithelial cell model  
(FHL-124). It was found that a key signature of EMT mediated by transforming growth  
factor-β (TGF- β) was inhibited by both wLX and sPX, since criss-cross stress fibers were not 
observed. Subsequently, MCF-10A cells, which serve as a model cell line to study inducible 
EMT, were utilized to investigate the impact of synthetic crosslinkers in more detail, i.e. the 
level of MMP-2 and MMP-9, the expression levels of E-cadherin and snail as well as the 
elasticity of cells before and after stimulation with TGF-β. Both MMP-2 and MMP-9 levels were 
increased in TGF-β induced cells compared to unstimulated cells. However, no significant 
decrease of MMP-levels, which could explain a decreased 3D invasion, was observed. Similar 
results were seen with immunocytochemistry staining. No evidence for an impact of wLX on 
expression levels of E-cadherin and snail cells was seen, compared to other TGF-β-induced 
control samples. In terms of biomechanical properties, TGF- β-stimulated MCF-10A cells were 
stiffer than unstimulated cells. The synthetic crosslinker wLX did not cause a clear stiffening of 
unstimulated MCF-10A cells, however this requires further exploration. Interestingly, wLX 
caused less stiffening of TGF-β-stimulated MCF-10A cells compared to controls, which might 
be an indicator that wLX indeed interact with EMT-related processes. For instance, the lack of 
formation of criss-cross stress fibers, as seen for wLX-transfected FHL-124 cells, could be a 
hint for cells being softer. However, whether wLX-transfected, TGF-β-stimulated MCF-10A 
cells are also inhibited from forming extensive stress fibers still needs to be investigated. 
Thus, these results clearly indicate that peptide-conjugated DNA structures are capable 
of functioning on particular systems inside of living cells. However, it still remains unclear how 
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exactly synthetic crosslinkers interfere with cellular processes. Different hypotheses of how 
these synthetic constructs act in cells were shown. First, crosslinkers could interfere with 
signaling pathways, such as the MRTF-dependent SRF signaling pathway, which is 
responsible for the expression of mostly cytoskeletal genes. In order to gain more information 
about possible interaction partners as well as up- or downregulated genes or proteins, 
microarrays and typical biochemical assays such as western blotting could be conducted. 
Second, synthetic actin crosslinkers could cause a mechanical effect on cellular systems, as 
these could physically link two actin filaments together and thus stiffen the whole cell. 
Therefore, the influence of synthetic crosslinkers on adhesion and contraction forces could be 
explored via AFM and traction force microscopy, respectively. One third, last assumption could 
be that synthetic crosslinkers sterically interfere with actin dynamics in cells and therewith 
cause a decrease in migration and invasion of MDA-MB-231 cells or the lack of the formation 
of criss-cross stress fibers in wLX-treated, TGF-β-stimulated MCF-10A cells. Therefore, 
pyrene assays would need to be repeated and, as mentioned above, actin remodeling 
dynamics could be studied in more detail via FRAP. Further insights into how synthetic 
crosslinkers affect actin kinetics in vitro could be achieved by investigations of crosslinkers 
with an altered affinity towards F-actin as well as a change in geometry, e.g. an increased 
number of binding domains. This highlights a particular strength of this synthetic system, as 
such systematic changes would only involve choosing a different actin-binding peptide or 
altering the underlying DNA template. Ideally, all these studies should be conducted on one 
specific cell line to be finally able to combine all the different clues in one model. 
The work presented here nicely illustrates how DNA-based biomimetics can be used to 
study reconstituted and cellular systems. For instance, by changing one single parameter of a 
synthetically fabricated actin crosslinker, i.e. binding affinity, the bulk properties of 
reconstituted actin networks were drastically altered. Biological systems comprise proteins with 
many other geometries, sizes or strengths, which could be immediately studied in more detail 
by functionalized DNA nanostructures to determine their impact. Linking this to changes in the 
cellular function could possibly provide tools to develop a clean model system for assessing 
the impact of these properties on whole-cell function. This could provide insights into specific 
diseases linked to the natural counterparts. Moreover, DNA nanotechnology provides a 
playground of various possible functionalization, which allows one to even go beyond the limits 
of natural crosslinks. Completely new bio-inspired materials could be designed, for example 
by changing the number of binding domains (valency) or the addition of different signal-
responsive switching mechanisms. For instance, the development of an artificial DNA-based 
hydrogel which can be reversibly switched from stiff to soft by changing its mesh size could 
provide insights in the behavior of cells and would be an interesting tool for both researchers 
as well as bioengineers. Generally, this work shows the validity of this overall approach of 
Conclusion and Outlook 
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using programmable nanofabrication in order to engineer biocompatible, biomimetic constructs 
which could be used to help to unravel the complexity of life. 
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8 Supplemental information 
I Step-wise assembly of DNA tetrahedra 
 
 
Figure S 1│Step-wise assembly of DNA tetrahedra. Step-wise formation of DNA tetrahedra was 
monitored via 6 % (v/v) native polyacrylamide gel electrophoresis (PAGE) and visualized by SYBR® 
Gold Nucleic Acid Gel Strain staining. M, GeneRuler™ Low Range DNA Ladder; 1, TetS1; 
2, TetS1 + TetS2; 3, TetS1 + TetS2 + TetS3; 4, full DNA tetrahedron. Aggregations are indicated at the 
top of the gel. DNA sequences are to be found in Table 4. The assembly conditions are described in 
4.23.1.
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II Assembly of PTO-capped, CPP-functionalized DNA trimers 
 
 
Figure S 2│CPP-conjugation to PTO-capped DNA trimers. PTO-capped DNA trimers labeled with a 
Cy3 dye were covalently coupled to two CPP (azide - sC18) utilizing a copper free click chemistry 
approach (2.2.4). The conjugation procedure was observed via 6 % (v/v) native PAGE and visualized 
by SYBR® Gold Nucleic Acid Gel Strain staining. M, GeneRuler™ Low Range DNA Ladder; 
U, unmodified PTO-capped Cy3-labeled DNA trimer; F, PTO-capped Cy3-labeled DNA trimer carrying 
two CPP. These samples were applied to cells later on (Figure 33). 
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III EcoRV-HF® digestion of sPX 
 
 
Figure S 3│Cleavage of sPX by EcoRV-HF®. (A) Digestion of sPX through EcoRV-HF® was analyzed 
via 10 % (v/v) native PAGE and visualized by SYBR® Gold Nucleic Acid Gel Strain staining. 
M, GeneRulerTM Low Range DNA Ladder; U, sPX w/o EcoRV-HF® incubation; D, sPX incubated for 1 h 
at 37 °C with EcoRV-HF® according to manufacturers’ manual. (B) Band intensities were analyzed using 
ImageJ.
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IV Elasticity burst occurring with the natural occurring actin crosslinker fascin 
 
 
Figure S 4│Evolution of the elasticity during actin polymerization in presence of fascin over time. 
Actin polymerization in presence of fascin was investigated via dynamic shear rheology. The elastic 
modulus G´ of actin enriched with different concentrations of the natural occurring actin crosslinker 
fascin (R = 0.1, 0.01) was measured over time as explained in 4.32. 
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V Structural morphologies induced by different sPX concentrations 
 
 
Figure S 5│Structural phases of actin networks polymerized in presence of sPX. Actin was 
polymerized at 3 µM in presence of wLX at (A) R = 0.01, (B) R = 0.1 and (C) R = 1, respectively. Actin 
was mixed with TRITC-Phalloidin at a molar ratio of 3 : 1 for visualization with spinning disc confocal 
microscopy. The detailed experimental setup is explained in 4.34. 
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VI Cloning of pTagGFP-N 
 
 
Figure S 6│Cloning of pTag-LifeAct-GFP-N. (A) The linearization of pTagGFP-N through restriction 
digest with BamHI and EcoRI was analyzed by 1 % (w/v) agarose gel electrophoresis (4.15.1). 
M, GeneRulerTM 1 kb DNA Ladder; U, undigested pTagGFP-N; D, pTagGFP-N digested with BamHI 
and EcoRI. (B) Colony PCR of five selected clones. The resulting PCR product was expected to be 
325 bp. M, GeneRulerTM 1 kb DNA Ladder; 1 - 5, PCR fragment resulting from colony PCR of clones 
1 - 5. 
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VII DNA sequence of pTag-LifeAct-GFP-N 
 
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATA
ACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTG
GCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGG
CATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTAC
CATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCT
CCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAAC
TCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTGGTTTAGT
GAACCGTCAGATCCGCTAGCGCTACCGGACTCAGATCTCGAGCTCAAGCTTCGAATTCATGGGCGTGGCCG
ACCTGATCAAGAAGTTCGAGAGCATCAGCAAGGAGGAGGATCCACCGGTCGCCACCATGAGCGGGGGCGA
GGAGCTGTTCGCCGGCATCGTGCCCGTGCTGATCGAGCTGGACGGCGACGTGCACGGCCACAAGTTCAGC
GTGCGCGGCGAGGGCGAGGGCGACGCCGACTACGGCAAGCTGGAGATCAAGTTCATCTGCACCACCGGCA
AGCTGCCCGTGCCCTGGCCCACCCTGGTGACCACCCTCTGCTACGGCATCCAGTGCTTCGCCCGCTACCCC
GAGCACATGAAGATGAACGACTTCTTCAAGAGCGCCATGCCCGAGGGCTACATCCAGGAGCGCACCATCCT
CTTCCAGGACGACGGCAAGTACAAGACCCGCGGCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGC
ATCGAGCTGAAGGGCAAGGACTTCAAGGAGGACGGCAACATCCTGGGCCACAAGCTGGAGTACAGCTTCAA
CAGCCACAACGTGTACATCATGCCCGACAAGGCCAACAACGGCCTGGAGGTGAACTTCAAGACCCGCCACA
ACATCGAGGGCGGCGGCGTGCAGCTGGCCGACCACTACCAGACCAACGTGCCCCTGGGCGACGGCCCCG
TGCTGATCCCCATCAACCACTACCTGAGCACTCAGACCGCCATCAGCAAGGACCGCAACGAGGCCCGCGAC
CACATGGTGCTCCTGGAGTCCTTCAGCGCCTGCTGCCACACCCACGGCATGGACGAGCTGTACAGGTAAAG
CGGCCGCGACTCTAGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCAC
ACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGT
TACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCC
AAACTCATCAATGTATCTTAAGGCGTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTA
AATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATA
GGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGA
AAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGT
GGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCT
GCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCAGGTGGCACTTTTCGGGGA
AATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACC
CTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTCCTGAGGCGGAAAGAACCAGCTGTGGAATGTGTGT
CAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCA
GCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTC
AGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGC
CCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCGGCCTCTGAGCTATTCCAGAAGTA
GTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAGATCGATCAAGAGACAGGATGAGGATCGTTTCGCA
TGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGG
GCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTT
TGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAAGACGAGGCAGCGCGGCTATCGTGGCTGGCCA
CGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGG
CGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGC
AATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGC
GAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCG
CCAGCCGAACTGTTCGCCAGGCTCAAGGCGAGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCG
ATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTG
TGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCT
GACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGAC
GAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGAT
TTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATC
CTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCTAGGGGGAGGCTAACTGAAACACGGAAGGA
GACAATACCGGAAGGAACCCGCGCTATGACGGCAATAAAAAGACAGAATAAAACGCACGGTGTTGGGTCGT
TTGTTCATAAACGCGGGGTTCGGTCCCAGGGCTGGCACTCTGTCGATACCCCACCGAGACCCCATTGGGGC
CAATACGCCCGCGTTTCTTCCTTTTCCCCACCCCACCCCCCAAGTTCGGGTGAAGGCCCAGGGCTCGCAGC
CAACGTCGGGGCGGCAGGCCCTGCCATAGCCTCAGGTTACTCATATATACTTTAGATTGATTTAAAACTTCAT
TTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTC
GTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATC
TGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTT
TTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGC
CACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCC
AGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGG
CTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGC
GTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGT
CGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTC
GCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGC
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AACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTG
ATTCTGTGGATAACCGTATTACCGCCATGCAT 
 
Figure S 7│DNA sequence of pTag-LifeAct-GFP-N. DNA sequence encoding LifeAct® (purple) was 
inserted into MCS of pTag-GFP-N via EcoRI (yellow) and BamHI (turquoise) overhangs. Sequence 
encoding GFP is shown in grey. Colony-PCR was conducted in order to identify positive clones. 
Corresponding sequences, where forward and reverse colony PCR primers bound, are underlined. 
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VIII 3D migration and invasion of wLX-treated MDA-MB-231 cells after 36 h 
 
 
Figure S 8│3D migration and invasion of wLX-treated MDA-MB-231 cells after 36 h.  
(A) MDA-MB-231 cells were transfected with 300 nM wLX, 300 nM single LifeAct® 60bp DNA and 
Lipofectamine only for 4 h. Cells were detached and seeded into (A) uncoated culture wells to 
investigate 3D migration and (B) 1X  BME-coated culture wells to analyze 3D invasion. Cells were 
incubated for 36 h and migrated and invaded cells subsequently stained via Calcein AM fluorescent dye. 
Under consideration of a Calcein AM standard curve as well as the seeded cell count, the number of 
cells was calculated from measured fluorescence intensities. The detailed experimental setup is to be 
found in 4.40.4. The percentage of migrated and invaded cells that were treated with Lipofectamine only 
was set to 100 %. All other samples were normalized to this control, respectively. 
 
 
A B 
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IX Contour plots of RT-DC measurements for MCF-10A treated w/ or w/o TGF-β 
 
Figure S 9│Real-time deformability cytometry (RT-DC) of MCF-10A treated w/ or w/o TGF-β.  
MCF-10A cells stimulated for 48 h with or without 10 ng/ml TGF-β after transfection for 6 h with 
Lipofectamine only, 300 nM wLX or 300 nM 60bp DNA were analyzed via RT-DC234 at a flow-rate of 
0.12 µl/s. Contours of MCF-10A cells transfected with (A) Lipofectamine only, (B) 300 nM 60bp DNA 
and (C) 300 nM wLX are shown as dotted lines, i.e. cells treated w/ TGF-β in green and w/o TGF-β in 
magenta. The detailed experimental setup is to be found in 4.40.5 and 4.40.6. 
A 
B 
C 
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X Toxicity of LipofectamineTM 3000 
 
 
Figure S 10│Cytotoxic effect of LipofectamineTM 3000 in MCF-10A and MDA-MB-231 cells.  
MCF-10A as well as MDA-MB-231 cells were incubated for 2 h w/o and w/ different concentrations of 
LipofectamineTM 3000. The toxicity of Lipofectamine was determined via apoptosis assay, as described 
in 4.40.1, 24 h post treatment. Cells incubated with 7 % (v/v) DMSO served as positive control. The 
experimental setup is explained in 4.37.7.2.
B 
A 
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XI Internalization of DNA at different LipofectamineTM 3000 concentrations 
 
 
Figure S 11│Internalization of DNA at different LipofectamineTM 3000 concentrations.  
MDA-MB-231 cells were incubated for 2 h with Cy3-labeled 60nt DNA complexed w/o and w/ different 
concentrations of LipofectamineTM 3000. The mean fluorescence intensity of cell populations was 
determined via flow cytometry (iQue Screener). The experimental setup is described in 4.37.7.1. 
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XII DNA internalization efficacies 
 
 
Figure S 12│Internalization efficacies of Cy3-labeled 60bp DNA in different cell lines. (A) HeLa, 
(B) MDA-MB-231 and (C) MCF-10A cells were incubated for 2 h to 4 h with 300 nM and 600 nM Cy3-
labeled 60nt DNA complexed with 0.75 % (v/v) LipofectamineTM 3000. Cells treated with only 
Lipofectamine served as control. Cells were analyzed via flow cytometry and internalization efficacies 
were calculated by the relative number of positively classified cells compared to negative control 
populations. Internalization efficacies are listed in Table S 1. 
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XIII DNA internalization efficacies (statistical analysis) 
 
Table S 1│Internalization efficacies of Cy3-labeled 60bp DNA in different cell lines 
Concentration of 
Cy3-60bp DNA 
Transfection 
time 
Cell lines 
HeLa MDA-MB-231 MCF-10A 
300 nM 2 h 59.32 %   
300 nM 4 h  99.46 % 95.21 % 
600 nM 2 h 59.54 % 96.68 % 87.34 % 
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